Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.


Funktionen

  • Direktor/in, Innere Klinik (Tumorforschung)

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Zaun, Gregor; Borchert, Sabrina; Metzenmacher, Martin; Lueong, Smiths; Wiesweg, Marcel; Zaun, Yasmin; Pogorzelski, Michael; Behrens, Franziska; Schildhaus, Hans-Ulrich; Virchow, Isabel; Kasper, Stefan; Schuler, Martin; Theurer, Sarah; Liffers, Sven
    Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies
    In: European Journal of Cancer (EJC) Jg. 200 (2024) 113540
  • Nurtsch, Angelina; Teufel, Martin; Jahre, Lisa Maria; Esber, André; Rausch, Raya; Tewes, Mitra; Schöbel, Christoph; Palm, Stefan; Schuler, Martin; Schadendorf, Dirk; Skoda, Eva-Maria; Bäuerle, Alexander
    Drivers and barriers of patients’ acceptance of video consultation in cancer care
    In: Digital Health Jg. 10 (2024)
  • Fasching, Peter A.; Decker, Thomas; Hartkopf, Andreas; Nusch, Arnd; Heinrich, Bernhard J.; Kurbacher, Christian; Fuchs, Roswitha; Tesch, Hans; Krabisch, Petra; Huober, Jens; Kümmel, Sherko; Brucker, Sara; Janni, Wolfgang; Schneeweiss, Andreas; Schuler, Martin; Fehm, Tanja; Lüftner, Diana; Quiering, Claudia; Voges, Claudia; Kreuzeder, Julia; Reinisch, Mattea
    Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole : Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer
    In: European Journal of Cancer (EJC) Jg. 198 (2024) 113480
  • Kästner, Anika; Kron, Anna; van den Berg, Neeltje; Moon, Kilson; Scheffler, Matthias; Schillinger, Gerhard; Pelusi, Natalie; Hartmann, Nils; Rieke, Damian Tobias; Stephan-Falkenau, Susann; Schuler, Martin; Wermke, Martin; Weichert, Wilko; Klauschen, Frederick; Haller, Florian; Hummel, Horst-Dieter; Sebastian, Martin; Gattenlöhner, Stefan; Bokemeyer, Carsten; Esposito, Irene; Jakobs, Florian; von Kalle, Christof; Büttner, Reinhard; Wolf, Jürgen; Hoffmann, Wolfgang
    Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany : A historical cohort analysis
    In: The Lancet Regional Health - Europe Jg. 36 (2024) 100788
  • Hamacher, Rainer; Pabst, Kim M.; Cheung, Phyllis F.; Heilig, Christoph E.; Hüllein, Jennifer; Liffers, Sven-Thorsten; Borchert, Sabrina; Costa, Pedro Fragoso; Schaarschmidt, Benedikt; Kessler, Lukas; Miera, Monika A.; Droste, Margret; Akbulut, Merve; Falkenhorst, Johanna; Zarrad, Fadi; Kostbade, Karina; Mavroeidi, Ilektra A.; Glimm, Hanno; Umutlu, Lale; Schuler, Martin; Hübschmann, Daniel; Bauer, Sebastian; Fröhling, Stefan; Herrmann, Ken; Siveke, Jens; Schildhaus, Hans-Ulrich; Fendler, Wolfgang
    Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 2, S. 252 - 257
  • Doerr, Fabian; Leschczyk, Tobias; Grapatsas, Konstantinos; Menghesha, Hruy; Baldes, Natalie; Schlachtenberger, Georg; Heldwein, Matthias B.; Michel, Maximilian; Quaas, Alexander; Hagmeyer, Lars; Höpker, Katja; Wahlers, Thorsten; Darwiche, Kaid; Taube, Christian; Schuler, Martin; Hekmat, Khosro; Bölükbas, Servet
    Postoperative Tobacco Cessation Improves Quality of Life, Lung Function and Long-Term Survival in Non-Small-Cell Lung Cancer Patients
    In: Cancers Jg. 16 (2024) Nr. 2, 465
  • Subbiah, Vivek; Hu, Mimi I.; Mansfield, Aaron S.; Taylor, Matthew H.; Schuler, Martin; Zhu, Viola W.; Hadoux, Julien; Curigliano, Giuseppe; Wirth, Lori; Gainor, Justin F.; Alonso, Guzman; Adkins, Douglas; Godbert, Yann; Ahn, Myung-Ju; Cassier, Philippe A.; Cho, Byoung Chul; Lin, Chia-Chi; Zalutskaya, Alena; Barata, Teresa; Trask, Peter; Scalori, Astrid; Bordogna, Walter; Heinzmann, Sebastian; Brose, Marcia S.
    Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer : Updated Efficacy and Safety Data from the ARROW Study
    In: Thyroid Jg. 34 (2024) Nr. 1, S. 26 - 40
  • Keyl, J.; Bucher, A.; Jungmann, F.; Hosch, R.; Ziller, A.; Armbruster, R.; Malkomes, P.; Reissig, T.M.; Koitka, S.; Tzianopoulos, I.; Keyl, P.; Kostbade, K.; Albers, David; Markus, P.; Treckmann, Jürgen-Walter; Naßenstein, Kai; Haubold, Johannes; Makowski, M.; Forsting, Michael; Baba, Hideo Andreas; Kasper, Stefan; Siveke, Jens T.; Nensa, Felix; Schuler, Martin; Kaissis, G.; Kleesiek, Jens; Braren, R.
    Prognostic value of deep learning-derived body composition in advanced pancreatic cancer : A retrospective multicenter study
    In: ESMO Open Jg. 9 (2024) Nr. 1, 102219
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus
    68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients : A Single-Center Retrospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 10, S. 1540 - 1549
  • Virchow, Isabel; Treckmann, Jürgen-Walter; Prasnikar, Nicole; Linden, Gabriele; Markus, Peter; Schumacher, Brigitte; Albers, David; Herold, Thomas; Ting, Saskia; Schmidt, Hartmut; Radunz, Sonja; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. 3, S. 89 - 99
  • Maßmann, M.; Treckmann, Jürgen Walter; Markus, P.; Schumacher, B.; Albers, D.; Ting, Saskia; Mende, B.; Roehrle, J.; Virchow, I.; Rosery, V.; Laue, K.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Schmid, Kurt Werner; Baba, Hideo Andreas; Siveke, Jens; Paul, A.; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel; Kasper, Stefan
    A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 5085 - 5094
  • Schmidt, Kira; Krawutschke, Marvin; Kowalski, Axel; Pasche, Saskia; Bialek, Anna; Schweig, Theresa; Weismüller, Benjamin; Tewes, Mitra; Schuler, Martin; Hamacher, Rainer; Müller, Bernhard W.; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin; Fink, Madeleine
    Cancer Patients’ Age-Related Benefits from Mobile Neurofeedback-Therapy in Quality of Life and Self-efficacy : A Clinical Waitlist Control Study
    In: Applied Psychophysiology Biofeedback Jg. 48 (2023) Nr. 2, S. 217 - 227
  • Roehrle, Julius; Kasper, Stefan; Treckmann, Jürgen-Walter; Markus, Peter; Schumacher, Brigitte; Albers, David; Wendling, Johanna; Ting, Saskia; Mende, Bastian; Maßmann, Marlene; Markus, Maximilian; Virchow, Isabel; Rosery, Vivian; Laue, Katharina; Zaun, Gregor; Kostbade, Karina; Pogorzelski, Michael; Reissig, Timm M.; Liffers, Sven-Thorsten; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Schuler, Martin; Siveke, Jens; Wiesweg, Marcel
    Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. 4, S. 140 - 150
  • Keyl, Julius; Hosch, René; Berger, Aaron; Ester, Oliver; Greiner, Tobias; Bogner, Simon; Treckmann, Jürgen; Ting, Saskia; Schumacher, Brigitte; Albers, David; Markus, Peter; Wiesweg, Marcel; Forsting, Michael; Nensa, Felix; Schuler, Martin; Kasper, Stefan; Kleesiek, Jens
    Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer
    In: Journal of Cachexia, Sarcopenia and Muscle Jg. 14 (2023) Nr. 1, S. 545 - 552
  • Sikosek, Tobias; Horos, Rastislav; Trudzinski, Franziska; Jehn, Julia; Frank, Maurice; Rajakumar, Timothy; Klotz, Laura V.; Mercaldo, Nathaniel; Kahraman, Mustafa; Heuvelman, Marco; Taha, Yasser; Gerwing, Jennifer; Skottke, Jasmin; Daniel-Moreno, Alberto; Sanchez-Delgado, Marta; Bender, Sophie; Rudolf, Christina; Hinkfoth, Franziska; Tikk, Kaja; Schenz, Judith; Weigand, Markus A.; Feindt, Peter; Schumann, Christian; Christopoulos, Petros; Winter, Hauke; Kreuter, Michael; Schneider, Marc A.; Muley, Thomas; Walterspacher, Stephan; Schuler, Martin; Darwiche, Kaid; Taube, Christian; Hegedus, Balazs; Rabe, Klaus F.; Rieger-Christ, Kimberly; Jacobsen, Francine L.; Aigner, Clemens; Reck, Martin; Bankier, Alexander A.; Sharma, Amita; Steinkraus, Bruno R.
    Early Detection of Lung Cancer Using Small RNAs
    In: Journal of Thoracic Oncology Jg. 18 (2023) Nr. 11, S. 1504 - 1523
  • Warnecke, Eva; Salvador Comino, Maria Rosa; Kocol, Dilara; Hosters, Bernadette; Wiesweg, Marcel; Bauer, Sebastian; Welt, Anja; Heinzelmann, Anna; Müller, Sandy; Schuler, Martin; Teufel, Martin; Tewes, Mitra
    Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological Inpatients
    In: Cancers Jg. 15 (2023) Nr. 11, 3029
  • Pant, Shubham; Schuler, Martin; Iyer, Gopa; Witt, Olaf; Doi, Toshihiko; Qin, Shukui; Tabernero, Josep; Reardon, David A.; Massard, Christophe; Minchom, Anna; Lugowska, Iwona; Carranza, Omar; Arnold, Dirk; Gutierrez, Martin; Winter, Helen; Stuyckens, Kim; Crow, Lauren; Najmi, Saltanat; Hammond, Constance; Thomas, Shibu; Santiago-Walker, Ademi; Triantos, Spyros; Sweiti, Hussein; Loriot, Yohann; Greco, Martin Alberto; Coward, Jim; Joshua, Anthony; Karapetis, Christos; Hart, Christopher; Zhang, Alison; Prenen, Hans; Goeminne, Jean-Charles; Machiels, Jean-Pascal; Rottey, Sylvie; Corassa, Marcelo; Molin, Graziela Zibetti Dal; Tiscoski, Katsuki; Jardim, Denis Leonardo Fontes; Mak, Milena; Fu, Wei; Yao, Herui; Huang, Jing; Jiang, Haiping; Chen, Baoshi; Yan, Dong; Yang, Yu; Le Tourneau, Christophe; Penel, Nicolas; Salas, Sébastien; Blay, Jean-Yves; Brachet, Pierre-Emmanuel; Durando, Xavier; Emambux, Sheik; Ravaud, Alain; Folprecht, Gunnar; Ahrens, Marit; Golf, Alexander; Haag, Georg Martin; Lordick, Florian; Desuki, Alexander; Cazzaniga, Marina; Ciardiello, Fortunato; Milella, Michele; Koyama, Takafumi; Hirooka, Yoshiki; Okamoto, Wataru; Aogi, Kenjiro; Kuboki, Yasutoshi; Lee, Jungyun; Kim, Sung-Bae; Ahn, Myung-Ju; Chang, Jong Hee; Kim, Yong-Man; Nam, Do-Hyun; Park, Jae-Sung; Paz-Ares, Luis; Moreno, Victor; Cervantes, Andres; Calvo, Mariona; Falcon, Alejandro; Gonzalez, Antonio; Martinez Bueno, Alejandro; García-Corbacho, Javier; Longo, Federico; Yen, Chia-Jui; Chen, Jen-Shi; Hou, Ming-Feng; Chao, Yee; Rau, Kun-Ming; Chiu, Tai-Jan; Feng, Yin-Hsun; Hsu, Chih-Hung; Huang, Wen-Tsung; Lai, Kuan-Ming; Yeh, Su-peng; Palmer, Daniel; Welsh, Liam; Plummer, Ruth; Iyer, Gopakumar; Bilen, Mehmet; Arrowsmith, Edward; Spigel, David Robert; Zandberg, Dan Paul; Doroshow, Deborah; Lu-Emerson, Christine; Moezi, Mehdi; Paulson, Scott; Ward, Patrick; Chaves, Jorge; Grigg, Claud; Hussein, Atif; Manda, Sudhir; Monticelli, Michael; Qamar, Rubina; Richey, Stephen L; Tamura, David; Wilks, Sharon
    Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR) : An international, single-arm, phase 2 study
    In: The Lancet Oncology Jg. 24 (2023) Nr. 8, S. 925 - 935
  • Kraskowski, Oliver; Stratmann, Jan A.; Wiesweg, Marcel; Eberhardt, Wilfried; Metzenmacher, Martin; Schmid, Kurt Werner; Herold, Thomas; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Laue, Katharina; Zaun, Gregor; Kasper, Stefan; Hense, Jörg; Sebastian, Martin; Schuler, Martin; Pogorzelski, Michael
    Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 11, S. 9243 - 9252
  • Kansy, Benjamin A.; Wehrs, Tim P.; Bruderek, Kirsten; Si, Yu; Ludwig, Sonja; Droege, Freya; Hasskamp, Pia; Henkel, Uta; Dominas, Nina; Hoffmann, Thomas K.; Horn, Peter A.; Schuler, Martin; Gauler, Thomas C.; Lindemann, Monika; Lang, Stephan; Bankfalvi, Agnes; Brandau, Sven
    HPV-associated head and neck cancer is characterized by distinct profiles of CD8⁺ T cells and myeloid-derived suppressor cells
    In: Cancer Immunology, Immunotherapy Jg. 72 (2023) S. 4367 - 4383
  • Rosery, Vivian; Mika, Stephan; Schmid, Kurt Werner; Reis, Henning; Stuschke, Martin; Treckmann, Jürgen; Markus, Peter; Schumacher, Brigitte; Albers, David; Mende, Bastian; Lahner, Harald; Wiesweg, Marcel; Schuler, Martin; Siveke, Jens; Kasper, Stefan
    Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 4315 - 4325
  • Zurloh, M.; Goetz, M.; Herold, T.; Treckmann, Jürgen-Walter; Markus, P.; Schumacher, B.; Albers, D.; Rink, A.; Rosery, V.; Zaun, G.; Kostbade, K.; Pogorzelski, M.; Ting, S.; Schmidt, H.; Stiens, R.; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Virchow, I.
    Impact of encorafenib on survival of patients with BRAFV⁶⁰⁰E-mutant metastatic colorectal cancer in a real-world setting
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 14, S. 12903 - 12912
  • Stockhammer, Paul; Baumeister, Hannah; Ploenes, Till; Bonella, Francesco; Theegarten, Dirk; Dome, Balazs; Pirker, Christine; Berger, Walter; Hegedüs, Luca; Baranyi, Marcell; Schuler, Martin; Deshayes, Sophie; Bölükbas, Servet; Aigner, Clemens; Blanquart, Christophe; Hegedüs, Balazs
    Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma
    In: Lung Cancer Jg. 185 (2023) 107360
  • Dy, Grace K.; Govindan, Ramaswamy; Velcheti, Vamsidhar; Falchook, Gerald S.; Italiano, Antoine; Wolf, Jürgen; Sacher, Adrian G.; Takahashi, Toshiaki; Ramalingam, Suresh S.; Dooms, Christophe; Kim, Dong-Wan; Addeo, Alfredo; Desai, Jayesh; Schuler, Martin; Tomasini, Pascale; Hong, David S.; Lito, Piro; Tran, Qui; Jones, Simon; Anderson, Abraham; Hindoyan, Antreas; Snyder, Wendy; Skoulidis, Ferdinandos; Li, Bob T.
    Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Small-Cell Lung Cancer : 2-Year Analysis of CodeBreaK 100
    In: Journal of Clinical Oncology (JCO) Jg. 41 (2023) Nr. 18, S. 3311 - 3317
  • Dy, Grace K.; Govindan, Ramaswamy; Velcheti, Vamsidhar; Falchook, Gerald S.; Italiano, Antoine; Wolf, Jürgen; Sacher, Adrian G.; Takahashi, Toshiaki; Ramalingam, Suresh S.; Dooms, Christophe; Kim, Dong-Wan; Addeo, Alfredo; Desai, Jayesh; Schuler, Martin; Tomasini, Pascale; Hong, David S.; Lito, Piro; Tran, Qui; Jones, Simon; Anderson, Abraham; Hindoyan, Antreas; Snyder, Wendy; Skoulidis, Ferdinandos; Li, Bob T.
    Long-term benefit of sotorasib in patients with KRAS G12C–mutated non–small-cell lung cancer : Plain language summary
    In: Future Oncology (2023) in press
  • Kersting, David; Mavroeidi, Ilektra-Antonia; Settelmeier, Stephan; Seifert, Robert; Schuler, Martin; Herrmann, Ken; Rassaf, Tienush; Rischpler, Christoph
    Molecular Imaging Biomarkers in Cardiooncology : A View on Established Technologies and Future Perspectives
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 2, S. 29S - 38S
  • Fink, Madeleine; Pasche, Saskia; Schmidt, Kira; Tewes, Mitra; Schuler, Martin; Mülley, Bernhard W.; Schadendorf, Dirk; Scherbaum, Norbert; Kowalski, Axel; Skoda, Eva-Maria; Teufel, Martin
    Neurofeedback Treatment Affects Affective Symptoms, But Not Perceived Cognitive Impairment in Cancer Patients : Results of an Explorative Randomized Controlled Trial
    In: Integrative Cancer Therapies Jg. 22 (2023) in press
  • Grapatsas, Konstantinos; Dörr, Fabian; Menghesha, Hruy; Schuler, Martin; Grünwald, Viktor; Bauer, Sebastian; Schmidt, Hartmut H. -J.; Lang, Stephan; Kimmig, Rainer; Kasper, Stefan; Baldes, Natalie; Bölükbas, Servet
    New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung Metastases
    In: Cancers Jg. 15 (2023) Nr. 17, 4355
  • Schuler, Martin; Bölükbas, Servet; Darwiche, Kaid; Theegarten, Dirk; Herrmann, Ken; Stuschke, Martin
    Personalized Treatment for Patients With Lung Cancer
    In: Deutsches Ärzteblatt international Jg. 120 (2023) Nr. 17, S. 300 - 310
  • Sequist, Lecia V; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Mok, Tony; Geater, Sarayut Lucien; Orlov, Sergey; Tsai, Chun-Ming; Boyer, Michael; Su, Wu-Chou; Bennouna, Jaafar; Kato, Terufumi; Gorbunova, Vera; Lee, Ki Hyeong; Shah, Riyaz; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Schuler, Martin
    Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
    In: Journal of Clinical Oncology (JCO) Jg. 41 (2023) Nr. 16, S. 2869 - 2876
  • Grapatsas, Konstantinos; Menghesha, Hruy; Dörr, Fabian; Baldes, Natalie; Schuler, Martin; Stuschke, Martin; Darwiche, Kaid; Taube, Christian; Bölükbas, Servet
    Pneumonectomy for Primary Lung Tumors and Pulmonary Metastases : A Comprehensive Study of Postoperative Morbidity, Early Mortality, and Preoperative Clinical Prognostic Factors
    In: Current Oncology Jg. 30 (2023) Nr. 11, S. 9458 - 9474
  • Okumus, Özlem; Mardanzai, Khaled; Plönes, Till; Theegarten, Dirk; Darwiche, Kaid; Schuler, Martin; Nensa, Felix; Hautzel, Hubertus; Hermann, Ken; Stuschke, Martin; Hegedus, Balazs; Aigner, Clemens
    Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancer
    In: Lung Cancer Jg. 176 (2023) S. 82 - 88
  • Maier, Daniel; Vehreschild, Jörg Janne; Uhl, Barbara; Meyer, Sandra; Berger-Thürmel, Karin; Boerries, Melanie; Braren, Rickmer; Grünwald, Viktor; Hadaschik, Boris; Palm, Stefan; Singer, Susanne; Stuschke, Martin; Juárez, David; Delpy, Pierre; Lambarki, Mohamed; Hummel, Michael; Engels, Cäcilia; Andreas, Stefanie; Gökbuget, Nicola; Ihrig, Kristina; Burock, Susen; Keune, Dietmar; Eggert, Angelika; Keilholz, Ulrich; Schulz, Hagen; Büttner, Daniel; Löck, Steffen; Krause, Mechthild; Esins, Mirko; Ressing, Frank; Schuler, Martin; Brandts, Christian; Brucker, Daniel P.; Husmann, Gabriele; Oellerich, Thomas; Metzger, Patrick; Voigt, Frederik; Illert, Anna L.; Theobald, Matthias; Kindler, Thomas; Sudhof, Ursula; Reckmann, Achim; Schwinghammer, Felix; Nasseh, Daniel; Weichert, Wilko; von Bergwelt-Baildon, Michael; Bitzer, Michael; Malek, Nisar; Öner, Öznur; Schulze-Osthoff, Klaus; Bartels, Stefan; Haier, Jörg; Ammann, Raimund; Schmidt, Anja Franziska; Guenther, Bernd; Janning, Melanie; Kasper, Bernd; Loges, Sonja; Stilgenbauer, Stephan; Kuhn, Peter; Tausch, Eugen; Runow, Silvana; Kerscher, Alexander; Neumann, Michael; Breu, Martin; Lablans, Martin; Serve, Hubert
    Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform
    In: European Journal of Epidemiology Jg. 38 (2023) Nr. 5, S. 573 - 586
  • Zaun, Gregor; Weber, Manuel; Metzenmacher, Martin; Wiesweg, Marcel; Hilser, Thomas; Zaun, Yasmin; Liffers, Sven; Pogorzelski, Michael; Virchow, Isabel; Eberhardt, Wilfried; Theurer, Sarah; Sabbah, Tanja Abu; Reissig, Timm M.; Stuschke, Martin; Kürten, Cornelius; Hussain, Timon; Lang, Stephan; Kasper, Stefan; Fendler, Wolfgang; Herrmann, Ken; Schuler, Martin
    SUVmₐₓ Above 20 in ¹⁸F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 8, S. 1191 - 1194
  • Reissig, T.M.; Tzianopoulos, I.; Liffers, S.-T.; Rosery, V.K.; Guyot, M.; Ting, S.; Wiesweg, Marcel; Kasper, S.; Meister, P.; Herold, T.; Schmidt, H.H.; Schumacher, B.; Albers, David; Markus, P.; Treckmann, J.; Schuler, Martin; Schildhaus, Hans-Ulrich; Siveke, Jens
    Smaller panel, similar results : Genomic profiling and molecularly informed therapy in pancreatic cancer
    In: ESMO Open Jg. 8 (2023) Nr. 3, 101539
  • Strickler, John H.; Satake, Hironaga; George, Thomas J.; Yaeger, Rona; Hollebecque, Antoine; Garrido-Laguna, Ignacio; Schuler, Martin; Burns, Timothy F.; Coveler, Andrew L.; Falchook, Gerald S.; Vincent, Mark; Sunakawa, Yu; Dahan, Laetitia; Bajor, David; Rha, Sun-Young; Lemech, Charlotte; Juric, Dejan; Rehn, Marko; Ngarmchamnanrith, Gataree; Jafarinasabian, Pegah; Tran, Qui; Hong, David S.
    Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer
    In: The New England Journal of Medicine Jg. 388 (2023) Nr. 1, S. 33 - 43
  • de Langen, Adrianus Johannes; Johnson, Melissa L; Mazieres, Julien; Dingemans, Anne-Marie C; Mountzios, Giannis; Pless, Miklos; Wolf, Jürgen; Schuler, Martin; Lena, Hervé; Skoulidis, Ferdinandos; Yoneshima, Yasuto; Kim, Sang-We; Linardou, Helena; Novello, Silvia; van der Wekken, Anthonie J; Chen, Yuanbin; Peters, Solange; Felip, Enriqueta; Solomon, Benjamin J; Ramalingam, Suresh S.; Dooms, Christophe; Lindsay, Colin R; Ferreira, Carlos Gil; Blais, Normand; Obiozor, Cynthia C; Wang, Yang; Mehta, Bhakti; Varrieur, Tracy; Ngarmchamnanrith, Gataree; Stollenwerk, Björn; Waterhouse, David; Paz-Ares, Luis
    Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG¹²C mutation : a randomised, open-label, phase 3 trial
    In: Lancet Jg. 401 (2023) Nr. 10378, S. 733 - 746
  • Hegedüs, Luca; Okumus, Özlem; Mairinger, Fabian; Ploenes, Till; Reuter, Sebastian; Schuler, Martin; Welt, Anja; Vega-Rubin-de-Celis, Silvia; Theegarten, Dirk; Bankfalvi, Agnes; Aigner, Clemens; Hegedüs, Balazs
    TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy
    In: Lung Cancer Jg. 178 (2023) S. 237 - 246
  • Martens, Uwe M.; Schröder, Jan; Bengsch, Fee; Sellmann, Ludger; Busies, Sabine; Frank-Gleich, Stefanie; Zaiss, Matthias; Decker, Thomas; Schneeweiss, Andreas; Schuler, Martin; Grebhardt, Sina; Zacharias, Stefan; Marschner, Norbert; Kasenda, Benjamin; Potthoff, Karin; Vannier, Corinne
    The INFINITY study protocol : A retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice
    In: BMC Cancer Jg. 23 (2023) Nr. 1, 543
  • Biersching, T.; Schweda, A.; Oechsle, K.; Nauck, F.; Schuler, U.; Hense, Jörg; Weber, M.; Junghanss, C.; Kramer, T.; Ostgathe, C.; Thuss-Patience, P.; Van Oorschot, B.; Teufel, Martin; Schuler, Martin; Bausewein, C.; Tewes, Mitra; Gahr, S.; Berendt, J.; Benze, G.; Rosenbruch, J.; Neukirchen, M.; Schwarz, J.; Reinholz, U.; Roch, C.
    The OUTREACH study: Oncologists of German university hospitals in rotation on a palliative care unit : Evaluation of attitude and competence in palliative care and hospice
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 7, S. 2929 - 2936
  • Kessler, Lukas; Ferdinandus, Justin; Hirmas, Nader; Bauer, Sebastian; Dirksen, Uta; Zarrad, Fadi; Nader, Michael; Chodyla, Michal; Milosevic, Aleksandar; Umutlu, Lale; Schuler, Martin; Podleska, Lars; Schildhaus, Hans-Ulrich; Fendler, Wolfgang; Hamacher, Rainer; Chodyla, Michal-Kamil
    68Ga-FAPI as a Diagnostic Tool in Sarcoma : Data from the 68Ga-FAPI PET Prospective Observational Trial
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 1, S. 89 - 95
  • Chan, Stephen L.; Schuler, Martin; Kang, Yoon-Koo; Yen, Chia-Jui; Edeline, Julien; Choo, Su Pin; Lin, Chia-Chi; Okusaka, Takuji; Weiss, Karl-Heinz; Macarulla, Teresa; Cattan, Stéphane; Blanc, Jean-Frederic; Lee, Kyung-Hun; Maur, Michela; Pant, Shubham; Kudo, Masatoshi; Assenat, Eric; Zhu, Andrew X.; Yau, Thomas; Lim, Ho Yeong; Bruix, Jordi; Geier, Andreas; Guillén-Ponce, Carmen; Fasolo, Angelica; Finn, Richard S.; Fan, Jia; Vogel, Arndt; Qin, Shukui; Riester, Markus; Katsanou, Vasiliki; Chaudhari, Monica; Kakizume, Tomoyuki; Gu, Yi; Porta, Diana Graus; Myers, Andrea; Delord, Jean-Pierre
    A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
    In: Journal of Experimental & Clinical Cancer Research Jg. 41 (2022) Nr. 1, 189
  • Yang, James Chih-Hsin; Schuler, Martin; Popat, Sanjay; Miura, Satoru; Park, Keunchil; Passaro, Antonio; De Marinis, Filippo; Solca, Flavio; Märten, Angela; Kim, Edward S.
    Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations : An Updated Database of 1023 Cases Brief Report
    In: Frontiers in Oncology Jg. 12 (2022) 834704
  • Metzenmacher, Martin; Hegedüs, Balazs; Forster, Jan; Schramm, Alexander; Horn, Peter; Klein, Christoph A.; Bielefeld, Nicola; Ploenes, Till; Aigner, Clemens; Theegarten, Dirk; Schildhaus, Hans-Ulrich; Siveke, Jens; Schuler, Martin; Lueong, Smiths S.
    Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer
    In: Translational Oncology Jg. 15 (2022) Nr. 1, 101279
  • Wessolly, Michael; Stephan-Falkenau, Susann; Streubel, Anna; Wiesweg, Marcel; Borchert, Sabrina; Mairinger, Elena; Kollmeier, Jens; Reis, Henning; Bauer, Torsten; Schmid, Kurt Werner; Mairinger, Thomas; Schuler, Martin; Mairinger, Fabian D.
    Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy
    In: BMC Cancer Jg. 22 (2022) Nr. 1, 46
  • Guberina, Maja; Guberina, Nika; Pöttgen, Christoph; Gauler, Thomas; Richlitzki, Cedric; Metzenmacher, Martin; Wiesweg, Marcel; Plönes, Till; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, Hubertus; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin; Eberhardt, Wilfried
    Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factors
    In: Immunotherapy Jg. 14 (2022) Nr. 12, S. 927 - 944
  • Ferdinandus, Justin; Costa, Pedro Fragoso; Kessler, Lukas; Weber, Manuel; Hirmas, Nader; Kostbade, Karina; Bauer, Sebastian; Schuler, Martin; Ahrens, Marit; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Grafe, Hong; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang; Hamacher, Rainer
    Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors : A Case Series of 9 Patients
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 727 - 734
  • Guberina, Nika; Pöttgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Plönes, Till; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Darwiche, Kaid; Aigner, Clemens; Eberhardt, Wilfried; Stuschke, Martin
    Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
    In: Radiation Oncology Jg. 17 (2022) Nr. 1, 126
  • Keyl, J.; Kasper, S.; Wiesweg, Marcel; Götze, J.; Schönrock, M.; Sinn, M.; Berger, A.; Nasca, E.; Kostbade, K.; Schumacher, B.; Markus, P.; Treckmann, Jürgen-Walter; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Siveke, Jens; Schuler, Martin; Kleesiek, J.
    Multimodal survival prediction in advanced pancreatic cancer using machine learning
    In: ESMO Open Jg. 7 (2022) Nr. 5, 100555
  • Chwallek, Daniel; Schweda, Adam; Neukirchen, M.; Hense, Jörg; Schwartz, J.; Mallmann, Bernhard; Teufel, Martin; Schuler, Martin; Tewes, Mitra
    PARPACT – Paramedic Palliative Care Test : Validierung eines Tests für palliatives Wissen und Selbstwirksamkeitserwartung bei Mitarbeiter*innen im Rettungswesen
    In: Der Schmerz Jg. 36 (2022) Nr. 5, S. 333 - 341
  • Müller, S.; Fink, M.; Hense, Jörg; Comino, M. R. Salvador; Schuler, M.; Teufel, Martin; Tewes, Mitra
    Palliative care outpatients in a German comprehensive cancer center : identifying indicators for early and late referral
    In: BMC Palliative Care Jg. 21 (2022) Nr. 1, 221
  • Subbiah, Vivek; Cassier, Philippe A.; Siena, Salvatore; Garralda, Elena; Paz-Ares, Luis; Garrido, Pilar; Nadal, Ernest; Vuky, Jacqueline; Lopes, Gilberto; Kalemkerian, Gregory P.; Bowles, Daniel W.; Seetharam, Mahesh; Chang, Jianhua; Zhang, Hui; Green, Jennifer; Zalutskaya, Alena; Schuler, Martin; Fan, Yun; Curigliano, Giuseppe
    Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
    In: Nature Medicine Jg. 28 (2022) Nr. 8, S. 1640 - 1645
  • Schuler, Martin; Zimmer, Lisa; Kim, Kevin B.; Sosman, Jeffrey A.; Ascierto, Paolo A.; Postow, Michael A.; De Vos, Filip Y.F.L.; van Herpen, Carla M.L.; Carlino, Matteo S.; Johnson, Douglas B.; Berking, Carola; Reddy, Micaela B.; Harney, Allison S.; Berlin, Jordan D.; Amaria, Rodabe N.
    Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma
    In: Clinical Cancer Research Jg. 28 (2022) Nr. 14, S. 3002 - 3010
  • Krebs, Matthew G.; Malapelle, Umberto; André, Fabrice; Paz-Ares, Luis; Schuler, Martin; Thomas, David M.; Vainer, Gilad; Yoshino, Takayuki; Rolfo, Christian
    Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer
    In: JAMA Oncology Jg. 8 (2022) Nr. 12, S. 1830 - 1839
  • Guberina, Maja; Herrmann, Ken; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Karpf-Wissel, Rüdiger; Santiago Garcia, Alina; Darwiche, Kaid; Stuschke, Martin
    Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
    In: Scientific Reports Jg. 12 (2022) Nr. 1, 17511
  • Scheffler, Matthias; Wiesweg, Marcel; Michels, Sebastian; Nogová, Lucia; Kron, Anna; Herold, Thomas; Scheel, Andreas H.; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Fassunke, Jana; Darwiche, Kaid; Aigner, Clemens; Schaufler, Diana; Riedel, Richard; Fischer, Rieke; Koleczko, Sophia; Schildhaus, Hans-Ulrich; Merkelbach-Bruse, Sabine; Schmid, Kurt Werner; Büttner, Reinhard; Wolf, Jürgen; Schuler, Martin
    Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications
    In: Lung Cancer Jg. 168 (2022) S. 10 - 20
  • Fendler, Wolfgang; Pabst, Kim M.; Kessler, Lukas; Fragoso Costa, Pedro; Ferdinandus, Justin; Weber, Manuel; Lippert, Maria; Lückerath, Katharina; Umutlu, Lale; Kostbade, Karina; Mavroeidi, Ilektra A.; Schuler, Martin; Ahrens, Marit; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens; Hamacher, Rainer
    Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
    In: Clinical Cancer Research Jg. 28 (2022) Nr. 19, S. 4346 - 4353
  • Thumser-Henner, Clotilde; Oeck, Sebastian; Kalmbach, Sophie; Forster, Jan; Kindl, Franziska; Sak, Ali; Schramm, Alexander; Schuler, Martin
    Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer
    In: Cell Death and Disease Jg. 13 (2022) Nr. 6, 529
  • Metzenmacher, Martin; Hegedüs, Balazs; Forster, Jan; Schramm, Alexander; Horn, Peter; Klein, Christoph A.; Bielefeld, Nicola; Ploenes, Till; Aigner, Clemens; Siveke, Jens; Schuler, Martin; Lueong, Smiths S.
    The clinical utility of cfRNA for disease detection and surveillance : A proof of concept study in non-small cell lung cancer
    In: Thoracic Cancer (2022) in press
  • Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Plönes, Till
    Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms
    In: Die Innere Medizin Jg. 63 (2022) Nr. 7, S. 717 - 723
  • Peuker, Caroline A.; Yaghobramzi, Sarvenaz; Grunert, Corinna; Keilholz, Luisa; Gjerga, Enio; Hennig, Steffen; Schaper, Sigrid; Na, Il-Kang; Keller, Ulrich; Brucker, Sara; Decker, Thomas; Fasching, Peter; Fehm, Tanja; Janni, Wolfgang; Kümmel, Sherko; Schneeweiss, Andreas; Schuler, Martin; Lüftner, Diana; Busse, Antonia
    Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer : findings from the RIBECCA trial
    In: European Journal of Cancer (EJC) Jg. 162 (2022) S. 45 - 55
  • Metzenmacher, Martin; Kopp, Hans-Georg; Griesinger, Frank; Reinmuth, Niels; Sebastian, Martin; Serke, Monika; Waller, Cornelius Florian; Thomas, Michael; Eggert, Jochen; Schmid-Bindert, Gerald; Hoiczyk, Mathias; Christoph, Daniel; Kimmich, Martin; Deuß, Burkhard; Seifert, Stephanie; Held, Swantje; Schuler, Martin; Herold, Thomas; Breitenbücher, Frank; Eberhardt, Wilfried
    A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer
    In: Therapeutic Advances in Medical Oncology Jg. 13 (2021)
  • Metzenmacher, Martin; Goetz, Moritz; Herold, Thomas; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Eberhardt, Wilfried; Schuler, Martin; Wiesweg, Marcel
    Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V⁶⁰⁰-mutated Squamous Cell Lung Cancer : Concurrent Evolvement of PTEN and MEK1 Mutations
    In: Clinical Lung Cancer Jg. 22 (2021) Nr. 5, S. E668 - E672
  • Rosery, Vivian; Reis, Henning; Savvatakis, Konstantinos; Kowall, Bernd; Stuschke, Martin; Paul, Andreas; Dechene, Alexander; Yang, JiaJin; Zhao, Ben; Borgers, Arianna; Kasper, Stefan; Schuler, Martin; Cheung, Phyllis F.; Siveke, Jens
    Antitumor immune response is associated with favorable survival in GEP-NEN G3
    In: Endocrine-Related Cancer Jg. 28 (2021) Nr. 10, S. 683 - 693
  • Mrotzek, Simone M.; Lena, Alessia; Hadzibegovic, Sara; Ludwig, Ria; Al-Rashid, Fadi; Mahabadi, Amir Abbas; Mincu, Raluca I.; Michel, Lars; Johannsen, Laura; Hinrichs, Lena; Schuler, Martin; Keller, Ulrich; Anker, Stefan D.; Landmesser, Ulf; Rassaf, Tienush; Anker, Markus S.; Totzeck, Matthias
    Assessment of coronary artery disease during hospitalization for cancer treatment
    In: Clinical Research in Cardiology Jg. 110 (2021) Nr. 2, S. 200 - 210
  • Wiesweg, Marcel; Preuß, Cedric; Roeper, Julia; Metzenmacher, Martin; Eberhardt, Wilfried; Stropiep, Ursula; Wedeken, Katrin; Reis, Henning; Herold, Thomas; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schmid, Kurt Werner; Falk, Markus; Heukamp, Lukas; Tiemann, Markus; Griesinger, Frank; Schuler, Martin
    BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy
    In: European Journal of Cancer (EJC) Jg. 149 (2021) S. 211 - 221
  • Frikkel, Johanna; Beckmann, Mingo B.; de Lazzari, Nico; Götte, Miriam; Kasper, Stefan; Hense, Jörg; Schuler, Martin; Teufel, Martin; Tewes, Mitra
    Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months : A comparative study
    In: Supportive Care in Cancer Jg. 29 (2021) Nr. 9, S. 5127 - 5137
  • Markus, M.; Abendroth, Annalena; Noureddine, R.; Paul, Andreas; Breitenbuecher, Sandra; Virchow, Isabel; Schmid, Kurt Werner; Markus, Peter; Schumacher, Brigitte M.; Wiesweg, Marcel; Wendling, Johanna; Mende, Bastian; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology Jg. 147 (2021) Nr. 2, S. 579 - 591
  • Guberina, Maja; Sak, Ali; Pöttgen, Christoph; Tinhofer-Keilholz, Ingeborg; Budach, Volker; Balermpas, Panagiotis; Von der Grün, Jens; Rödel, Claus Michael; Gkika, Eleni; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Belka, Claus; Pigorsch, Steffi; Combs, Stephanie E.; Mönnich, David; Zips, Daniel; De-Colle, Chiara; Welz, Stefan; Linge, Annett; Lohaus, Fabian; Baretton, Gustavo; Gauler, Thomas; Baumann, Michael; Krause, Mechthild; Schuler, Martin; Bankfalvi, Agnes; Höing, Benedikt; Lang, Stephan; Stuschke, Martin
    Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
    In: The Pharmacogenomics Journal Jg. 21 (2021) Nr. 2, S. 273
  • Schuler, Martin
    Corrigendum to “Inhibiting fibroblast growth factor receptors in cancer – The next generation”
    In: Annals of Oncology Jg. 32 (2021) Nr. 1, S. 126
  • Guberina, Maja; Sak, Ali; Pöttgen, Christoph; Tinhofer-Keilholz, Ingeborg; Budach, Volker; Balermpas, Panagiotis; Von der Grün, Jens; Rödel, Claus Michael; Gikka, Eleni; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Belka, Claus; Pigorsch, Steffi; Combs, Stephanie; Mönnich, David; Zips, Daniel; De-Colle, Chiara; Welz, Stefan; Linge, Annett; Lohaus, Fabian; Baretton, Gustavo; Gauler, Thomas; Baumann, Michael; Krause, Mechthild; Schuler, Martin; Bankfalvi, Agnes; Höing, Benedikt; Lang, Stephan; Stuschke, Martin
    ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
    In: The Pharmacogenomics Journal Jg. 21 (2021) Nr. 1, S. 37 - 46
  • Şahin, Uǧur; Türeci, Özlem; Manikhas, Georgiy Moiseevich; Lordick, Florian; Rusyn, Andrii; Vynnychenko, Ihor A.; Dudov, Asen; Bazin, Igor S.; Bondarenko, Igor; Melichar, Bohuslav; Dhaene, Karl F.L.; Wiechen, Kai; Huber, Claudia; Maurus, Daniel; Arozullah, A.; Park, J.W.; Schuler, Martin; Al-Batran, Salah Eddin
    FAST : a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma
    In: Annals of Oncology Jg. 32 (2021) Nr. 5, S. 609 - 619
  • Adamczyk, Alexandra; Pastille, Eva; Kehrmann, Jan; Vu, Vivian P.; Geffers, Robert; Wasmer, Marie-Hélène; Kasper, Stefan; Schuler, Martin; Lange, Christian; Muggli, Beat; Rau, Tilman T.; Klein, Diana; Hansen, Wiebke; Krebs, Philippe; Buer, Jan; Westendorf, Astrid
    GPR15 facilitates recruitment of regulatory T cells to promote colorectal cancer
    In: Cancer Research Jg. 81 (2021) Nr. 11, S. 2970 - 2982
  • Ho, Cassandra S. L.; Tüns, Alicia I.; Schildhaus, Hans-Ulrich; Wiesweg, Marcel; Grüner, Barbara M.; Hegedus, Balazs; Schuler, Martin; Schramm, Alexander; Oeck, Sebastian
    HER2 mediates clinical resistance to the KRASG¹²C inhibitor sotorasib, which is overcome by co-targeting SHP2
    In: European Journal of Cancer (EJC) Jg. 159 (2021) S. 16 - 23
  • Pogorzelski, Michael; Hilser, Thomas; Ting, Saskia; Kansy, Benjamin; Gauler, Thomas; Stuschke, Martin; Schmid, Kurt Werner; Lang, Stephan; Grünwald, Viktor; Schuler, Martin; Kasper, Stefan
    Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
    In: Frontiers in Oncology Jg. 11 (2021) 635096
  • Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Ploenes, Till; Pöttgen, Christoph; Guberina, Nika; Herrmann, Ken; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Stuschke, Martin
    Impact of EBUS-TBNA in addition to [¹⁸F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 2894 - 2903
  • Stefani, Dirk; Plönes, Till; Viehof, Jan; Darwiche, Kaid; Stuschke, Martin; Schuler, Martin; Aigner, Clemens
    Lung Cancer Surgery after Neoadjuvant Immunotherapy
    In: Cancers Jg. 13 (2021) Nr. 16, 4033
  • Chih-Hsin Yang, J.; Schuler, Martin; Popat, S.; Miura, S.; Heeke, S.; Passaro, A.; de Marinis, F.; Park, K.; Kim, E.S.
    MO01.36 Afatinib in Asian and Non-Asian Patients (pts) with EGFR Mutation-Positive (EGFRm+) NSCLC Harboring Major Uncommon Mutations
    In: Journal of Thoracic Oncology Jg. 16 (2021) Nr. 1, S. 31
  • Hautzel, Hubertus; Alnajdawi, Yazan; Fendler, Wolfgang; Rischpler, Christoph; Darwiche, Kaid; Eberhardt, Wilfried; Umutlu, Lale; Theegarten, Dirk; Stuschke, Martin; Schuler, Martin; Aigner, Clemens; Herrmann, Ken; Plönes, Till
    N-staging in large cell neuroendocrine carcinoma of the lung : diagnostic value of [¹⁸F]FDG PET/CT compared to the histopathology reference standard
    In: EJNMMI Research Jg. 11 (2021) Nr. 1, 68
  • Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Pöttgen, Christoph; Guberina, Nika; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Karpf-Wissel, Rüdiger; Schuler, Martin; Herrmann, Ken; Stuschke, Martin
    Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definition
    In: Radiation Oncology Jg. 16 (2021) Nr. 1, 176
  • Wick, Antje; Bahr, Oliver; Schuler, Martin; Rohrberg, Kristoffer; Chawla, Sant P.; Janku, Filip; Schiff, David; Heinemann, Volker; Narita, Yoshitaka; Lenz, Heinz-Josef; Ikeda, Masafumi; Ando, Yuichi; Wick, Wolfgang; Steinbach, Joachim P.; Burger, Michael C.; Wenger, Katharina; Lassen, Ulrik; Sankhala, Kamalesh K.; Roggia, Cristiana; Genvresse, Isabelle; Munhoz, Catya; Rentzsch, Christine; Reschke, Susanne; Langer, Simon; Wagner, Markus; Kaulfuss, Stefan; Cai, Charles; Lagkadinou, Eleni; Jeffers, Michael; Peña, Carol; Tabatabai, Ghazaleh
    Phase I assessment of safety and therapeutic activity of BAY1436032 in patients with IDH1-mutant solid tumors
    In: Clinical Cancer Research Jg. 27 (2021) Nr. 10, S. 2723 - 2733
  • Valdivia, Daniel; Cheufou, Danjouma; Fels, Benjamin; Puhlvers, Stephan; Mardanzai, Khaled; Zaatar, Mohamed; Weinreich, Gerhard; Taube, Christian; Theegarten, Dirk; Stuschke, Martin; Schuler, Martin; Stamatis, Georgios; Hegedus, Balazs; Aigner, Clemens
    Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial Tumors
    In: Pathology & Oncology Research Jg. 27 (2021) S. 629993
  • Subbiah, Vivek; Hu, Mimi I.; Wirth, Lori J.; Schuler, Martin; Mansfield, Aaron S.; Curigliano, Giuseppe; Brose, Marcia S.; Zhu, Viola W.; Leboulleux, Sophie; Bowles, Daniel W.; Baik, Christina S.; Adkins, Douglas; Keam, Bhumsuk; Matos, Ignacio; Garralda, Elena; Gainor, Justin F.; Lopes, Gilberto; Lin, Chia-Chi; Godbert, Yann; Sarker, Debashis; Miller, Stephen G.; Clifford, Corinne; Zhang, Hui; Turner, Christopher D.; Taylor, Matthew H.
    Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW) : a multi-cohort, open-label, registrational, phase 1/2 study
    In: The Lancet Diabetes and Endocrinology Jg. 9 (2021) Nr. 8, S. 491 - 501
  • Guberina, Maja; Pöttgen, Christoph; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Aigner, Clemens; Ploenes, Till; Umutlu, Lale; Gauler, Thomas; Darwiche, Kaid; Stamatis, Georgios; Theegarten, Dirk; Hautzel, Hubertus; Jentzen, Walter; Guberina, Nika; Herrmann, Ken; Eberhardt, Wilfried E.E.; Stuschke, Martin
    Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1684 - 1691
  • Skoulidis, Ferdinandos; Li, Bob T.; Dy, Grace K.; Price, Timothy J.; Falchook, Gerald S.; Wolf, Jürgen; Italiano, Antoine; Schuler, Martin; Borghaei, Hossein; Barlesi, Fabrice; Kato, Terufumi; Curioni-Fontecedro, Alessandra; Sacher, Adrian; Spira, Alexander; Ramalingam, Suresh S.; Takahashi, Toshiaki; Besse, Benjamin; Anderson, Abraham; Ang, Agnes; Tran, Qui; Mather, Omar; Henary, Haby; Ngarmchamnanrith, Gataree; Friberg, Gregory; Velcheti, Vamsidhar; Govindan, Ramaswamy
    Sotorasib for Lung Cancers with KRAS p.G12C Mutation
    In: The New England Journal of Medicine Jg. 384 (2021) Nr. 25, S. 2371 - 2381
  • Zaun, Gregor; Schuler, Martin
    Systemische Tumortherapien des CUP-Syndroms
    In: Der Onkologe Jg. 27 (2021) Nr. 7, S. 658 - 662
  • Yang, James Chih-Hsin; Schuler, Martin; Popat, Sanjay; Miura, Satoru; Heeke, Simon; Park, Keunchil; Märten, Angela; Kim, Edward S.
    Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations : A Database of 693 Cases
    In: Journal of Thoracic Oncology Jg. 15 (2020) Nr. 5, S. 803 - 815
  • Bhat, Hilal; Zaun, Gregor; Hamdan, Thamer A.; Lang, Judith; Adomati, Tom; Schmitz, Rosa; Friedrich, Sarah-Kim; Bergerhausen, Michael; Cham, Lamin B.; Li, Fanghui; Ali, Murtaza; Zhou, Fan; Khairnar, Vishal; Duhan, Vikas; Brandenburg, Tim; Machlah, Yara Maria; Schiller, Maximilian; Berry, Arshia; Xu, Haifeng; Vollmer, Jörg; Häussinger, Dieter; Thier, Beatrice; Pandyra, Aleksandra A.; Schadendorf, Dirk; Paschen, Annette; Schuler, Martin; Lang, Philipp A.; Lang, Karl S.
    Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression
    In: Frontiers in Immunology Jg. 11 (2020) S. 1849
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Höhler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Reis, Henning; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kostbade, Karina; Virchow, Isabel; Ting, Saskia; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Wiesweg, Marcel; Schuler, Martin; Trarbach, Tanja
    Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer : The CEBIFOX Trial
    In: Clinical Colorectal Cancer Jg. 19 (2020) Nr. 4, S. 236 - 247.e6
  • Welt, Anja; Wiesweg, Marcel; Theurer, Sarah; Abenhardt, Wolfgang; Groschek, Matthias; Müller, Lothar; Schröder, Jan; Tewes, Mitra; Chiabudini, Marco; Potthoff, Karin; Bankfalvi, Agnes; Marschner, Norbert; Schuler, Martin; Breitenbücher, Frank
    Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression
    In: Cancer Medicine Jg. 9 (2020) Nr. 13, S. 4527 - 4539
  • Wiesweg, Marcel; Herold, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Herrmann, Ken; Nensa, Felix; Schildhaus, Hans-Ulrich; Schuler, Martin
    Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation
    In: Lung Cancer Jg. 139 (2020) S. 165 - 168
  • Bilecz, Agnes; Stockhammer, Paul; Theegarten, Dirk; Kern, Izidor; Jakopovic, Marko; Samarzija, Miroslav; Klikovits, Thomas; Hoda, Mir A.; Döme, Balázs; Oberndorfer, Felicitas; Muellauer, Leonhard; Fillinger, János; Kovács, Ildikó; Pirker, Christine; Schuler, Martin; Plönes, Till; Aigner, Clemens; Klepetko, Walter; Berger, Walter; Brcic, Luka; Laszlo, Viktória; Hegedus, Balazs
    Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma
    In: Histopathology Jg. 77 (2020) Nr. 1, S. 55 - 66
  • Guberina, Nika; Pöttgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Plönes, Till; Krebs, Bettina; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Jöckel, Karl-Heinz; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Eberhardt, Wilfried
    Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment : Only few risks left to improve
    In: European Journal of Cancer (EJC) Jg. 138 (2020) S. 156 - 168
  • Wiesweg, Marcel; Schuler, Martin; Schildhaus, Hans-Ulrich
    Crizotinib in ROS1 and MET deregulated NSCLC-letter
    In: Clinical Cancer Research Jg. 26 (2020) Nr. 7, S. 1774
  • Stockhammer, Paul; Ploenes, Till; Theegarten, Dirk; Schuler, Martin; Maier, Sandra; Aigner, Clemens; Hegedus, Balazs
    Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma
    In: Lung Cancer Jg. 139 (2020) S. 124 - 132
  • Reissig, Timm M.; Sara, Linda; Ting, Saskia; Reis, Henning; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Herold, Thomas; Aigner, Clemens; Darwiche, Kaid; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel
    ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer
    In: Lung Cancer Jg. 149 (2020) S. 10 - 16
  • Peuker, CA; Yaghobramzi, S; Lüftner, D.; Brucker, S; Decker, T; Fasching, P; Fehm, T; Janni, W; Kümmel, Sherko; Schneeweiss, A; Schuler, Martin; Busse, A
    Einfluss des CDK4/6-Inhibitors Ribociclib auf die periphere Immunantwort beim Hormonrezeptor-positiven Mammakarzinom
    In: Geburtshilfe und Frauenheilkunde Jg. 80 (2020) Nr. 6, S. e53
  • Frikkel, Johanna; Götte, Miriam; Beckmann, Mingo B.; Kasper, Stefan; Hense, Jörg; Teufel, Martin; Schuler, Martin; Tewes, Mitra
    Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patients
    In: BMC Palliative Care Jg. 19 (2020) Nr. 1, S. 43
  • Nothdurft, Silke; Thumser-Henner, Clotilde; Breitenbücher, Frank; Okimoto, Ross A.; Dorsch, Madeleine; Opitz, Christiane A.; Sadik, Ahmed; Esser, Charlotte; Hölzel, Michael; Asthana, Saurabh; Forster, Jan; Beisser, Daniela; Kalmbach, Sophie; Grüner, Barbara M.; Bivona, Trever G.; Schramm, Alexander; Schuler, Martin
    Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis
    In: Oncogenesis Jg. 9 (2020) Nr. 11, S. 102
  • Stockhammer, Paul; Ho, Cassandra Su Lyn; Hegedus, Luca; Lotz, Gabor; Molnár, Eszter; Bankfalvi, Agnes; Herold, Thomas; Kalbourtzis, Stavros; Ploenes, Till; Eberhardt, Wilfried; Schuler, Martin; Aigner, Clemens; Schramm, Alexander; Hegedus, Balazs
    HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model
    In: Lung Cancer Jg. 144 (2020) S. 20 - 29
  • Welt, Anja; Bogner, Simon; Arendt, Marina; Kossow, Josef; Huffziger, Antonia; Pohlkamp, Christian; Steiniger, Heike; Becker, Ute; Alashkar, Ferras; Kohl, Marzena; Wiesweg, Marcel; Richly, Heike; Hense, Jörg; Scheulen, Max Ernst; Schuler, Martin; Seeber, Siegfried; Tewes, Mitra
    Improved survival in metastatic breast cancer : results from a 20-year study involving 1033 women treated at a single comprehensive cancer center
    In: Journal of Cancer Research and Clinical Oncology (2020)
  • Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Kollmeier, Jens; Misch, Daniel; Stephan-Falkenau, Susann; Mairinger, Thomas; Walter, Robert F.H.; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Köster, Johannes; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin
    Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context
    In: European Journal of Cancer (EJC) Jg. 140 (2020) S. 76 - 85
  • Schuler, Martin; Berardi, Rossana; Lim, Darren Wan Teck; de Jonge, Maja J. A.; Bauer, Todd M.; Azaro, Analía; Gottfried, Maya; Han, Jiyoun; Lee, Dae-hee; Wollner, M.; Hong, David S.; Vogel, Arndt; Delmonte, Angelo; Akimov, Mikhail; Ghebremariam, Samson; Cui, X.; Nwana, N.; Giovannini, Monica; Kim, Tae-min
    Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer : Clinical and biomarker results from a phase I trial
    In: Annals of Oncology Jg. 31 (2020) Nr. 6, S. 789 - 797
  • Bang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck; Bauer, Todd M.; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette
    Phase 1 study of capmatinib in MET-positive solid tumor patients : Dose escalation and expansion of selected cohorts
    In: Cancer Science Jg. 111 (2020) Nr. 2, S. 536 - 547
  • Bardia, Aditya; Gounder, Mrinal; Rodon, Jordi; Janku, Filip; Lolkema, Martijn P.; Stephenson, Joe J.; Bedard, Philippe L.; Schuler, Martin; Sessa, Cristiana; LoRusso, Patricia; Thomas, Michael; Maacke, Heiko; Evans, Helen; Sun, Yongjian; Tan, Daniel S.W.
    Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations
    In: The Oncologist Jg. 24 (2020) Nr. 1, S. e160 - e169
  • Metzenmacher, Martin; Váraljai, Renáta; Hegedüs, Balazs; Cima, Igor; Forster, Jan; Schramm, Alexander; Scheffler, Björn; Horn, Peter; Klein, Christoph A.; Szarvas, Tibor; Reis, Henning; Bielefeld, Nicola; Rösch, Alexander; Aigner, Clemens; Kunzmann, Volker; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Lueong, Smiths S.
    Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancer
    In: Cancers Jg. 12 (2020) Nr. 2, S. 353
  • Such, Lina; Zhao, Fang; Liu, Derek; Thier, Beatrice; Le-Trilling, Vu Thuy Khanh; Sucker, Antje; Coch, Christoph; Pieper, Natalia; Howe, Sebastian; Bhat, Hilal; Kalkavan, Halime; Ritter, Cathrin; Brinkhaus, Robin; Ugurel, Selma; Köster, Johannes; Seifert, Ulrike; Dittmer, Ulf; Schuler, Martin; Lang, Karl S.; Kufer, Thomas A.; Hartmann, Gunther; Becker, Jürgen; Horn, Susanne; Ferrone, Soldano; Liu, David; Van Allen, Eliezer M.; Schadendorf, Dirk; Griewank, Klaus; Trilling, Mirko; Paschen, Annette
    Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy
    In: The Journal of Clinical Investigation (JCI) Jg. 130 (2020) Nr. 8, S. 4266 - 4281
  • Schuler, Martin
    The quest for efficient trial designs in precision oncology
    In: The Lancet Oncology Jg. 21 (2020) Nr. 12, S. 1539 - 1541
  • Ghanim, Bahil; Rosenmayr, Anna; Stockhammer, Paul; Vogl, Melanie; Celik, Ali; Bas, Aynur; Kurul, Ismail Cuneyt; Akyurek, Nalan; Varga, Alexander; Plönes, Till; Bankfalvi, Agnes; Hager, Thomas; Schuler, Martin; Hackner, Klaus; Errhalt, Peter; Scheed, Axel; Seebacher, Gernot; Hegedus, Balazs; Stubenberger, Elisabeth; Aigner, Clemens
    Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion : the impact of C-reactive protein and immune-checkpoint inhibition
    In: Scientific Reports Jg. 10 (2020) Nr. 1, S. 5784
  • Türeci, Özlem; Sahin, Ugur; Schulze-Bergkamen, Henning; Zvirbule, Zanete; Lordick, Florian; Koeberle, Dieter; Thuss-Patience, Peter C.; Ettrich, Thomas J.; Arnold, Dirk; Bassermann, Florian; Al-Batran, Salah Eddin; Wiechen, K.; Dhaene, Karl F. L.; Maurus, D.; Gold, M.; Huber, Christopher H.; Krivoshik, Andrew P.; Arozullah, A.; Park, J. W.; Schuler, Martin
    A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus : the MONO study
    In: Annals of Oncology Jg. 30 (2019) Nr. 9, S. 1487 - 1495
  • Taylor, Matthew H.; Gainor, Justin F.; Hu, Mimi I-Nan; Zhu, Viola Weijia; Lopes, Gilberto; Leboulleux, Sophie; Brose, Marcia S.; Schuler, Martin; Bowles, Daniel W.; Kim, Dong-Wan; Baik, Christina S; Garralda, Elena; Lin, Chia-Chi; Adkins, Douglas; Sarker, Debashis; Curigliano, Giuseppe; Zhang, Hui; Clifford, Corinne; Turner, Christopher D.; Subbiah, Vivek
    Activity and tolerability of BLU-667, a highly potent and selective RET inhibitor, in patients with advanced RET-altered thyroid cancers
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15_Suppl, S. 6018
  • Juric, Dejan; Janku, Filip; Rodón, Jordi; Burris, Howard A.; Mayer, Ingrid A.; Schuler, Martin; Seggewiss-Bernhardt, Ruth; Gil-Martin, Marta; Middleton, Mark R.; Baselga, José; Bootle, Douglas; Demanse, David; Blumenstein, Lars; Schumacher, Karl; Huang, Alan; Quadt, Cornelia; Rugo, Hope S.
    Alpelisib Plus Fulvestrant in PIK3CA -Altered and PIK3CA -Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer : A Phase 1b Clinical Trial
    In: JAMA Oncology Jg. 5 (2019) Nr. 2, S. e184475
  • Totzeck, Matthias; Schuler, Martin; Stuschke, Martin; Heusch, Gerd; Rassaf, Tienush
    Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease
    In: International Journal of Cardiology Jg. 280 (2019) S. 163 - 175
  • Pöttgen, Christoph; Kleinhans, J.; Gauler, Thomas; Wrede, Karsten; Schuler, Martin; Aigner, Clemens; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Cerebral Recurrence after trimodal Therapy of Patients with locally advanced NSCLC - Prognostic Factors and prognostic Importance
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 195 (2019) Nr. Suppl. 1, S. S66 - S67
  • Subbiah, Vivek; Gervais, Radj; Riely, Gregory; Hollebecque, Antoine; Blay, Jean-Yves; Felip, Enriqueta; Schuler, Martin; Gonçalves, Anthony; Italiano, Antonio; Keedy, Vicki; Chau, Ian; Puzanov, Igor; Raje, Noopur S.; Meric-Bernstam, Funda; Makrutzki, Martina; Riehl, Todd; Pitcher, Bethany; Baselga, Jose; Hyman, David M.
    Efficacy of vemurafenib in patients with non–small-cell lung cancer with BRAF V600 mutation : An open-label, single-arm cohort of the histology-independent VE-Basket study
    In: JCO Precision Oncology Jg. 3 (2019) S. 1 - 9
  • Schuler, Martin; Paz-Ares, Luis; Sequist, Lecia V.; Hirsh, Vera; Lee, Ki Hyeong; Wu, Yi-Long; Lu, Shun; Zhou, Caicun; Feng, Jifeng; Ellis, Stuart H.; Samuelsen, Carl H.; Tang, Wenbo; Märten, Angela; Ehrnrooth, Eva; Park, Keunchil; Yang, James Chih-Hsin
    First-line afatinib for advanced EGFRm+ NSCLC : Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials
    In: Lung Cancer Jg. 133 (2019) S. 10 - 19
  • Schuler, Martin; Tan, Eng-Huat; O’Byrne, Kenneth; Zhang, Li; Boyer, Michael; Mok, Tony; Hirsh, Vera; Yang, James Chih-Hsin; Lee, Ki Hyeong; Lu, Shun; Shi, Yuankai; Kim, Sang-We; Laskin, Janessa; Kim, Dong-Wan; Arvis, Catherine Dubos; Kölbeck, Karl; Massey, Dan; Märten, Angela; Paz-Ares, Luis; Park, Keunchil
    First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7) : impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression
    In: Journal of Cancer Research and Clinical Oncology Jg. 145 (2019) Nr. 6, S. 1569 - 1579
  • Joos, Stefan; Nettelbeck, Dirk M.; Reil-Held, Anette; Engelmann, Katja; Moosmann, Alexandra; Eggert, Angelika; Hiddemann, Wolfgang; Krause, Mechthild; Peters, Christoph; Schuler, Martin; Schulze-Osthoff, Klaus; Serve, Hubert; Wick, Wolfgang; Puchta, Josef; Baumann, Michael
    German Cancer Consortium (DKTK) : A national consortium for translational cancer research
    In: Molecular Oncology Jg. 13 (2019) Nr. 3, S. 535 - 542
  • Wiesweg, Marcel; Kasper, Stefan; Worm, Karl; Herold, Thomas; Reis, Henning; Sara, Linda; Metzenmacher, Martin; Abendroth, Annalena; Darwiche, Kaid; Aigner, Clemens; Wedemeyer, Heiner; Helfritz, Fabian A.; Stuschke, Martin; Schumacher, Brigitte; Markus, Peter; Paul, Andreas; Rahmann, Sven; Schmid, Kurt Werner; Schuler, Martin
    Impact of RAS mutation subtype on clinical outcome : a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
    In: Oncogene Jg. 38 (2019) Nr. 16, S. 2953 - 2966
  • Abendroth, A.; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Wiesweg, Marcel; Köhler, Johannes; Markus, M.; Mende, B.; Dechene, Alexander; Schuler, Martin; Kasper, Stefan
    Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols
    In: Journal of Cancer Research and Clinical Oncology Jg. 145 (2019) Nr. 2, S. 445 - 455
  • Cheufou, Danjouma Housmanou; Valdivia, Daniel; Puhlvers, Stephan; Fels, Benjamin; Weinreich, Gerhard; Taube, Christian; Theegarten, Dirk; Stuschke, Martin; Schuler, Martin; Hegedus, Balazs; Stamatis, Georgios; Aigner, Clemens
    Lymph Node Involvement and the Surgical Treatment of Thymic Epithelial and Neuroendocrine Carcinoma
    In: The Annals of Thoracic Surgery Jg. 107 (2019) Nr. 6, S. 1632 - 1638
  • Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Walter, Robert; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; McCutcheon, A.; Köster, J.; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin
    Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer
    In: Annals of Oncology Jg. 30 (2019) Nr. 4, S. 655 - 657
  • Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia; Goetze, Thorsten O.; Meiler, Johannes; Kasper, Stefan; Kopp, Hans-Georg; Mayer, Frank; Haag, Georg Martin; Luley, Kim; Lindig, Udo; Schmiegel, Wolff; Pohl, Michael; Stoehlmacher, Jan; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Fischbach, Wolfgang; Mahlberg, Rolf; Trojan, Jörg; Koenigsmann, Michael; Martens, Uwe M.; Thuss-Patience, Peter; Egger, Matthias; Block, Andreas; Heinemann, Volker; Illerhaus, Gerald; Moehler, Markus; Schenk, Michael; Kullmann, Frank; Behringer, Dirk M.; Heike, Michael; Pink, Daniel; Teschendorf, Christian; Löhr, Carmen; Bernhard, Helga; Schuch, Gunter; Rethwisch, Volker; Weikersthal, Ludwig Fischer von; Hartmann, Jörg T.; Kneba, Michael; Daum, Severin; Schulmann, Karsten; Weniger, Jörg; Belle, Sebastian; Gaiser, Timo; Oduncu, Fuat S.; Güntner, Martina; Hozaeel, Wael; Reichart, Alexander; Jäger, Elke; Kraus, Thomas; Mönig, Stefan; Bechstein, Wolf O.; Schuler, Martin; Schmalenberg, Harald; Hofheinz, Ralf D.
    Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4) : A randomised, phase 2/3 trial
    In: Lancet Jg. 393 (2019) Nr. 10184, S. 1948 - 1957
  • Guberina, Maja; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Theegarten, Dirk; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph
    Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trial
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 7, S. 1439 - 1447
  • Schuler, Martin; Cho, Byoung Chul; Sayehli, Cyrus Michael; Navarro, Alejandro; Soo, Ross A.; Richly, Heike; Cassier, Philippe Alexandre; Tai, David; Penel, Nicolas; Nogova, Lucia; Park, Se Hoon; Schostak, Martin; Gajate, Pablo; Cathomas, Richard; Rajagopalan, Prabhu; Grevel, Joachim; Bender, Sebastian; Boix, Oliver; Nogai, Hendrik; Ocker, Matthias; Ellinghaus, Peter; Joerger, Markus
    Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression : a phase 1 dose-escalation and dose-expansion study
    In: The Lancet Oncology Jg. 20 (2019) Nr. 10, S. 1454 - 1466
  • Park, Keunchil; Bennouna, Jaafar; Boyer, Michael; Hida, Toyoaki; Hirsh, Vera; Kato, Terufumi; Lu, Shun; Mok, Tony; Nakagawa, Kazuhiko; O'Byrne, Kenneth; Paz-Ares, Luis; Schuler, Martin; Sibilot, Denis Moro; Tan, Eng-Huat; Tanaka, Hiroshi; Wu, Yi-Long; Yang, James C.-H.; Zhang, Li; Zhou, Caicun; Märten, Angela; Tang, Wenbo; Yamamoto, Nobuyuki
    Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer
    In: Lung Cancer Jg. 132 (2019) S. 126 - 131
  • Pastille, Eva; Wasmer, Marie-Hélène; Adamczyk, Alexandra; Vu, Vivian P.; Mager, Lukas F.; Phuong, Nhi Ngo Thi; Palmieri, Vittoria; Simillion, Cedric; Hansen, Wiebke; Kasper, Stefan; Schuler, Martin; Muggli, Beat; McCoy, Kathy D.; Buer, Jan; Zlobec, Inti; Westendorf, Astrid; Krebs, Philippe
    The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
    In: Mucosal Immunology Jg. 12 (2019) Nr. 4, S. 990 - 1003
  • Sahin, Ugur; Tureci, Özlem; Manikhas, Georgy M.; Lordick, Florian; Rusyn, Andriy; Vynnychenko, Ihor; Dudov, Assen; Bazin, Igor; Bondarenko, Igor; Melichar, Bohuslav; Dhaene, Karl; Wiechen, Kai; Maurus, Daniel; Schuler, Martin; Al-Batran, Salah-Eddin
    Zolbetuximab combined with EOX as first-line therapy in advanced CLDN18.2+ gastric (G) and gastroesophageal junction (GEJ) adenocarcinoma : Updated results from the FAST trial.
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 4_Suppl, S. 16
  • Tamiya, A.; Märten, A.; Popat, S.; Yamamoto, N.; Yang, J.C-H.; Hirsh, V.; Wu, Y-L.; Schuler, Martin; O'Byrne, K.
    143PD Competing central nervous system or systemic progression analysis for patients with EGFR mutation-positive NSCLC receiving afatinib in LUX-Lung 3, 6, and 7
    In: Journal of Thoracic Oncology Jg. 13 (2018) Nr. 4, S. S84 - S85
  • Sahin, Ugur; Schuler, Martin; Richly, Heike; Bauer, Stefan; Krilova, Anna; Dechow, Tobias; Jerling, Markus; Utsch, Magdalena; Rohde, Christoph; Dhaene, Karl; Huber, Christoph; Türeci, Özlem
    A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer
    In: European Journal of Cancer (EJC) Jg. 100 (2018) S. 17 - 26
  • Wu, Yi-Long; Sequist, Lecia V.; Tan, Eng-Huat; Geater, Sarayut L.; Orlov, Sergey; Zhang, Li; Lee, Ki Hyeong; Tsai, Chun-Ming; Kato, Terufumi; Barrios, Carlos H.; Schuler, Martin; Hirsh, Vera; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Boyer, Michael; Mok, Tony; Peil, Barbara; Märten, Angela; Chih-Hsin Yang, James; Paz-Ares, Luis; Park, Keunchil
    Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non–Small-Cell Lung Cancer : Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e465 - e479
  • Zaun, Gregor; Schuler, Martin; Herrmann, Ken; Tannapfel, Andrea
    CUP syndrome : Metastatic malignancy with unknown primary tumor
    In: Deutsches Ärzteblatt international Jg. 115 (2018) Nr. 10, S. 157 - 162
  • Yang, J. C.; Wu, Y.; Hirsh, V.; O'Byrne, K.; Yamamoto, N.; Popat, S.; Tamiya, A.; Kaen, D.; Marten, A.; Schuler, Martin
    Competing CNS or Systemic Progression Analysis for EGFR Mutation-Positive NSCLC Patients on Afatinib in LUX-Lung 3, 6, and 7
    In: Journal of Thoracic Oncology Jg. 13 (2018) Nr. Suppl. 9, S. 163
  • Yang, J.C.-.; Wu, Y.; Hirsh, V.; O’Byrne, K.; Yamamoto, N.; Popat, S.; Tamiya, A.; Kaen, D.; Märten, A.; Schuler, Martin
    Competing CNS or Systemic Progression Analysis for EGFR Mutation-Positive NSCLC Patients on Afatinib in LUX-Lung 3, 6, and 7
    In: Journal of Thoracic Oncology Jg. 13 (2018) Nr. 9, Suppl., S. 163
  • Wu, Yi-Long; Hirsh, Vera; Sequist, Lecia V.; Hu, Cheng-Ping; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Schuler, Martin; Mok, Tony; Yamamoto, Nobuyuki; O’Byrne, Kenneth; Geater, Sarayut L.; Zhou, Caicun; Massey, Dan; Märten, Angela; Lungershausen, Juliane; Yang, James Chih-Hsin
    Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6)
    In: The Patient Jg. 11 (2018) Nr. 1, S. 131 - 141
  • Hamacher, Rainer; Kämpfe, Dietrich; Reuter-Jessen, Kirsten; Pöttgen, Christoph; Podleska, Lars; Farzaliyev, Farhad; Steinau, Hans-Ulrich; Schuler, Martin; Schildhaus, Hans-Ulrich; Bauer, Sebastian
    Dramatic response of a PD-L1- positive advanced angiosarcoma of the scalp to pembrolizumab
    In: JCO Precision Oncology Jg. 2 (2018)
  • Cappuzzo, Federico; Soo, Ross; Hochmair, Maximilian; Schuler, Martin; Lam, Kwok Chi; Stehle, Gerd; Cseh, Agnieszka; Lorence, Robert M; Linden, Stephan; Forman, Nicole D; Hilbe, Wolfgang; Jazieh, Abdul Rahman; Tsai, Chun-Ming
    Global named patient use program of afatinib in advanced non-small-cell lung carcinoma patients who progressed following prior therapies
    In: Future Oncology Jg. 14 (2018) Nr. 15, S. 1477 - 1486
  • Grünwald, Viktor; Schuler, Martin H.; Schöffski, Patrick; Kopp, Hans-Georg; Bauer, Sebastian; Kasper, Bernd; Lindner, Lars H.; Chemnitz, Jens M.; Crysandt, Martina; Stein, Alexander; Steffen, B.; Richter, Stephan; Kneba, Michael; Egerer, Gerlinde; Zimmermann, S.; Karch, Annika; Kunitz, Annegret
    Health-related quality of life (HR-QoL) in elderly soft tissue sarcoma (STS) patients from the randomized phase II EPAZ study comparing pazopanib (PAZ) and doxorubicin (DOX) in first line
    In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii577
  • Gautschi, O.; Drilon, A.; Milia, J.; Lusque, A.; Mhanna, L.; Li, B.; Sabari, J.; Cortot, A.; Besse, B.; Mezquita, L.; Solomon, B.; Thai, A.; Couraud, S.; Veilion, R.; Mascaux, C.; Barlesi, F.; Van den Heuvel, M.; Schouten, R.; Wakelee, H.; Mah, A.; Camidge, D. R.; Ng, T.; Peled, N.; Lilach, Y.; Popat, S.; Ou, S.; Zhu, V.; Velcheti, V.; Fontecedro, A. C.; Akhoundova, D.; Fruh, M.; Zalcman, G.; Gounant, V.; Novello, S.; Bironzo, P.; Felip, E.; Martinez-Marti, A.; Moro-Sibilot, D.; Rosell, R.; Karachaliou, N.; Schuler, Martin; Wiesweg, Marcel; Diebold, J.; Mazieres, J.
    Immunotherapy for Non-Small Cell Lung Cancers (NSCLC) with Oncogenic Driver Mutations : New Results from the Global IMMUNOTARGET Registry
    In: Journal of Thoracic Oncology Jg. 13 (2018) Nr. Suppl. 10, S. 367
  • Nadjm, S.; Pöttgen, Christoph; Gauler, Thomas; Exner, J. P.; Krebs, B.; Cheufou, D.; Umutlu, Lale; Deuschl, C.; Darwiche, Kaid; Schuler, Martin; Eberhardt, Wilfried; Stuschke, Martin
    Investigations of Long-term Survivors with locally advanced NSCLC on Morbidity of curative Therapy - Analysis of neurocognitive Effects
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 194 (2018) Nr. Suppl. 1, S. 110
  • Reis, Henning; Metzenmacher, Martin; Goetz, Moritz; Savvidou, Nikoleta; Darwiche, Kaid; Aigner, Clemens; Herold, Thomas; Eberhardt, Wilfried; Skiba, Charlotte; Hense, Jörg; Virchow, Isabel; Westerwick, Daniela; Bogner, Simon; Ting, Saskia; Kasper, Stefan; Stuschke, Martin; Nensa, Felix; Herrmann, Ken; Hager, Thomas; Schmid, Kurt Werner; Schuler, Martin; Wiesweg, Marcel
    MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e441 - e463
  • Reis, Henning; van der Vos, Kristan E.; Niedworok, Christian; Herold, Thomas; Módos, Orsolya; Szendroi, Attila; Hager, Thomas; Ingenwerth, Marc; Vis, Daniël J.; Behrendt, Mark A.; de Jong, Jeroen; van der Heijden, Michiel S.; Peyronnet, Benoit; Mathieu, Romain; Wiesweg, Marcel; Ablat, Jason; Okon, Krzysztof; Tolkach, Yuri; Keresztes, David; Nagy, Nikolett; Bremmer, Felix; Gaisa, Nadine T.; Chlosta, Piotr; Kriegsmann, Joerg; Kovalszky, Ilona; Timar, József; Kristiansen, Glen; Radzun, Heinz-Joachim; Knüchel, Ruth; Schuler, Martin; Black, Peter C.; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; van Rhijn, Bas W.G.; Nyirády, Péter; Szarvas, Tibor
    Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
    In: International Journal of Cancer Jg. 143 (2018) Nr. 7, S. 1764 - 1773
  • Tewes, Mitra; Rettler, Teresa Maria; Beckmann, Mingo; Scheer, Karin; Ritterbusch, Ulrike; Schuler, Martin; Hense, Jörg
    Patient-Reported-Outcome-Messung (PROM) psychosozialer Belastung und Symptome für ambulante Patienten unter kurativer oder palliativer Tumortherapie : eine retrospektive Analyse eines Comprehensive Cancer Center
    In: Der Onkologe Jg. 24 (2018) Nr. 1, S. 69 - 75
  • Rodon, Jordi; Pérez-Fidalgo, Alejandro; Krop, Ian E.; Burris, Howard; Guerrero-Zotano, Angel; Britten, Carolyn D.; Becerra, Carlos; Schellens, Jan; Richards, Donald A.; Schuler, Martin; Abu-Khalaf, Maysa; Johnson, Faye M.; Ranson, Malcolm; Edenfield, Jeff; Silva, Antonio P.; Hackl, Wolfgang; Quadt, Cornelia; Demanse, David; Duval, Vincent; Baselga, Jose
    Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer
    In: Cancer Chemotherapy and Pharmacology Jg. 82 (2018) Nr. 2, S. 285 - 298
  • Juric, Dejan; Rodon, Jordi; Tabernero, Josep; Janku, Filip; Burris, Howard A.; Schellens, Jan H.M.; Middleton, Mark R.; Berlin, Jordan; Schuler, Martin; Marta, Gil-Martin; Rugo, Hope S.; Ruth, Seggewiss-Bernhardt; Huang, Alan; Bootle, Douglas; Demanse, David; Blumenstein, Lars; Coughlin, Christina; Quadt, Cornelia; Baselga, José
    Phosphatidylinositol 3-kinase a–selective inhibition with alpelisib (BYL719) in PIK3CA-altered solid tumors : Results from the first-in-human study
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 13, S. 1291 - 1299
  • Wiesweg, Marcel; Reis, Henning; Köster, Tobias; Goetz, Moritz; Worm, Karl; Herold, Thomas; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Markus, Peter; Virchow, Isabel; Kostbade, Karina; Wolf, Nathalie; Zaun, Gregor; Metzenmacher, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
    In: Clinical Colorectal Cancer Jg. 17 (2018) Nr. 2, S. e331 - e352
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Pre-therapeutic metabolic Tumor Volume (MTV) in (18) F-FDG-PET/CT as a prognostic Factor in Patients with Stage IIIA-IIIB NSCLC before Trimodal Therapy or definitive Chemoradiotherapy - Results of Phase 3 Study
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 194 (2018) Nr. Suppl.1, S. S41 - S42
  • Tewes, Mitra; Rettler, Teresa; Wolf, Nathalie; Hense, Jörg; Schuler, Martin; Teufel, Martin; Beckmann, Mingo
    Predictors of outpatients’ request for palliative care service at a medical oncology clinic of a German comprehensive cancer center
    In: Supportive Care in Cancer Jg. 26 (2018) Nr. 10, S. 3641 - 3647
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Cheufou, D.; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Pretreatment metabolic volume in PET : Prognostic in lung cancer? German ESPATUE randomised phase3trial
    In: Radiotherapy and Oncology (The Green Journal) Jg. 127 (2018) Nr. Suppl.1, S. S253 - S254
  • Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Worm, Karl; Christoph, Daniel; Wiesweg, Marcel; Freitag, Lutz; Schmid, Kurt Werner; Theegarten, Dirk; Hager, Thomas; Koenig, Michael J.; He, Kai; Taube, Christian; Schuler, Martin; Breitenbücher, Frank
    Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 6, S. e879 - e884
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gauler, Thomas; Guberina, M.; Darwiche, Kaid; Aigner, Clemens; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Stuschke, Martin
    Sequential Dose Escalation Study NEOAHA for locally advanced NSCLC - Phase I-Results of Stage 1 (Integrated Boost-Radiation in neoadjuvant Therapy)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 194 (2018) Nr. Suppl. 1, S. S23 - S24
  • Joerger, M.; Soo, R. A.; Cho, B. C.; Navarro, A.; Sayehli, C. M.; Richly, Heike; Tai, D.; Kim, D. W.; Wolf, J.; Cassier, P.; Bender, S.; Ellinghaus, P.; Ince, S.; Rajagopalan, P.; Ocker, M.; Schuler, Martin
    A novel mRNA-based patient selection strategy identifies fibroblast growth factor receptor (FGFR) inhibitor-sensitive tumors : Results from rogaratinib Phase-1 study
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
  • Van Geel, Robin M. J. M.; Tabernero, Josep; Elez, Elena; Bendell, Johanna C.; Spreafico, Anna; Schuler, Martin; Yoshino, Takayuki; Delord, Jean-Pierre; Yamada, Yasuhide; Lolkema, Martijn P.; Faris, Jason E.; Eskens, Ferry A. L. M.; Sharma, Sunil; Yaeger, Rona; Lenz, Heinz-Josef; Wainberg, Zev A.; Avsar, Emin; Chatterjee, Arkendu; Jaeger, Savina; Tan, Eugene; Maharry, Kati; Demuth, Tim; Schellens, Jan H. M.
    A phase Ib dose-escalation study of encorafenib and cetuximab with or without alpelisib in metastatic BRAF-mutant colorectal cancer
    In: Cancer Discovery Jg. 7 (2017) Nr. 6, S. 610 - 619
  • Schadendorf, Dirk; Schuler, Martin
    Checkpointinhibitoren
    In: Der Onkologe Jg. 23 (2017) Nr. 8, S. 619 - 625
  • Breitenbücher, Frank; Von Pawel, Joachim; Sebastian, Martin; Kortsik, Cornelius; Ting, Saskia; Kasper, Stefan; Wohlschläger, Jeremias; Worm, Karl; Morresi-Hauf, Alicia; Schad, Arno; Westerwick, Daniela; Wehler, Beatrice; Werner, Martin; Munzert, Gerd; Gaschler-Markefski, Birgit; Schmid, Kurt Werner; Schuler, Martin
    Comprehensive biomarker analyses in patients with advanced or metastatic non-small cell lung cancer prospectively treated with the polo-like Kinase 1 Inhibitor BI2536
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. 7-8, S. 435 - 439
  • Wieczorek, Sarah A.; Breitenbücher, Frank; Soni, Aashish; Paul-Konietzko, Katja; Ziegler, Sophie; Sak, Ali; Iliakis, George; Schuler, Martin
    Deregulated BCL-2 family proteins impact on repair of DNA double-strand breaks and are targets to overcome radioresistance in lung cancer
    In: Journal of Cancer Research and Clinical Oncology Jg. 143 (2017) Nr. 9, S. 1733 - 1744
  • Al-Batran, S. E.; Pauligk, C.; Homann, N.; Schmalenberg, H.; Kopp, H. G.; Haag, G. M.; Luley, K.; Folprecht, G.; Probst, S.; Thuss-Patience, P.; Trojan, J.; Koenigsmann, M.; Lindig, U.; Pohl, M.; Kasper, Stefan; Hler, M. M.; Goetze, T.; Schuler, Martin; Jaeger, E.; Hofheinz, R. D.
    Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer : Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
  • Wu, Yi-Long; Sequist, Lecia V; Hu, Cheng-Ping; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Li, Wei; Hou, Mei; Schuler, Martin; Mok, Tony; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Gibson, Neil; Massey, Dan; Kim, Miyoung; Yang, James Chih-Hsin
    EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients : analysis of LUX-Lung 3 and 6
    In: British Journal of Cancer (BJC) Jg. 116 (2017) Nr. 2, S. 175 - 185
  • Nogova, Lucia; Sequist, Lecia V.; Garcia, Jose Manuel Perez; Andre, Fabrice; Delord, Jean-Pierre; Hidalgo, Manuel; Schellens, Jan H.M.; Cassier, Philippe A.; Camidge, D. Ross; Schuler, Martin; Vaishampayan, Ulka; Burris, Howard; Tian, G. Gary; Campone, Mario; Wainberg, Zev A.; Lim, Wan-Teck; LoRusso, Patricia; Shapiro, Geoffrey I.; Parker, Katie; Chen, Xueying; Choudhury, Somesh; Ringeisen, Francois; Graus-Porta, Diana; Porter, Dale; Isaacs, Randi; Buettner, Reinhard; Wolf, Jürgen
    Evaluation of BGJ398, a Fibroblast growth factor receptor 1-3 kinase inhibitor, in patientswith advanced solid tumors harboring genetic alterations in fibroblast growth factor receptors : Results of a global phase I, dose-escalation and dose-expansion study
    In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 2, S. 157 - 165
  • Tureci, Özlem; Wiechen, Kai; Bazin, Igor; Maurus, Daniel; Schuler, Martin; Zvirbule, Zanete; Sahin, Ugur; Dhaene, Karl; Al-Batran, Salah-Eddin; Vynnychenko, Ihor; Melichar, Bohuslav; Rusyn, Andriy V.; Manikhas, Georgy; Dudov, Assen; Lordick, Florian
    Expression of Claudin 18.2 and HER2 in gastric, gastroesophageal junction, and esophageal cancers : Results from the FAST study
    In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) S. 4038 - 4038
  • Schuler, Martin; Paz-Ares, L.; Sequist, L. V.; Tan, E. H.; Mok, T.; Hirsh, V.; O'Byrne, K.; Zhang, Lihua; Yamamoto, N.; Boyer, M.; Shah, R.; Bennouna, J.; Dickgreber, N. J.; De Greve, J.; Love, J.; Marten, A.; Fan, J.; Ehrnrooth, E.; Park, K.; Yang, JCH
    First-line afatinib for advanced EGFR mutation-positive (EGFRm plus ) NSCLC : analysis of long-term responders in the Phase III LUX-Lung 3, 6 and 7 trials
    In: European Journal of Cancer (EJC) Jg. 72 1 (2017) S. 176 - S177
  • Schuler, Martin; Paz-Ares, L.; Sequist, L. V.; Wu, Y. L.; Geater, S. L.; Marten, A.; Fandrey, Joachim; Park, K.; Yang, JCH
    First-line afatinib for advanced EGFRm1 NSCLC : Analysis of long-term responders (LTRs) in the LUX-Lung (LL) 3, 6 and 7 trials
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 2,
  • Schuler, Martin; Paz-Ares, L.; Sequist, L. V.; Sebastian, M.; Wu, Y. L.; Geater, S. L.; Marten, A.; Fan, J.; Park, K.; Yang, JCH
    First-line afatinib in patients with EGFR mutation-positive (EGFRm+) non-small-cell lung cancer (NSCLC) : analysis of long-term responders (LTRs) in the LUX-Lung 3, 6 and 7 trials
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 172
  • Hochmair, M.; Cappuzzo, F.; Tsai, C. M.; Schuler, Martin; Lam, K. C.; Stehle, G.; Cseh, A.; Lorence, R. M.; Linden, S.; Carriere, P.; Soo, R.
    Global named patient use (NPU) program of afatinib in heavily pretreated advanced NSCLC patients who progressed following prior therapies, including erlotinib or gefitinib
    In: European Journal of Cancer (EJC) Jg. 72 1 (2017) S. 183 - S184
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Heinzelmann, F.; Cheufou, D.; Kimmich, M.; Friedel, G.; Schmidberger, H.; Darwiche, Kaid; Jendrossek, Verena; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer : secondary analysis of a randomized trial
    In: Annals of Oncology Jg. 28 (2017) Nr. 5, S. 1084 - 1089
  • Tewes, Mitra; Peis, Michael Wilhelm; Bogner, Simon; Theysohn, Jens; Reinboldt, Marcus Paul; Schuler, Martin; Welt, Anja
    Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer : efficacy, safety and prognostic parameters
    In: Journal of Cancer Research and Clinical Oncology Jg. 143 (2017) Nr. 10, S. 2131 - 2141
  • Wiesweg, Marcel; Eberhardt, Wilfried; Reis, Henning; Ting, Saskia; Savvidou, Nikoleta; Skiba, Charlotte; Herold, Thomas; Christoph, Daniel; Meiler, Johannes; Worm, Karl; Kasper, Stefan; Theegarten, Dirk; Hense, Jörg; Hager, Thomas; Darwiche, Kaid; Oezkan, Filiz; Aigner, Clemens; Welter, Stefan; Kühl, Hilmar; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin
    High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 1, S. 54 - 64
  • Okimoto, Ross A; Breitenbücher, Frank; Olivas, Victor R; Wu, Wei; Gini, Beatrice; Hofree, Matan; Asthana, Saurabh; Hrustanovic, Gorjan; Flanagan, Jennifer; Tulpule, Asmin; Blakely, Collin M; Haringsma, Henry J; Simmons, Andrew D; Gowen, Kyle; Suh, James; Miller, Vincent A; Ali, Siraj; Schuler, Martin; Bivona, Trever G.
    Inactivation of Capicua drives cancer metastasis
    In: Nature Genetics Jg. 49 (2017) Nr. 1, S. 87 - 96
  • Thress, Kenneth S.; Jacobs, Vivien; Angell, Helen K.; Yang, James Chih-Hsin; Sequist, Lecia V.; Blackhall, Fiona; Su, Wu-Chou; Schuler, Martin; Wolf, Jürgen; Gold, Kathryn A.; Cantarini, Mireille; Barrett, J. Carl; Jänne, Pasi A.
    Modulation of Biomarker Expression by Osimertinib : Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I Trial
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 10, S. 1588 - 1594
  • Kasper, Stefan; Reis, Henning; Ziegler, Sophie; Nothdurft, Silke; Mueller, Andre; Goetz, Moritz; Wiesweg, Marcel; Phasue, Jeannette; Ting, Saskia; Wieczorek, Sarah; Even, Anna; Worm, Karl; Pogorzelski, Michael; Breitenbuecher, Sandra; Meiler, Johannes; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Breitenbücher, Frank; Schuler, Martin
    Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy
    In: OncoTarget Jg. 8 (2017) Nr. 28, S. 45898 - 45917
  • Al-Batran, S. E.; Pauligk, C.; Homann, N.; Schmalenberg, H.; Kopp, H. G.; Haag, G. M.; Luley, K. B.; Schmiegel, W.; Folprecht, G.; Probst, S.; Prasnikar, N.; Thuss-Patience, P.; Fischbach, W.; Trojan, J.; Koenigsmann, M.; Goetze, T. O.; Kraus, T. W.; Battmann, A.; Moenig, S. P.; Bechstein, W.; Gaiser, T.; Tannapfel, A.; Jäger, E.; Schuler, Martin; Lindig, U.; Pohl, M.; Kasper, Stefan; Möhler, M.; Hofheinz, R. D.
    Perioperative chemotherapy with docetaxel, oxaliplatin and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO) : a rando
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 200 - 201
  • Al-Batran, Salah-Eddin; Homann, Nils; Schmalenberg, Harald; Kopp, Hans-Georg; Haag, Georg Martin; Luley, Kim Barbara; Schmiegel, Wolff H.; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Thuss-Patience, Peter C.; Fischbach, Wolfgang; Trojan, Jorg; Koenigsmann, Michael; Pauligk, Claudia; Goetze, Thorsten Oliver; Jaeger, Elke; Meiler, Johannes; Schuler, Martin; Hofheinz, Ralf
    Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO) : A multicenter, randomized phase 3 trial
    In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 15_suppl, 4004
  • Schuler, Martin; Chan, S. L.; Yen, C.; Lin, C.; Choo, S. P.; Weiss, K.; Geier, A.; Okusaka, T.; Lim, H. Y.; Macarulla, T.; Zhu, A. X.; Kakizume, T.; Gu, Y.; Porta, D. G.; Myers, A. P.; Delord, J.
    Phase I/II study of FGF401 in adult patients (pts) with hepatocellular carcinoma (HCC) or solid tumors and positive FGFR4/KLB expression
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, S. 234 - 235
  • Sebastian, M.; Schuler, Martin; Schulz, C.; Deschler-Baier, B.; Kimmich, M.; Hilgert-Daute, K.; Griesinger, F.
    Randomised Phase III study of osimertinib vs platinum-pemetrexed for EGFR T790M-positive advanced NSCLC (AURA3)
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 170
  • Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Christoph, Daniel; Worm, Karl; Freitag, Lutz; Schmid, Kurt Werner; Hager, Thomas; Breitenbücher, Frank; Schuler, Martin
    Rapid and Highly Sensitive EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA Specimen of Lung Adenocarcinoma
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. Suppl. 1, S. S1201 - S1201
  • Scheulen, Max Ernst; Kaempgen, Eckhart; Keilholz, Ulrich; Heinzerling, Lucie; Ochsenreither, Sebastian; Abendroth, Annalena; Huger, Ralf A.; Grubert, Matthias; Wetter, Axel; Guberina, Nika; Bauer, Sebastian; Schuler, Gerold; Bornfeld, Norbert; Schuler, Martin; Richly, Heike
    STREAM : A randomized discontinuation, blinded, placebo-controlled phase II study of sorafenib (5) treatment of chemonaive patients (pts) with metastatic uveal melanoma (MUM)
    In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 15, S. 9511
  • Kalkavan, Halime; Sharma, Piyush; Kasper, Stefan; Helfrich, Iris; Pandyra, Aleksandra A.; Gassa, Asmae; Virchow, Isabel; Flatz, Lukas; Brandenburg, Tim; Namineni, Sukumar; Heikenwalder, Mathias; Höchst, Bastian; Knolle, Percy A.; Wollmann, Guido; Von Laer, Dorothee; Drexler, Ingo; Rathbun, Jessica; Cannon, Paula M.; Scheu, Stefanie; Bauer, Jens; Chauhan, Jagat; Häussinger, Dieter; Willimsky, Gerald; Löhning, Max; Schadendorf, Dirk; Brandau, Sven; Schuler, Martin; Lang, Philipp A.; Lang, Karl S.
    Spatiotemporally restricted arenavirus replication induces immune surveillance and type i interferon-dependent tumour regression
    In: Nature Communications Jg. 8 (2017) S. 14447
  • Sequist, L.; Wu, Y. L.; Schuler, Martin; Kato, T.; Yang, JCH; Tanaka, H.; Hida, T.; Lu, S.; Park, K.; Laurie, S.; Bennouna, J.; Sibilot, D. M.; Marten, A.; Peil, B.; Ehrnrooth, E.; Yamamoto, N.; Nakagawa, K.
    Subsequent therapies post-afatinib among patients (pts) with EGFR mutation-positive (EGFRm plus ) NSCLC in LUX-Lung (LL) 3, 6 and 7
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
  • Cappuzzo, Federico; Soo, Ross Andrew; Hochmair, Maximilian Johannes; Schuler, Martin; Mok, Tony Shu Kam; Stehle, Gerd; Cseh, Agnieszka; Lorence, Robert M..; Linden, Stephan; Forman, Nicole D.; Tsai, Chunming
    1236P - Global named patient use (NPU) program of afatinib, an oral ErbB family blocker, in heavily pretreated advanced non-small cell lung carcinoma (NSCLC) patients who progressed following prior therapies, including erlotinib or gefitinib (E/G)
    In: Annals of Oncology Jg. 27 (2016) Nr. Supplement 6, S. vi427
  • Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Jürgen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Sutradhar, Santosh; Li, Siyu; Szczudlo, Tomasz; Yovine, Alejandro; Shaw, Alice T
    Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1) : updated results from the multicentre, open-label, phase 1 trial
    In: The Lancet Oncology Jg. 17 (2016) Nr. 4, S. 452 - 463
  • Fein, Luis; Wu, Yi-Long; Sequist, Lecia V; Geater, Sarayut L; Orlov, Sergey; Lee, Ki Hyeong; Tsai, Chun-Ming; Kato, Terufumi; Kiura, Katsuyuki; Barrios, Carlos H; Schuler, Martin; Hirsh, Vera; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Mok, Tony; Massey, Dan; Märten, Angela; Chih-Hsin Yang, James
    Afatinib Versus Chemotherapy for EGFR Mutation-Positive NSCLC Patients Aged >=65 Years : Subgroup Analysis of LUX-Lung 3/6: P1.33: Track: Advanced NSCLC
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 10 Supplement, S. 202 - S.203
  • Yang, J C-H; Park, K; Kim, J-H; Bennouna, J; Chen, Y-M; Chouaid, C; De Marinis, F; Feng, J-F; Grossi, F; Kim, D-W; Liu, X; Lu, S; Strausz, J; Vinnyk, Y; Wiewrodt, R; Zhou, C; Wang, B; Chand, V K; Planchard, D; Ignatius Ou, Sai Hong; Planchard, David; Park, Keunchil; Schuler, Martin; Yang, James; Chand, Vikram; Rohr, Klaus; Bagnes, Claudia; Martin, Claudio Marcelo; Recondo, Gonzalo; Zarba, Juan Jose; Blajman, Cesar; Richardet, Martín; McLachlan, Sue-Anne; Parente, Phillip; Underhill, Craig; Crombie, Catherine; Mainwaring, Paul; Greil, Richard; Humblet, Yves; Bustin, Frédérique; Carestia, Luciano; Galdermans, Danny; Lambrechts, Marc; Delval, Laetitia; Vercauter, Piet; Zhou, Caicun; Wang, Jin; Huang, Cheng; Lin, Xiaoyan; Wu, Yilong; Liu, Xiaoqing; Cheng, Ying; Qin, Shukui; Feng, Jifeng; Huang, Jianjin; Zhang, Yiping; Lu, Shun; Zereu, Manuela; Garicochea, Bernardo; Zadra, Cyntia Albuquerque; Riska, Henrik; Alanko, Tuomo; Cadranel, Jacques; Chouaid, Christos; Zalcman, Gérard; Sibilot, Denis Moro; Perol, Maurice; Planchard, David; Bennouna, Jaafar; Fournel, Pierre; Gervais, Radj; Rotarski, Maciej; Coudert, Bruno; Schuler, Martin; Thomas, Michael; Wehler, Thomas; Faehling, Martin; Keilholz, Ulrich; Laack, Eckart; von Pawel, Joachim; Huber, Rudolf; Dickgreber, Nicolas; Wiewrodt, Rainer; Mark, Zsuzsanna; Tehenes, Sandor; Strausz, Janos; Sarosi, Veronika; Prabhash, Kumar; Jain, Minish; Venkatesan, Srinivasan; Sharma, Lalit; Dadhich, Hemant; Nagarkar, Rajnish Vasant; Onn, Amir; Gottfried, Maya; Stemmer, Solomon; Migliorino, Maria Rita; Grossi, Francesco; Bidoli, Paolo; Bearz, Alessandra; Gridelli, Cesare; Milandri, Carlo; Platania, Marco; Ceresoli, Giovanni Luca; Cruciani, Giorgio; Delgado, Francisco Gutierrez; Gonzalez Perez, José Luis; Luna, Gabriela Alvarado; Baca, Othon Padilla; Aerts, J G J V; Stigt, J A; Dingemans, A M C; Herder, G J M; Gans, S J M; Salas Sánchez, Jorge Fernando; Alvarez Barreda, Renzo Luzgardo; Pantigoso, Wilbert Rodriguez; Palomino, Osbert Luis Mejia; Jaskiewicz, Piotr; Kazarnowicz, Andrzej; Serwatowski, Piotr; Szczesna, Aleksandra; Jassem, Jacek; Lubennikov, Vladimir; Karaseva, Nina; Orlov, Sergey; Ragulin, Yuri; Garrido, Pilar; González Larriba, José Luis; Camps, Carlos; Campelo, Rosario García; Lianes, Pilar; Cobo, Manuel; Felip, Enriqueta; Kim, Dong-Wan; Kim, Sang-We; Park, Keunchil; Kim, Joo-Hang; Han, Ji-Youn; Kim, Young-Chul; Yang, Chih-Hsin; Hsia, Te-Chun; Chen, Yuh-Min; Tsai, Ying-Huang; Chang, Gee-Chen; Tsao, Thomas Chang-Yao; Su, Wu-Chou; Huang, Ming-Shyan; Ho, Ching-Liang; Hsieh, Ruey-Kuen; Vinnyk, Yuriy; Popovych, Oleksandr; Ponomarova, Olga; Bondarenko, Igor; Polishchuk, Iryna; Shah, Riyaz; Mitra, Sanka; Popat, Sanjaykumar; Spicer, James; Toy, Elizabeth; Popat, Sanjaykumar; Talbot, Toby; Brown, Emma; Upadhyay, Sunil; Summers, Yvonne; Gurtler, Jayne; Meza, Luis; Thropay, John
    Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib : phase III randomized LUX-Lung 5 trial
    In: Annals of Oncology Jg. 27 (2016) Nr. 3, S. 417 - 423
  • Reimer, P.; Höhler, T.; Schuler, Martin; Markus, P.; Knipp, Heike; Schumacher, B.; Dechene, Alexander; Ting, Saskia; Kasper, S.; Meiler, Johannes; Kostbade, K.; Berger, W.; Herold, T.; Trarbach, Tanja; Linden, G.; Steinmetz, H.T.; Schmid, Kurt Werner; Worm, K.; Paul, A.
    Cetuximab biweekly (q2w) plus mFOLFOX6 as 1st line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) – Primary endpoint and subgroup analysis of the CEBIFOX trial
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl.6, S. 508P
  • Nel, Ivonne; Gauler, Thomas; Bublitz, Kira; Lazaridis, Lazaros; Goergens, André; Giebel, Bernd; Schuler, Martin; Hoffmann, Andreas-Claudius
    Circulating Tumor Cell Composition in Renal Cell Carcinoma
    In: PLoS ONE Jg. 11 (2016) Nr. 4, S. e0153018
  • Köhler, Jens; Schuler, Martin; Gauler, Thomas; Nöpel-Dünnebacke, Stefanie; Ahrens, Maike; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, Maria; Breitenbücher, Frank; Cheufou, Danjouma; Özkan, Filiz; Darwiche, Kaid; Hoiczyk, Mathias; Reis, Henning; Welter, Stefan; Eberhardt, Wilfried; Eisenacher, Martin; Teschler, Helmut; Stamatis, Georgios; Schmiegel, Wolff; Hahn, Stephan Albrecht; Baraniskin, Alexander
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    In: Journal of Cancer Research and Clinical Oncology Jg. 142 (2016) Nr. 4, S. 795 - 805
  • Tabernero, J.; van Geel, R.; Guren, T.; Yaeger, R.; Spreafico, A.; Faris, J.; Yoshino, T.; Yamada, Y.; Tae, W. K.; Bendell, J.; Schuler, Martin; Lenz, H. J.; Eskens, F.; Desai, J.; Hochster, H.; Avsar, E.; Demuth, T.; Sandor, V.; Elez, E.; Schellens, J.
    Combination of encorafenib and cetuximab with or without alpelisib in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC) : phase 2 results
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 2, S. ii127 - ii128
  • Stang, Andreas; Jöckel, Karl-Heinz; Kühl, Hilmar; Darwiche, Kaid; Schuler, Martin; Kowall, Bernd
    Concluding remarks : [Korrespondenz zu "Lung Cancer Screening Using Low Dose CT Scanning in Germany by Prof. Dr. med. Andreas Stang, MPH, Prof. Dr. med. Martin Schuler, Dr. rer. nat. Dr. rer. san. Bernd Kowall, Dr. med. Kaid Darwiche, PD Dr. med. Hilmar Kühl, and Prof. Dr. rer. nat. Karl-Heinz Jöckel in issue 38/2015"]
    In: Deutsches Ärzteblatt international Jg. 113 (2016) Nr. 17, S. 297 - 298
  • Stintzing, S.; Modest, D. P.; Jung, A.; Kirchner, T.; Schafer, R.; Sers, C.; Hildebrandt, B.; Daum, S.; Folprecht, G.; Schuler, Martin; Kasper, Stefan; Trojan, J.; Jaeger, D.; Schulze-Bergkamen, H.; von Weikersthal, L. F.; Schalhorn, A.; Heinemann, V.
    Differences in gene-expression in mCRC tissue samples with regard to tumor location and used chemotherapeutic substances : Data of the FIRE-1 study
    In: Journal of Clinical Oncology (JCO) Jg. 34 (2016) Nr. Suppl. 4, S. 562
  • Yang, J C-H; Sequist, L V; Zhou, C; Schuler, Martin; Geater, S L; Mok, T; Hu, C-P; Yamamoto, N; Feng, J; O'Byrne, K; Lu, S; Hirsh, V; Huang, Y; Sebastian, M; Okamoto, I; Dickgreber, N; Shah, R; Märten, A; Massey, D; Wind, S; Wu, Y-L
    Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma : post hoc analyses of the randomized LUX-Lung 3 and 6 trials
    In: Annals of Oncology Jg. 27 (2016) Nr. 11, S. 2103 - 2110
  • Schuler, Martin; Sequist, Lecia; Popat, Sanjay; Mok, Tony; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Wu, Yi-Long
    First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 3, S. 380 - 390
  • Stang, Andreas; Kowall, Bernd; Schuler, Martin; Jöckel, Karl-Heinz
    Früherkennung von Lungenkrebs : Low-dose-Computertomographie-Screening
    In: Der Onkologe Jg. 22 (2016) Nr. 8, S. 568 - 577
  • Al-Batran, Salah-Eddin; Hofheinz, Ralf D; Pauligk, Claudia; Kopp, Hans-Georg; Haag, Georg Martin; Luley, Kim Barbara; Meiler, Johannes; Homann, Nils; Lorenzen, Sylvie; Schmalenberg, Harald; Probst, Stephan; Koenigsmann, Michael; Egger, Matthias; Prasnikar, Nicole; Caca, Karel; Trojan, Jörg; Martens, Uwe M; Block, Andreas; Fischbach, Wolfgang; Mahlberg, Rolf; Clemens, Michael; Illerhaus, Gerald; Zirlik, Katja; Behringer, Dirk M; Schmiegel, Wolff; Pohl, Michael; Heike, Michael; Ronellenfitsch, Ulrich; Schuler, Martin; Bechstein, Wolf O; Königsrainer, Alfred; Gaiser, Timo; Schirmacher, Peter; Hozaeel, Wael; Reichart, Alexander; Goetze, Thorsten O; Sievert, Mark; Jäger, Elke; Mönig, Stefan; Tannapfel, Andrea
    Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO
    In: The Lancet Oncology Jg. 17 (2016) Nr. 12, S. 1697 - 1708
  • Al-Batran, S. E.; Schuler, Martin; Zvirbule, Z.; Manikhas, G.; Lordick, F.; Tureci, O.; Huber, C.; Sahin, U.
    IMAB362 : a novel immunotherapeutic antibody targeting the tight-junction protein component CLAUDIN18.2 in gastric cancer
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 2, S. ii141 - ii142
  • Barrios, Carlos H; Wu, Yi-Long; Chih-Hsin Yang, James; Sequist, Lecia V; Geater, Sarayut L; Mok, Tony; Hu, Cheng-Ping; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Lu, Shun; Hirsh, Vera; Sebastian, Martin; Okamoto, Isamu; Shah, Riyaz; Märten, Angela; Massey, Dan; Wind, Sven; Schuler, Martin
    Impact of Dose Adjustment on Afatinib Safety and Efficacy in EGFR Mutation-Positive NSCLC: Post-Hoc Analyses of LUX-Lung 3/6: Track: Advanced NSCLC
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 10 Supplement, S. 210 - S. 211
  • Schuler, Martin; Yang, J; Sequist, L V; Yamamoto, N; Zhou, C; O'Byrne, K; Hirsh, V; Mok, T; Shah, R; Wu, Y-L
    Impact of dose adjustment on the safety and efficacy of afatinib in patients (pts) with advanced EGFR mutation-positive non-small cell lung cancer (NSCLC): Post-hoc analyses of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6) : 138PD
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. Suppl. 4, S. 116 - 117
  • Falkenhorst, Johanna; Grunewald, Susanne; Mühlenberg, Thomas; Marino-Enriquez, Adrian; Reis, Anna-Carina; Corless, Christopher; Heinrich, Michael; Treckmann, Jürgen-Walter; Podleska, Lars; Schuler, Martin; Fletcher, Jonathan Alfred; Bauer, Sebastian
    Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib
    In: OncoTarget Jg. 7 (2016) Nr. 27, S. 41390 - 41403
  • Schuler, Martin; Yang, J. C.-H.; Planchard, D.
    Reply to the letter to the editor ‘What is the clinical impact of the LUX-Lung 5 trial?’ by Addeo
    In: Annals of Oncology Jg. 27 (2016) Nr. 6, S. 1172 - 1173
  • Hoya, V.; Stuschke, Martin; Sauerwein, Wolfgang; Bornfeld, Norbert; Metz, Klaus; Schuler, Martin; Kasper, Stefan
    Small cell neuroendocrine carcinoma of the right eye : A case report
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 189 - 189
  • Joerger, M.; Soo, R.; Cho, B.C.; Mendivil, A. Navarro; Sayehli, C.; Richly, Heike; Tai, D.; Kim, D.-W.; Wolf, J.; Cassier, P.; Ellinghaus, P.; Hildebrandt, S.; Behre, S.; Helmbrecht, C.; Kerpen, S.; Zielinski, D.; Ince, S.; Rajagopalan, P.; Ocker, M.; Schuler, Martin
    developmental therapeuticsPhase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levels
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, 360O_PR
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, Eleni; Freitag, Lutz; Lübcke, Wolfgang; Welter, Stefan; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Stamatis, Georgios; Stuschke, Martin
    Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy
    In: Journal of Thoracic Disease Jg. 7 (2015) Nr. 3, S. 264 - 272
  • Wu, Y. L.; Sequist, L. V.; Geater, S. L.; Orlov, S.; Lee, K. H.; Tsai, C. M.; Kato, T.; Kiura, K.; Barrios, C. H.; Schuler, Martin; Hirsh, V.; Yamamoto, N.; OByrne, K.; Mok, T.; Massey, D.; Marten, A.; Yang, J. C. H.
    Afatinib (A) versus chemotherapy (CT) for EGFR mutation-positive NSCLC patients (pts) aged ≥65 years : Subgroup analyses of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)
    In: Annals of Oncology Jg. 26 (2015) Nr. S 9: ESMO Asia Congress, 18-21 December 2015, Singapore : Submitted Abstracts, S. 136 - 137
  • Schuler, Martin; Yang, J. C. H.; Park, K.; Chand, V. K.; Wang, B.; Planchard, D.
    Afatinib (a) plus paclitaxel (p) following progression on a monotherapy in patients (pts) with metastatic non-small-cell lung cancer (nsclc) who previously benefited from erlotinib (e)/gefitinib (g) : a global randomised phase iii triallux-lung 5 (ll5)
    In: Annals of Oncology Jg. 26 (2015) Nr. S 1, S. i33 - i34
  • Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Orlov, Sergey; Mok, Tony; Boyer, Michael; Su, Wu-Chou; Lee, Ki Hyeong; Kato, Terufumi; Massey, Dan; Shahidi, Mehdi; Zazulina, Victoria; Sequist, Lecia V
    Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6) : analysis of overall survival data from two randomised, phase 3 trials
    In: The Lancet Oncology Jg. 16 (2015) Nr. 2, S. 141 - 151
  • Breitenbücher, Frank; Schuler, Martin; Markova, Boyka
    Alternative tumor suppressor mechanisms in lung carcinomas - modulation of senescence by growth factor-induced signaling
    In: Cancer Research Jg. 75 (2015) Nr. 15 Suppl., S. 1033
  • Richly, Heike; Kim, Tae Min; Schuler, Martin; Kim, Dong-Wan; Harrison, Simon J.; Shaw, Alice T.; Boral, Anthony L.; Yovine, Alejandro; Solomon, Benjamin
    Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma
    In: Blood Jg. 126 (2015) Nr. 10, S. 1257 - 1258
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hoehler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Ting, Saskia; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kosbade, Karina; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) : Primary endpoint and subgroup analysis of the CEBIFOX trial
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15 Suppl., S. 3568
  • Yang, James C.-H.; Sequist, Lecia V.; Geater, Sarayut Lucien; Tsai, Chun-Ming; Mok, Tony Shu Kam; Schuler, Martin; Yamamoto, Nobuyuki; Yu, Chong-Jen; Ou, Sai-Hong I.; Zhou, Caicun; Massey, Daniel; Zazulina, Victoria; Wu, Yi-Long
    Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations : A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
    In: The Lancet Oncology Jg. 16 (2015) Nr. 7, S. 830 - 838
  • George, Julie; Lim, Jing Shan; Jang, Se Jin; Cun, Yupeng; Ozretia, Luka; Kong, Gu; Leenders, Frauke; Lu, Xin; Fernández-Cuesta, Lynnette; Bosco, Graziella; Müller, Christian; Dahmen, Ilona; Jahchan, Nadine S.; Park, Kwon-Sik; Yang, Dian; Karnezis, Anthony N.; Vaka, Dedeepya; Torres, Angela; Wang, Maia Segura; Korbel, Jan O.; Menon, Roopika; Chun, Sung-Min; Kim, Deokhoon; Wilkerson, Matt; Hayes, Neil; Engelmann, David; Pützer, Brigitte; Bos, Marc; Michels, Sebastian; Vlasic, Ignacija; Seidel, Danila; Pinther, Berit; Schaub, Philipp; Becker, Christian; Altmüller, Janine; Yokota, Jun; Kohno, Takashi; Iwakawa, Reika; Tsuta, Koji; Noguchi, Masayuki; Muley, Thomas; Hoffmann, Hans; Schnabel, Philipp A.; Petersen, Iver; Chen, Yuan; Soltermann, Alex; Tischler, Verena; Choi, Chang-Min; Kim, Yong-Hee; Massion, Pierre P.; Zou, Yong; Jovanovic, Dragana; Kontic, Milica; Wright, Gavin M.; Russell, Prudence A.; Solomon, Benjamin; Koch, Ina; Lindner, Michael; Muscarella, Lucia A.; La Torre, Annamaria; Field, John K.; Jakopovic, Marko; Knezevic, Jelena; Castaños-Vélez, Esmeralda; Roz, Luca; Pastorino, Ugo; Brustugun, Odd-Terje; Lund-Iversen, Marius; Thunnissen, Erik; Köhler, Jens; Schuler, Martin; Botling, Johan; Sandelin, Martin; Sanchez-Cespedes, Montserrat; Salvesen, Helga B.; Achter, Viktor; Lang, Ulrich; Bogus, Magdalena; Schneider, Peter M.; Zander, Thomas; Ansén, Sascha; Hallek, Michael; Wolf, Jürgen; Vingron, Martin; Yatabe, Yasushi; Travis, William D.; Nürnberg, Peter; Reinhardt, Christian; Perner, Sven; Heukamp, Lukas; Büttner, Reinhard; Haas, Stefan A.; Brambilla, Elisabeth; Peifer, Martin; Sage, Julien; Thomas, Roman K.
    Comprehensive genomic profiles of small cell lung cancer
    In: Nature Jg. 524 (2015) Nr. 7563, S. 47 - 53
  • Tewes, Mitra; Kasimir-Bauer, Sabine; Welt, Anja; Schuler, Martin; Kimmig, Rainer; Aktas, Bahriye
    Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer
    In: Journal of Cancer Research and Clinical Oncology Jg. 141 (2015) Nr. 1, S. 87 - 92
  • Jaeger, Savina; Spreafico, Anna; van Geel, Robin; Bendell, Johanna C.; Lolkema, Martijn P.; Tabernero, Josep; Lenz, Heinz-Josef; Schellens, Jan H. M.; Avsar, Emin; Wainberg, Zev A.; Yoshino, Takayuki; Eskens, Ferry A. L. M.; Sharma, Sunil; Delord, Jean-Pierre; Schuler, Martin; Chatterjee, Arkendu; Faris, Jason E.; Yaeger, Rona; Demuth, Tim; Yamada, Yasuhide
    Final biomarker analysis of the phase I study of the selective BRAF V600 inhibitor encorafenib (LGX818) combined with cetuximab with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF-mutant colorectal cancer
    In: Cancer Research Jg. 75 (2015) Nr. 15 Suppl., S. CT136
  • Reis, Henning; Herold, Thomas; Ting, S.; Worm, Karl Heinz; Huber, U.; Christoph, Daniel; Eberhardt, Wilfried; Kostbade, K.; Kasper, Stefan; Stamatis, Georgios; Welter, Stefan; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Theegarten, Dirk; Schmidt, K. W.; Schuler, Martin; Wiesweg, Marcel
    HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas
    In: Lung Cancer Jg. 88 (2015) Nr. 1, S. 34 - 41
  • Passaro, A.; Yang, J. C.; Ahn, M.; Dickgreber, N. J.; Halmos, B.; Hirsh, V.; Hochmair, M. J.; Levy, B. P.; de Marinis, F.; Mok, T.; OByrne, K.; Okamoto, I.; Schuler, Martin; Sebastian, M.; Shah, R.; Tan, E.; Yamamoto, N.; Marten, A.; Wind, S.; Carbone, D. P.
    Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC)
    In: Annals of Oncology Jg. 26 (2015) Nr. S 6, S. vi73 - vi89
  • Yang, James Chih-Hsin; Ahn, Myung-Ju; Dickgreber, Nicolas J.; Halmos, Balazs; Hirsh, Vera; Hochmair, Maximilian J.; Levy, Benjamin Philip; De Marinis, Filippo; Mok, Tony; O´Byrne, Kenneth; Okamoto, Isamu; Schuler, Martin; Sebastian, Martin; Shah, Riyaz N. H; Tan, Eng-Huat; Yamamoto, Nobuyuki; Marten, Angela; Massey, Dan; Wind, Sven; Carbone, David Paul
    Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC)
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 8073
  • Mühlenberg, Thomas; Grunewald, Susanne; Treckmann, Jürgen-Walter; Podleska, Lars; Schuler, Martin; Fletcher, Jonathan A.; Bauer, Sebastian
    Inhibition of KIT-Glycosylation by 2-Deoxyglucose Abrogates KIT-Signaling and Combination with ABT-263 Synergistically Induces Apoptosis in Gastrointestinal Stromal Tumor
    In: PLoS ONE Jg. 10 (2015) Nr. 3, S. e0120531
  • Stang, Andreas; Schuler, Martin; Kowall, Bernd; Darwiche, Kaid; Kühl, Hilmar; Jöckel, Karl-Heinz
    Lungenkrebsscreening mit Low-Dose-Computertomographie in Deutschland : Hochrechnung der Kennzahlen des National Lung Screening Trial
    In: Deutsches Ärzteblatt international Jg. 112 (2015) Nr. 38, S. 637 - 644
  • Pogorzelski, M.; Ting, Saskia; Gauler, Thomas; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, Stephan; Bergmann, Christoph; Brandau, Sven; Abu-Jawad, J.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapies
    In: Oral Oncology Jg. 51 (2015) Nr. 5, S. e39
  • Wu, Y. L.; Sequist, L. V.; Schuler, Martin; Yamamoto, N.; Zhou, C.; Hu, C. P.; OByrne, K.; Hirsh, V.; Mok, T.; Zazulina, V.; Yang, J. C. H.
    Overall survival (OS) with afatinib (A) vs chemotherapy (CT) in patients (pts) with NSCLC harboring EGFR mutations (mut) : Subgroup analyses by race in LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)
    In: Annals of Oncology Jg. 26 (2015) Nr. S 9: ESMO Asia Congress, 18-21 December 2015, Singapore : Submitted Abstracts, S. 136
  • Janku, F.; Juric, D.; Cortes, J.; Rugo, H.; Burris, H. A.; Schuler, Martin; Deschler-Baier, B.; Middleton, M. R.; Gil-Martin, M.; Berlin, J.; Winer, E.; Bootle, D.; Blumenstein, L.; Demanse, D.; Coughlin, C.; Quadt, C.; Baselga, J.
    Phase I study of the PI3K alpha inhibitor BYL719 plus fulvestrant in patients with PIK3CA-altered and wild type ER+/HER2-locally advanced or metastatic breast cancer
    In: Cancer Research Jg. 75 (2015) Nr. S 9, S. 9 - 13
  • Eberhardt, Wilfried; Pöttgen, Christoph; Gauler, Thomas; Friedel, Godehard; Veit, Stefanie; Heinrich, Vanessa; Welter, Stefan; Budach, Wilfried; Spengler, Werner; Kimmich, Martin; Fischer, Berthold; Schmidberger, Heinz; De Ruysscher, Dirk; Belka, Claus; Cordes, Sebastian; Hepp, Rodrigo; Lütke-Brintrup, Diana; Lehmann, Nils; Schuler, Martin; Jöckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin
    Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 35, S. 4194 - 4201
  • Bauer, Sebastian; Herold, Thomas; Mühlenberg, Thomas; Reis, Anna-Carina; Falkenhorst, Johanna; Backs, Miriam; Ketzer, Julia; Breitenbücher, Frank; Schuler, Martin; Grunewald, Susanne
    Plasma sequencing to detect a multitude of secondary KIT resistance mutations in metastatic gastrointestinal stromal tumors (GIST)
    In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 10518
  • Pöttgen, Christoph; Stuschke, Martin; Graupner, Britta; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, Eleni; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, Matthias; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried
    Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors
    In: BMC Cancer Jg. 15 (2015) Nr. 1, S. 363
  • Gautschi, Oliver; Bluthgen, Marie-Virginia; Smit, Egbert F.; Wolf, Jürgen; Früh, Martin; Petersenn, Stephan; Schuler, Martin; Zalcman, Gérard; Milia, Julie; Mazieres, Julien
    Targeted Therapy for Patients with BRAF-Mutant Lung Cancer : Results from the European EURAF Cohort
    In: Annals of Oncology Jg. 26 (2015) Nr. S 1: European Lung Cancer Conference (ELCC), Geneva, Switzerland, 15-18 April 2015 : Abstracts, S. i61
  • Gautschi, Oliver; Milia, Julie; Cabarrou, Bastien; Bluthgen, Marie-Virginia; Besse, Benjamin; Smit, Egbert F.; Wolf, Jürgen; Peters, Solange; Früh, Martin; Koeberle, Dieter; Oulkhouir, Youssouf; Schuler, Martin; Curioni-Fontecedro, Alessandra; Huret, Benjamin; Kerjouan, Mallorie; Michels, Sebastian; Pall, Georg; Rothschild, Sacha I.; Schmid-Bindert, Gerald; Scheffler, Matthias; Veillon, Rémi; Wannesson, Luciano; Diebold, Joachim; Zalcman, Gérard; Filleron, Thomas; Mazières, Julien
    Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort
    In: Journal of Thoracic Oncology Jg. 10 (2015) Nr. 10, S. 1451 - 1457
  • Hyman, David M.; Puzanov, Igor; Subbiah, Vivek; Faris, Jason E.; Chau, Ian; Blay, Jean‑Yves; Wolf, Jürgen; Raje, Noopur S.; Diamond, Eli L.; Hollebecque, Antoine; Gervais, Radj; Elez‑Fernandez, Maria Elena; Italiano, Antoine; Hofheinz, Ralf‑Dieter; Hidalgo, Manuel; Chan, Emily; Schuler, Martin; Lasserre, Susan Frances; Makrutzki, Martina; Sirzen, Florin; Veronese, Maria Luisa; Tabernero, Josep; Baselga, José
    Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations
    In: The New England Journal of Medicine Jg. 373 (2015) Nr. 8, S. 726 - 736
  • Hoffmann, Gesine; Breitenbücher, Frank; Schuler, Martin; Ehrenhofer-Murray, Ann
    A Novel Sirtuin 2 (SIRT2) Inhibitor with p53-dependent Pro-apoptotic Activity in Non-small Cell Lung Cancer
    In: The Journal of Biological Chemistry (JBC) Jg. 289 (2014) Nr. 8, S. 5208 - 5216
  • Wiesweg, M; Aydin, S; Köninger, Angela; Stein, Anja; Schara, Ulrike; van Roye, C; Hense, Jörg; Welt, Anja; Schuler, Martin
    Administration of Gemcitabine for Metastatic Adenocarcinoma during Pregnancy : A Case Report and Review of the Literature
    In: American Journal of Perinatology Reports Jg. 4 (2014) Nr. 1, S. 017 - 022
  • Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D; O'Shannessy, Daniel J; Gauler, Thomas; Wohlschläger, Jeremias; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R
    Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non–Small-Cell Lung Cancer Patients
    In: Clinical Lung Cancer Jg. 15 (2014) Nr. 5, S. 320 - 330.e3
  • Holczyk, M.; Herbrik, M.; Grabellus, Florian; Podleska, Lars; Pöttgen, Christoph; Schwindenhammer, B.; Bekas, V.; Schuler, Martin; Bauer, Sebastian
    Brain metastases in sarcoma patients : Incidence and outcome
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 10591
  • Shaw, A.; Mehra, R.; Tan, DSW; Felip, E.; Chow, LQM; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; Solomon, B. J.; Wolf, J.; Thomas, M.; Schuler, Martin; Liu, G.; Santoro, A.; Geraldes, M.; Sen, P.; Boral, A. J.; Yovine, A.; Kim, D. W.
    Ceritinib (LDK378) for treatment of patients with ALK-rearranged (ALK plus) non small cell lung cancer (NSCLO) and brain metastases (BM) in the ascend-1 trial
    In: Neuro-Oncology Jg. 16 (2014) Nr. Suppl. 5, S. v39
  • Shaw, Alice T; Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Juergen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Lau, Yvonne Y; Goldwasser, Meredith; Boral, Anthony L; Engelman, Jeffrey A
    Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
    In: The New England Journal of Medicine Jg. 370 (2014) Nr. 13, S. 1189 - 1197
  • Tan, DSW; Shaw, A. T.; Mehra, R.; Felip, E.; Chow, LQM; Camidge, D. R.; Vansteenkiste, J. F.; Sharma, S.; De Pas, T.; Riely, G. J.; Solomon, B. J.; Wolf, J.; Thomas, M.; Schuler, Martin; Liu, G.; Santoro, A.; Geraides, M.; Boral, A.; Yovine, A. J.; Kim, D. W.
    Ceritinib in Asian versus Caucasian patients (Pts) with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK plus ) NSCLC : Subgroup analysis of the ASCEND-1 trial
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 8078
  • Kim, D. W.; Mehra, R.; Tan, DSW; Felip, E.; Chow, LQM; Camidge, D. R.; Vansteenkiste, J. F.; Sharma, S.; De Pas, T.; Riely, G. J.; Solomon, B. J.; Wolf, J.; Thomas, M.; Schuler, Martin; Liu, G.; Santoro, A.; Geraldes, M.; Boral, A.; Yovine, A. J.; Shaw, A. T.
    Ceritinib in advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK plus ) non-small cell lung cancer (NSCLC) : Results of the ASCEND-1 trial
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 8003
  • Schuler, Martin; Yang, C. H.; Park, K.; Bennouna, J.; Chen, Y. M.; Chouaid, C.; De Marinis, F.; Feng, J. F.; Grossi, F.; Kim, D. W.; Liu, X. Q.; Lu, S.; Strausz, J.; Vinnyk, Y.; Wiewrodt, R.; Zhou, C. C.; Chand, V. K.; Wang, B. S.; Kim, J. H.; Planchard, D.; LUX-Lung 5 Investigators
    Continuation of afatinib beyond progression : Results of a randomized, open-label, phase III trial of afatanib plus paclitaxel (P) versus investigators choice chemotherapy (CT) in patients (pts) with metastatic non-small cell lung cancer (NSCLC) progressed
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 8019
  • Gauler, Thomas; Espenhain, L.; Hoiczyk, M.; Nel, I.; Parr, A.; Roder, J.; Schuler, Martin; Eberhardt, Wilfried; Roder, H.; Hoffmann, Andreas-Claudius
    Correlation of proteomics and first-line platinum-based chemotherapy in stage NSCLC in a large single-center cohort
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl.,
  • Wu, Y. L.; Sequist, L.; Hu, C. P.; Feng, J. F.; Lu, S.; Huang, Y. C.; Li, W.; Hou, M.; Schuler, Martin; Mok, T.; Yamamoto, N.; OByrne, K.; Hirsh, V.; Gibson, N.; Massey, D.; Kim, M.; Yang, JCH
    Detection of Epidermal Growth Factor Receptor (EGFR) Mutations in Circulating Cell-Free DNA in Two Phase III Studies (LUX-Lung 3 and LUX-Lung 6) of Afatinib vs Platinum-Based Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
    In: American Journal of Clinical Pathology Jg. 142 (2014) Nr. Suppl. 1, S. A182
  • Aktas, B.; Kasimir-Bauer, Sabine; Welt, Anja; Schuler, Martin; Kimmig, Rainer; Tewes, Mitra
    Detection of disseminated tumor cells in the bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. e22032
  • Breitenbücher, Frank; Hoffarth, Sandra; Worm, Karl; Cortes-Incio, Diana; Gauler, Thomas; Köhler, Jens; Herold, Thomas; Kurt Werner, Schmid; Freitag, Lutz; Kasper, Stefan; Schuler, Martin
    Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients
    In: PLoS ONE Jg. 9 (2014) Nr. 1, S. e85350
  • Grunewald, Susanne; Mühlenberg, Thomas; Rubin, B.; Schuler, Martin; Fletcher, J. A.; Bauer, Sebastian
    Effect of secondary KIT mutations on growth of GIST cells in the absence of selective pressure by imatinib in isogenic models of imatinib resistance
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 10555
  • Schuler, Martin; Fischer, Jürgen R.; Grohé, Christian; Gütz, Sylvia; Thomas, Michael; Kimmich, Martin; Schneider, Claus-Peter; Laack, Eckart; Märten, Angela; for the Afatinib Compassionate Use Consortium; Cortés-Incio, Diana; Gauler, Thomas
    Experience With Afatinib in Patients With Non-Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib
    In: The Oncologist Jg. 19 (2014) Nr. 10, S. 1100 - 1109
  • Kohler, J.; Schuler, Martin; Kasper, Stefan; Nensa, Felix; Hense, Jörg; Forsting, Michael; Kuhl, H.
    Formation of multiple pneumatoceles during anti-angiogenic treatment for metastatic colorectal cancer
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 84 - 85
  • Göbel, C.; Breitenbücher, Frank; Kalkavan, H.; Hähnel, Patricia S.; Kasper, Stefan; Hoffarth, Christian; Merches, Katja; Schild, Hans-Jörg; Lang, Karl S.; Schuler, Martin
    Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity
    In: Cell Death and Disease Jg. 5 (2014) Nr. 12, 1568
  • Pogorzelski, M-; Ting, Saskia; Gauler, Thomas; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, S.; Bergmann, Christoph; Brandau, Sven; Abu Jawad, Jehad; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy
    In: Cell Death and Disease Jg. 5 (2014) Nr. 2, e1091
  • Köhler, Jens; Schuler, Martin
    LUX-Lung 3: redundancy, toxicity or a major step forward? : Afatinib as front-line therapy for patients with metastatic EGFR-mutated lung cancer
    In: Future Oncology Jg. 10 (2014) Nr. 4, S. 533 - 540
  • Wiesweg, Marcel; Schuler, Martin
    Molekulare Labordiagnostik bei gastrointestinalen Tumorerkrankungen
    In: Der Gastroenterologe Jg. 9 (2014) Nr. 2, S. 127 - 137
  • Yang, JCH; Sequist, L. V.; Schuler, Martin; Mok, T.; Yamamoto, N.; OByrne, K. J.; Hirsh, V.; Geater, S. L.; Zhou, C. C.; Massey, D.; Zazulina, V.; Wu, Y. L.
    Overall survival (OS) in patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring common (Del19/L858R) epidermal growth factor receptor mutations (EGFR mut) : Pooled analysis of two large open-label phase III studies (LUX-Lung 3 [LL3] and
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 8004
  • Sequist, L. V.; Cassier, P.; Varga, A.; Tabernero, J.; Schellens, J. H.; Delord, J. P.; LoRusso, P.; Camidge, D. R.; Medina, M. H.; Schuler, Martin; Campone, M.; Tian, G. G.; Wong, S.; Corral, J.; Isaacs, R.; Sen, S. K.; Porta, D. G.; Kulkarni, S. G.; Lefebvre, C.; Wolf, J.
    Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors
    In: Cancer Research Jg. 74 (2014) Nr. 19 Suppl.,
  • Van Geel, R.; Elez, E.; Bendell, J. C.; Faris, J. E.; Lolkema, MPJK; Eskens, F.; Spreafico, A.; Kavan, P.; Delord, J. P.; Schuler, Martin; Wainberg, Z. A.; Yamada, Y.; Yoshino, T.; Demuth, T.; Avsar, E.; Chatterjee, A.; Zhu, P. J.; Bernards, R.; Tabernero, J.; Schellens, JHM
    Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor BYL719 in patients with advanced BRAF-mutant colorectal cancer
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 3514
  • Tabernero, J.; van Geel, R.; Bendell, J. C.; Spreafico, A.; Schuler, Martin; Yoshino, T.; Delord, J. P.; Yamada, Y.; Lolkema, M. P.; Fans, J. E.; Eskens, FALM; Sharma, S.; Yaeger, R.; Lenz, H. J.; Wainberg, Z.; Avsar, E.; Chatterjee, A.; Jaeger, S.; Demuth, T.; Schellens, JHM
    Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer
    In: European Journal of Cancer (EJC) Jg. 50 (2014) Nr. Suppl. 6, S. 199
  • Eberhardt, Wilfried; Gauler, Thomas; Pöttgen, Christoph; Friedel, G.; Veit, S.; Heinrich, V.; Welter, Stefan; Spengler, W.; Kimmich, M.; Fischer, B.; Schmidberger, H.; Gkika, E.; Cordes, S.; Hepp, R.; Luetke-Brintrup, D.; Lehmann, Nils; Schuler, Martin; Jöckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin; ESPATUE AIO ARO Clinical Trials
    Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 7510
  • Bauer, Sebastian; Hilger, Ralf A.; Mühlenberg, Thomas; Grabellus, Florian; Nagarajah, James; Hoiczyk, M.; Reichardt, A.; Ahrens, M.; Reichardt, P.; Grunewald, S.; Scheulen, Max Ernst; Pustowka, A.; Bock, E.; Schuler, Martin; Pink, D.
    Phase i study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
    In: British Journal of Cancer (BJC) Jg. 110 (2014) Nr. 5, S. 1155 - 1162
  • Ahnert, J. R.; Schuler, Martin; Machiels, JPH; Hess, D.; Paz-Ares, L.; Awada, A.; von Moos, R.; Steeghs, N.; Zambrano, C. C.; De Mesmaeker, P.; Richly, Heike; Herremans, C.; Joerger, M.; Jaime, J. C.; Alsina, M.; Baffert, F.; Demanse, D.; Duval, V.; Morozov, A.; Dirix, L.
    Phase lb study of BEZ235 plus either paclitaxel (PTX) in advanced solid tumors (aST) or PTX plus trastuzumab (TZ) in HER2+ breast cancer (BC)
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 621
  • Zambrano, C. C.; Schuler, Martin; Machiels, JPH; Hess, D.; Paz-Ares, L.; Awada, A.; von Moos, R.; Steeghs, N.; Ahnert, J. R.; De Mesmaeker, P.; Richly, Heike; Herremans, C.; Joerger, M.; Jaime, J. C.; Alsina, M.; Baffert, F.; Demanse, D.; Duval, V.; Morozov, A.; Dirix, L.
    Phase lb study of buparlisib (BKM120) plus either paclitaxel (PTX) in advanced solid tumors (aST) or PTX plus trastuzumab (TZ) in HER2+ breast cancer (BC)
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 627
  • Kuehnle, Marie-Christine; Attig, Sebastian; Britten, Cedrik Michael; Schulze-Bergkamen, Henning; Lordick, Florian; Von Wichert, Götz P. L .; Thuß-Patience, Peter C.; Stein, Alexander; Schuler, Martin; Bassermann, Florian; Şahin, Uǧur; Türeci, Özlem
    Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction
    In: Cancer Immunology, Immunotherapy Jg. 63 (2014) Nr. 12, S. 1273 - 1284
  • Schmidt, Lars Henning; Görlich, Dennis; Spieker, Tillmann; Rohde, Christian; Schuler, Martin; Mohr, Michael; Humberg, Julia; Sauer, Tim; Thoenissen, Nils; Huge, Andreas; Voss, Reinhard; Marra, Alessandro; Faldum, Andreas; Müller-Tidow, Carsten; Berdel, Wofgang E.; Wiewrodt, Rainer
    Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer
    In: Journal of Thoracic Oncology Jg. 9 (2014) Nr. 9, S. 1294 - 1304
  • Kordelas, L.; Bauer, Sebastian; Schuler, Martin; Beelen, Dietrich; Gauler, Thomas
    Successful resuscitation of a patient with ventricular fibrillation due to hypomagnesemia under cetuximab therapy
    In: TumorDiagnostik & Therapie Jg. 35 (2014) Nr. 1, S. 25 - 27
  • Kasper, Stefan; Schuler, Martin
    Targeted therapies in gastroesophageal cancer
    In: European Journal of Cancer (EJC) Jg. 50 (2014) Nr. 7, S. 1247 - 1258
  • Nogova, L.; Sequist, L. V.; Cassier, P. A.; Hidalgo, M.; Delord, J. P.; Schuler, Martin; Lim, W. T.; Camidge, D. R.; Buettner, R.; Heukamp, L. C.; Gardizi, M.; Scheffler, M.; Kambartel, K.; Ringeisen, F. P.; Sen, S.; Isaacs, R.; Joannaert, M.; Lefebvre, C.; Wolf, J.
    Targeting FGFR1-amplified lung squamous cell carcinoma with the selective pan-FGFR inhibitor BGJ398
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 8034
  • Mühlenberg, T.; Grunewald, S.; Schuler, Martin; Bauer, Sebastian
    Targeting glucose metabolism by 2-deoxyglucose in gastrointestinal stromal tumors
    In: Cancer Research Jg. 74 (2014) Nr. 19 Suppl.,
  • Pastille, Eva; Bardini, Katrin; Fleissner, Diana; Adamczyk, Alexandra; Frede, Annika; Wadwa, Munisch; Smolinski, Dorthe von; Kasper, Stefan; Sparwasser, Tim; Gruber, Achim D.; Schuler, Martin; Sakaguchi, Shimon; Roers, Axel; Müller, Werner; Hansen, Wiebke; Buer, Jan; Westendorf, Astrid
    Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer
    In: Cancer Research Jg. 74 (2014) Nr. 16, S. 4258 - 4269
  • Köhler, J.; Schuler, Martin
    Afatinib, Erlotinib and Gefitinib in the First-Line Therapy of EGFR Mutation-Positive Lung Adenocarcinoma : A Review
    In: Oncology Research and Treatment Jg. 36 (2013) Nr. 9, S. 510 - 518
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hoehler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Ting, Saskia; Markus, P.; Paul, Andreas; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) : An interim analysis of the CEBIFOX trial
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. e14502
  • Chen, Xiaofeng; Zhu, Quan; Zhu, Lingjun; Pei, Dong; Liu, Yiqian; Yin, Yongmei; Schuler, Martin; Shu, Yongqian
    Clinical perspective of afatinib in non-small cell lung cancer
    In: Lung Cancer Jg. 81 (2013) Nr. 2, S. 155 - 161
  • Juntermanns, Benjamin; Sotiropoulos, Georgios; Radunz, Sonia; Reis, Henning; Heuer, Matthias; Baba, Hideo Andreas; Canbay, Aliekber; Schuler, Martin; Gerken, Guido; Paul, Andreas; Kaiser, Gernot Maximil
    Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar Cholangiocarcinoma
    In: Annals of Surgical Oncology Jg. 20 (2013) Nr. 1, S. 277 - 284
  • Heusch, Philipp; Buchbender, Christian; Köhler, Jens; Nensa, Felix; Beiderwellen, Karsten; Kühl, Hilmar; Lanzman, Rotem S.; Wittsack, Hans-Jörg; Gomez, Benedikt; Gauler, Thomas; Schuler, Martin; Forsting, Michael; Bockisch, Andreas; Antoch, Gerald; Heusner, Till Alexander
    Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions : Initial results
    In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren Jg. 185 (2013) Nr. 11, S. 1056 - 1062
  • Simon, Susanne; Grabellus, Florian; Ferrera, Loretta; Galietta, Luis; Schwindenhammer, Benjamin; Mühlenberg, Thomas; Täger, Georg; Eilers, Grant; Treckmann, Jürgen-Walter; Breitenbücher, Frank; Schuler, Martin; Taguchi, Takahiro; Fletcher, Jonathan A.; Bauer, Sebastian
    DOG1 Regulates Growth and IGFBP5 in Gastrointestinal Stromal Tumors
    In: Cancer Research Jg. 73 (2013) Nr. 12, S. 3661 - 3670
  • Yang, JCH; Sequist, L.; OByrne, K.; Schuler, Martin; Mok, T.; Geater, S.; Massey, D.; OBrien, D.; Zazulina, V.; Wu, Y. L.
    Epidermal growth factor receptor (EGFR)-mediated adverse events (AEs) in patients (pts) with EGFR mutation positive (EGFR M plus ) non-small cell lung cancer treated with afatinib
    In: European Journal of Cancer (EJC) Jg. 49 (2013) Nr. Suppl. 2, S. 190
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Jörg; Gauler, Thomas; Köhler, Jens; Eberhardt, Wilfried; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbücher, Frank; Wohlschläger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lütkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt Werner; Schuler, Martin
    Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
    In: European Journal of Cancer (EJC) Jg. 49 (2013) Nr. 15, S. 3076 - 3082
  • Nel, I.; Gauler, Thomas; Eberhardt, Wilfried; Nickel, A. C.; Schuler, Martin; Thomale, Jürgen; Hoffmann, Andreas-Claudius
    Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment
    In: British Journal of Cancer (BJC) Jg. 109 (2013) Nr. 5, S. 1223 - 1229
  • Rebmann, Vera; Gauler, Thomas; Schott, B.; Schott, P.; Bauer, Sebastian; Opalka, Bertram; Stamatis, Georgios; Eberhardt, Wilfried; Schuler, Martin; Horn, Peter
    Free soluble HLA-G molecules but not exosome-derived soluble HLA-G molecules are of prognostic relevance in lung cancer patients
    In: Tissue Antigens Jg. 81 (2013) Nr. 5, S. 282 - 283
  • Falkenhorst, J.; Mühlenberg, Thomas; Grunewald, S.; Marino-Enriquez, A.; Schuler, Martin; Fletcher, J.; Bauer, Sebastian;
    IAP gene alterations and therapeutic modulation of IAPs by Smac mimetics in GIST
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 245 - 246
  • OByrne, K. J.; Sequist, L. V.; Schuler, Martin; Yamamoto, N.; Hirsh, V.; Mok, T.; Lungershausen, J.; Shahidi, M.; Palmer, M.; Yang, JCH
    LUX-Lung 3 : Symptom and health-related quality of life results from a randomized phase III study in 1st-line advanced NSCLC patients harbouring EGFR mutations
    In: Lung Cancer Jg. 79 (2013) Nr. Suppl. 1, S. 11
  • Kasper, Stefan; Breitenbücher, Frank; Reis, Henning; Brandau, Sven; Worm, K.; Köhler, J.; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Schuler, Martin
    Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade
    In: Oncogene Jg. 32 (2013) Nr. 23, S. 2873 - 2881
  • Sequist, Lecia V.; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Mok, Tony; Geater, Sarayut Lucien; Orlov, Sergey; Tsai, Chun-Ming; Boyer, Michael; Su, Wu-Chou; Bennouna, Jaafar; Kato, Terufumi; Gorbunova, Vera; Lee, Ki Hyeong; Shah, Riyaz; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Schuler, Martin
    Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 27, S. 3327 - 3334
  • Nell, I.; Gauler, Thomas; Nickel, A. C.; Alotaibi, S.; Thomale, Jürgen; Schuler, Martin; Hoffmann, Andreas-Claudius
    Pre-therapeutic ex-vivo repair kinetics of cisplatin-DNA-adducts in circulating tumor cells (CTC) as platinum resistance test
    In: Lung Cancer Jg. 79 (2013) Nr. Suppl. 1, S. 2
  • Welt, Anja; Tewes, Mitra; Aktas, Bahriye; Hoffmann, Oliver; Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Richly, Heike; Hense, Jörg; Palmer, Michael R.; Lee, Benjamin H.; Wendling, Johanna; Kossow, Josef; Scheulen, Max Ernst; Lehnerdt, Cathrin; Kohl, Marzena; Derks, Cordula; Skottky, Silke; Haus, Ulrike; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin; Kasper, Stefan
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
    In: Breast Cancer Research and Treatment Jg. 142 (2013) Nr. 1, S. 81 - 88
  • Juric, D.; Gonzalez-Angulo, A. M.; Burris, H. A.; Schuler, Martin; Schellens, J.; Berlin, J.; Gupta, A.; Seggewiss-Bernhardt, R.; Adamo, B.; Gil-Martin, M.; Bootle, D.; Boehm, M.; De Buck, S.; Demanse, D.; Quadt, C.; Baselga, J.
    Preliminary safety, pharmacokinetics and anti-tumor activity of BYL719, an alpha-specific P13K inhibitor in combination with fulvestrant : Results from a phase I study
    In: Cancer Research Jg. 73 (2013) Nr. Suppl. 24,
  • Gonzalez-Angulo, A. M.; Juric, D.; Argiles, G.; Schellens, JHM; Burris, H. A.; Berlin, J.; Middleton, M. R.; Schuler, Martin; Van Geel, R.; Helgason, T.; Bootle, D.; Boehm, M.; Goggin, T. K.; Demanse, D.; Quadt, C.; Baselga, J.
    Safety, pharmacokinetics, and preliminary activity of the α-specific PI3K inhibitor BYL719 : Results from the first-in-human study
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. 2531
  • Schuler, Martin; Zvirbule, Z.; Lordick, F.; Krilova, A.; Helbig, U.; Schulze-Bergkamen, H.; Thuss-Patience, P. C.; von Wichert, G.; Schulmann, K.; Trarbach, Tanja; Bauer, Sebastian; Mueller, C.; Al-Batran, S. E.; Huber, C.; Sahin, U.; Tureci, O.
    Safety, tolerability, and efficacy of the first-in-class antibody IMAB362 targeting claudin 18.2 in patients with metastatic gastroesophageal adenocarcinomas
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. 4080
  • Grunewald, S.; Mühlenberg, Thomas; Ketzer, J.; Backs, M.; Rubin, B.; Schuler, Martin; Fletcher, J.; Bauer, Sebastian;
    Secondary KIT mutations negatively impact cell growth in a novel isogenic model of imatinib-resistance in GIST
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 178 - 179
  • Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D.; O'Shannessy, Daniel J.; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Hoiczyk, M.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. 1, S. 19 - 30
  • Molzan, M.; Kasper, Stefan; Röglin, L.; Skwarczynska, M.; Sassa, T.; Inoue, T.; Breitenbücher, Frank; Ohkanda, J.; Kato, N.; Schuler, Martin; Ottmann, C.
    Stabilization of Physical RAF/14-3-3 Interaction by Cotylenin A as Treatment Strategy for RAS Mutant Cancers
    In: ACS Chemical Biology Jg. 8 (2013) Nr. 9, S. 1869 - 1875
  • Yang, James Chih-Hsin; Hirsh, Vera; Schuler, Martin; Yamamoto, Nobuyuki; O'Byrne, Kenneth J.; Mok, Tony S.K.; Zazulina, Victoria; Shahidi, Mehdi; Lungershausen, Juliane; Massey, Dan; Palmer, Michael; Sequist, Lecia V.
    Symptom control and quality of life in lux-lung 3 : A phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations
    In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 27, S. 3342 - 3350
  • Hoiczyk, Mathias; Grabellus, Florian; Podleska, Lars; Ahrens, Marit; Schwindenhammer, Benjamin; Täger, Georg; Pöttgen, Christoph; Schuler, Martin; Bauer, Sebastian
    Trabectedin in metastatic soft tissue sarcomas : Role of pretreatment and age
    In: International Journal of Oncology Jg. 43 (2013) Nr. 1, S. 23 - 28
  • Schmidt, L. H.; Spieker, T.; Schuler, Martin; Marra, A.; Wiebe, K.; Berdel, W.; Mueller-Tidow, C.; Rainer, W.
    Tumor laterality influences the prognostic impact of Bcl-2 expression in curatively resected NSCLC patients
    In: European Respiratory Journal (ERJ) Jg. 42 (2013) Nr. Suppl. 57,
  • Schuler, Martin
    Ärztliche Behandlung von an Krebs Erkrankten : Alles ganz anders?
    In: Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen (ZEFQ) Jg. 107 (2013) Nr. 2, S. 116 - 119
  • Schuler, Martin; Awada, Ahmad; Harter, Philipp; Canon, Jean Luc; Possinger, Kurt; Schmidt, Marcus; De Grève, Jacques; Neven, Patrick; Dirix, Luc; Jonat, Walter; Beckmann, Matthias W.; Schütte, Jochen; Fasching, Peter A.; Gottschalk, Nina; Besse-Hammer, Tatiana; Fleischer, Frank; Wind, Sven; Uttenreuther-Fischer, Martina; Piccart, Martine; Harbeck, Nadia
    A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer
    In: Breast Cancer Research and Treatment Jg. 134 (2012) Nr. 3, S. 1149 - 1159
  • Yang, J. C.; Schuler, Martin; Yamamoto, N.; OByrne, K. J.; Hirsh, V.; Mok, TSK; Massey, D.; Zazulina, V.; Shahidi, M.; Sequist, L. V.
    Activity of afatinib in uncommon epidermal growth factor receptor (EGFR) mutations in Lux-Lung 3, a phase III trial of afatinib or cisplatin/pemetrexed EGFR mutation-positive lung cancer
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 410 - 411
  • Kim, J. H.; Grossi, F.; De Marinis, F.; Cobo, M.; Yang, JCH; Ragulin, Y.; Bondarenko, I. N.; Chand, V. K.; Wang, B. S.; Gracien, E.; Schuler, Martin
    Afatinib monotherapy in patients with metastatic squamous cell carcinoma of the lung progressing after erlotinib/gefitinib (E/G) and chemotherapy : Interim subset analysis from a phase III trial
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. Suppl. 15,
  • Scheulen, Max Ernst; Richly, Heike; Kalkavan, H.; Hoffmann, Andreas-Claudius; Virchow, I.; Hilger, Ralf A.; Koeppen, Susanne; Sure, Ulrich; Schuler, Martin; Hense, Jörg
    An investigator-initiated monocentric phase I dose escalation trial of temsirolimus and irinotecan (TEMIR) in patients with relapsing glioblastoma multiforme (reGBM)
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. Suppl. 15, S. 2086
  • Kasper, Stefan; Meiler, Johannes; Schuler, Martin
    Antikörper zur adoptiven Immuntherapie solider Tumoren
    In: Der Onkologe Jg. 18 (2012) Nr. 9, S. 757 - 769
  • Olschlager, K.; Grabellus, Florian; Schnell, R.; Geffken, M.; Hoiczyk, M.; Ahrens, M.; Podleska, Lars; Tager, G.; Treckmann, Jürgen-Walter; Pöttgen, Christoph; Schuler, Martin; Bauer, Sebastian
    Chemotherapy in resectable sarcomas with complex karyotypes - a single center retrospective analysis
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 150 - 150
  • Christoph, Daniel; Hoffmann, Andreas-Claudius; Gauler, Thomas; Asuncion, Bernadette Reyna; Loewendick, Heike; Peglow, Anja; Hassan, Biftu; Tran, Cindy; Wynes, Murry W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 4, S. 766 - 767
  • Wolf, J.; Nogova, L.; Heukamp, L. C.; Bos, M.; Schuler, Martin; Sequist, L.; Tian, G. G.; Ringeisen, F.; Buettner, R.; Thomas, R.
    Developments in targeted therapy : FGFR1 inhibition in lung cancer
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. Suppl. 6, S. 23
  • Drescher, O.; Eberhardt, Wilfried; Prittwitz, R.; Gkika, E.; Korfee, Sönke; Theegarten, Dirk; Welter, Stefan; Krbek, T.; Stamatis, Georgios; Pöttgen, Christoph; Schuler, Martin; Christoph, Daniel
    Distribution pattern of metastases and their associations with survival of malignant pleural mesothelioma patients undergoing different treatment modalities
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 140
  • Nogova, L.; Gardizi, M.; Bos, MCA; Bitter, E.; Schildhaus, Hans-Ulrich; Heukamp, L. C.; Topelt, K.; Zander, T.; Scheffler, M.; Mattonet, C.; Gokkurt, E.; Risse, F.; Schuler, Martin; Sequist, L.; Tian, G. G.; Ringeisen, F.; Thomas, R.; Buttner, R.; Wolf, J.
    Early clinical evaluation of FGFR1 inhibition in lung cancer : Preliminary results of a phase I study in FGFR1 amplified lung cancer patients treated with BGJ398, a pan FGFR inhibitor
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 137
  • Christoph, Daniel; Asuncion, Bernadette Reyna; Mascaux, Celine; Tran, Cindy; Lu, Xian; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Theegarten, Dirk; Neumann, Volker; Hepp, Rodrigo; Welter, Stefan; Stamatis, Georgios; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, S. 1440 - 1448
  • Welter, Stefan; Grabellus, Florian; Bauer, Sebastian; Schuler, Martin; Eberhardt, Wilfried; Tötsch, M.; Stamatis, Georgios
    Growth patterns of lung metastases from sarcoma : prognostic and surgical implications from histology
    In: Interactive Cardiovascular and Thoracic Surgery Jg. 15 (2012) Nr. 4, S. 612 - 617
  • Kohler, J.; Worm, K.; Gauler, Thomas; Hoiczyk, M.; Theegarten, Dirk; Eberhardt, Wilfried; Hense, Jörg; Breitenbücher, Frank; Schmid, Kurt Werner; Schuler, Martin
    Impact of EGFR mutation status on clinical benefit from BIBW 2992 in patients (PTS) with advanced non-small lung cancer (NSCLC) progressing after chemotherapy (CTX) and erlotinib (E) or gefitinib (G) - a single center experience
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 437 - 438
  • Pogorzelski, M.; Ting, Saskia; Gauler, Thomas; Vossebein, I.; Breitenbucher, F.; Lang, Stephan; Hoffmann, T. K.; Bergmann, Christoph; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of HPV status on the response of head and neck cancers to the anti-EGFR antibody cetuximab
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 193 - 193
  • Meiler, Johannes; Guyot, M.; Hoffarth, S.; Wesarg, E.; Höhn, Y.; Breitenbücher, Frank; Schuler, Martin
    Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer
    In: Journal of Cancer Research and Clinical Oncology Jg. 138 (2012) Nr. 8, S. 1385 - 1394
  • Falkenhorst, J.; Mühlenberg, Thomas; Simon, S.; Grabellus, Florian; Breitenbucher, F.; Schuler, Martin; Fletcher, J. A.; Bauer, Sebastian
    Inhibitors of Apoptosis Proteins (IAPs) in gastrointestinal stromal tumors - a therapeutic target?
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 249
  • Schuler, Martin; Planchard, D.; Yang, JCH; Kim, J. H.; De Marinis, F.; Chen, Y. M.; Zhou, C. C.; Bennouna, J.; Liu, X. Q.; Feng, J. F.; Bidoli, P.; Strausz, J.; Ou, SHI; Chand, V. K.; Wang, B. S.; Munzert, G. M.; Park, K.
    Interim analysis of afatinib monotherapy in patients with metastatic NSCLC progressing after chemotherapy and erlotinib/gefitinib (E/G) in a trial of afatinib plus paclitaxel versus investigator's choice chemotherapy following progression on afatinib mono
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. Suppl. 15, S. 7557
  • Schuler, Martin; Planchard, D.; Yang, JCH; Kim, J. H.; De Marinis, F.; Chen, Y. M.; Zhou, C. C.; Bennouna, J.; Liu, X. Q.; Feng, J. F.; Bidoli, P.; Strausz, J.; Ou, SHI; Chand, V. K.; Wang, B. S.; Munzert, G. M.; Park, K.
    Interim analysis of afatinib monotherapy in patients with metastatic NSCLC progressing after chemotherapy and erlotinib/gefitinib (E/G) in a trial of afatinib plus paclitaxel versus investigators choice chemotherapy following progression on afatinib monot
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. Suppl. 15,
  • Hoiczyk, Mathias; Iliodromitis, Konstantinos; Bauer, Sebastian; Konorza, Thomas; Philipp, Sebastian; Bankfalvi, Agnes; Gerl, Jan Mikael; Schuler, Martin; Erbel, Raimund
    Intimal sarcoma of the pulmonary artery with unusual findings : a case report
    In: Clinical Research in Cardiology Jg. 101 (2012) Nr. 5, S. 397 - 401
  • Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Investigation of Folate Receptor alpha and Thymidylate Synthase Proteins Expression in metastatic Non-Small Cell Lung Cancer Patients treated with Pemetrexed-based Chemotherapy
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, Suppl. 4, S. S211 - S212
  • Sequist, L.; Schuler, Martin; Yamamoto, N.; OByrne, K.; Hirsh, V.; Mok, T.; Massey, D.; Zazulina, V.; Shahidi, M.; Yang, J.
    LUX-Lung 3 : A Randomized, Open-Label, Phase III Study of Afatinib vs Pemetrexed and Cisplatin as First-Line Treatment for Patients with Advanced Adenocarcinoma of the Lung Harboring EGFR-Activating Mutations (Subgroup Analysis)
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, Suppl. 4, S. 203
  • Yang, JCH; Schuler, Martin; Yamamoto, N.; OByrne, K. J.; Hirsh, V.; Mok, T.; Geater, S. L.; Orlov, S. V.; Tsai, C. M.; Boyer, M. J.; Su, W. C.; Bennouna, J.; Kato, T.; Gorbunova, V.; Lee, K. H.; Shah, RNH; Massey, D.; Lorence, R. M.; Shahidi, M.; Sequist, L. V.
    LUX-Lung 3 : A randomized, open-label, phase III study of afatinib versus pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR-activating mutations
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. Suppl. 15, S. LBA7500
  • Sequist, L. V.; Schuler, Martin; Yamamoto, N.; OByrne, K. J.; Hirsh, V.; Mok, TSK; Lungershausen, J.; Shahidi, M.; Palmer, M.; Yang, J. C.
    LUX-Lung 3 : Symptom and health-related quality of life results from a randomized phase III study in 1st-line advanced NSCLC patients harbouring EGFR mutations
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 402
  • Boyer, M.; Schuler, Martin; Yamamoto, N.; OByrne, K.; Hirsh, V.; Mok, T.; Massey, D.; Zazulina, V.; Shahidi, M.; Sequist, L.; Yang, J. C.
    Lux-Lung 3 : a randomized, open-label, phase III study of afatinib versus pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harbouring EGFR-activating mutations
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, Suppl. 3, S. 161
  • OByrne, K.; Schuler, Martin; Yamamoto, N.; Hirsh, V.; Mok, T.; Massey, D.; Zazulina, V.; Shahidi, M.; Sequist, L.; Yang, J.
    Lux-Lung 3 : A randomized, open-label, phase III study of afatinib vs. pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR activating mutations
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 7, S. 102
  • Yamamoto, N.; Schuler, Martin; OByrne, K.; Hirsh, V.; Mok, T.; Kato, T.; Yoshioka, H.; Okamoto, I.; Yokoyama, A.; Massey, D.; Jones, H.; Zazulina, V.; Shahidi, M.; Sequist, L.; Yang, JCH
    Lux-LungG 3 : Afatinib versus cisplatin and pemetrexed in Japanese patients with adenocarcinoma of the lung harboring an EGFR mutation
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 11, S. 8
  • Köhler, Johannes; Schuler, Martin
    Molekular zielgerichtete Tumortherapien : aktueller Stand und künftige Entwicklungen
    In: TumorDiagnostik & Therapie Jg. 33 (2012) Nr. 6, S. 311 - 314
  • Henze, Joern; Mühlenberg, Thomas; Simon, Susanne; Grabellus, Florian; Rubin, Brian; Täger, Georg; Schuler, Martin; Treckmann, Jürgen-Walter; Debiec-Rychter, Maria; Taguchi, Takahiro; Fletcher, Jonathan A.; Bauer, Sebastian
    P53 modulation as a therapeutic strategy in gastrointestinal stromal tumors
    In: PLoS ONE Jg. 7 (2012) Nr. 5,
  • Markova, Boyka; Hähnel, Patricia S.; Kasper, Stefan; Herbertz, Stephan; Schuler, Martin; Breitenbücher, Frank
    Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancer
    In: Journal of Cancer Research and Clinical Oncology Jg. 138 (2012) Nr. 4, S. 545 - 554
  • Ahnert, J. R.; Burris, H. A.; Schellens, JHM; Schuler, Martin; Goodman, O.; Britten, C.; Richards, D.; Demanse, D.; Silva, A.; Baselga, J.
    Phase I Dose-escalation Study of the Oral Dual MTOR/PI3K Inhibitor BEZ235, Solid Dispersion System (SDS) Sachet Formulation, in Patients with Advanced Solid Tumors
    In: European Journal of Cancer (EJC) Jg. 48 (2012) Nr. Suppl. 6, S. 112
  • Bauer, Sebastian; Hilger, Ralf A.; Grabellus, Florian; Nagarajah, James; Hoiczyk, M.; Reichardt, A.; Ahrens, M.; Pink, D.; Mühlenberg, Thomas; Scheulen, Max Ernst; Schuler, Martin; Reichardt, P.
    Phase I trial of panobinostat (P) and imatinib (IM) in patients with treatment-refractory gastrointestinal stromal tumors (GIST)
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. Suppl. 15, S. 10032
  • Dirix, L.; Schuler, Martin; Machiels, J.; Hess, D.; Awada, A.; Steeghs, N.; Paz-Ares, L.; von Moos, R.; Rabault, B.; Rodon, J.
    Phase IB dose-escalation study of BEZ235 or BKM 120 in combination with paclitaxel (PTX) in patients with advanced solid tumors
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 157 - 158
  • Schmidt, Markus; Rüttinger, Dominik; Sebastian, M.; Hanusch, Claus A.; Marschner, Norbert; Bäuerle, Patrick A.; Wolf, Andreas; Göppel, Gertrud; Oruzio, Daniel; Schlimok, Günter; Steger, Günther G.; Wolf, Christopher; Eiermann, Wolfgang; Lang, Alois; Schuler, Martin
    Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with epcampositive relapsed or refractory advanced-stage breast cancer
    In: Annals of Oncology Jg. 23 (2012) Nr. 9, S. 2306 - 2313
  • Hoiczyk, M.; Kuschel, P.; Grabellus, Florian; Geffken, M.; Ahrens, M.; Schuler, Martin; Bauer, Sebastian
    Rechallenge with ifosfamide-containing regimen as salvage option for patients with metastatic soft tissue sarcomas progressing after multiple pretreatments
    In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. Suppl. 15,
  • Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wohlschläger, Jeremias; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Significance of Folate Receptor alpha (FRA) and Thymidylate Synthase (TS) expression in metastatic non-small cell lung cancer patients treated with pemetrexed-based chemotherapy
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 34
  • Kasper, Stefan; Breitenbücher, Frank; Heidel, F.; Hoffarth, S.; Markova, B.; Schuler, Martin; Fischer, T.
    Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies
    In: Blood Cancer Journal Jg. 2 (2012) Nr. 3, S. e60
  • Kasper, Stefan; Reis, Henning; Breitenbücher, Frank; Markowetz, J.; Pogorzelski, M.; Trarbach, Tanja; Worm, K.; Schmid, Kurt Werner; Schuler, Martin
    Targeting the anti-apoptotic protein BCL-XL to overcome RAS mediated resistance to anti-EGFR antibody therapy in colorectal cancer
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 253
  • Welt, Anja; Kossow, J.; Tewes, Mitra; Seeber, S.; Schuler, Martin
    Trends in survival of patients with metastatic breast cancer
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 187
  • Wiesweg, Marcel; Kasper, Stefan; Wohlschläger, Jeremias; Ting, Saskia; Skottky, S.; Worm, K.; Derks, C.; Tewes, Mitra; Breitenbücher, Frank; Gauler, Thomas; Eberhardt, Wilfried; Ahrens, M.; Hoiczyk, M.; Meiler, Johannes; Hense, Jörg; Welt, Anja; Theegarten, Dirk; Freitag, Lutz; Kimmig, Rainer; Schmid, Kurt Werner; Schuler, Martin
    VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 204 - 204
  • Christoph, Daniel; Kasper, Stefan; Gauler, Thomas; Loesch, Christian; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Welter, Stefan; Stamatis, Georgios; Hirsch, Fred R.; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer
    In: British Journal of Cancer (BJC) Jg. 107 (2012) Nr. 5, S. 823 - 830
  • Ahrens, M.; Hoiczyk, M.; Grabellus, Florian; Täger, Georg; Pöttgen, Christoph; Schuler, Martin; Bauer, Sebastian
    Angiosarcomas of the adulthood - a large single center analysis
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 254 - 254
  • Aktas, B.; Kasimir-Bauer, Sabine; Kasper, Stefan; Derks, C.; Kimmig, Rainer; Schuler, Martin; Tewes, Mitra
    Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative Therapy
    In: Cancer Research Jg. 71 (2011) Nr. Suppl. 24,
  • Gauler, Thomas; Theegarten, Dirk; Parr, A.; Schuhr, I.; Schmid, Kurt Werner; Eberhardt, Wilfried; Schuler, Martin; Hoffmann, Andreas-Claudius
    Decrease of circulating tumor cells associates with response to platinum-based chemotherapy in patients with non-small cell lung cancer, but not with small cell lung cancer
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. 1114
  • Simon, S.; Grabellus, Florian; Täger, Georg; Treckmann, Jürgen-Walter; Schuler, Martin; Fletcher, J.; Bauer, Sebastian
    Development of xenograft-based in vivo models of gastrointestinal stromal tumors
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 253 - 253
  • Livingstone, Elisabeth; Trarbach, Tanja; Zimmer, Lisa; Schuler, Martin; Schadendorf, Dirk
    EGFR-Inhibitoren und Multityrosinkinaseinhibitoren : Interdisziplinäre Behandlung der kutanen Nebenwirkungen
    In: Deutsche Medizinische Wochenschrift - DMW Jg. 136 (2011) Nr. 1-2, S. 39 - 44
  • Schmidt, Marcus; Petry, Ilka Brigitte; Böhm, Daniel; Lebrecht, Antje; Törne, Christian von; Gebhard, Susanne; Gerhold-Ay, Aslihan; Cotarelo, Cristina; Battista, Marco; Schormann, Wiebke; Freis, Evgenia; Selinski, Silvia; Ickstadt, Katja; Rahnenführer, Jörg; Sebastian, Martin; Schuler, Martin; Koelbl, Heinz; Gehrmann, Mathias; Hengstler, Jan G.
    Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer
    In: Breast Cancer Research and Treatment Jg. 125 (2011) Nr. 3, S. 637 - 646
  • Christoph, DanielC; Kasper, Stefan; Gauler, ThomasC; Breitenbücher, Frank; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Hirsch, FredR; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Evaluation of Betav-Tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. 1078
  • Christoph, Daniel; Gauler, Thomas; Engelhard, M.; Theegarten, Dirk; Pöttgen, Christoph; Hepp, R.; Schuler, Martin; Hirsch, F.; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Evaluation of betaV-tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer (NSCLC)
    In: European Journal of Cancer (EJC) Jg. 47 (2011) Nr. Suppl. 4, S. 14
  • Becker, Silvan; Markova, Boyka; Wiewrodt, Rainer; Hoffarth, Sandra; Hähnel, Patricia S.; Pleiner, Sina; Schmidt, Lars Hennig; Breitenbücher, Frank; Schuler, Martin
    Functional and Clinical Characterization of the Putative Tumor Suppressor WWOX in Non-small Cell Lung Cancer
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 12, S. 1976 - 1983
  • Breitenbücher, Frank; Hoffarth, S.; Gauler, Thomas; Stergar, S. L.; Kasper, Stefan; Kohler, J.; Worm, K.; Marten, A.; Schmid, Kurt Werner; Schuler, Martin
    Highly sensitive detection of somatic epidermal growth factor receptor (EGFR) gene mutations in circulating tumor cells (CTC) from patients with non-small cell lung cancer treated with cisplatin/pemetrexed or afatinib
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S956 - S957
  • Christoph, DanielC; Wohlschläger, Jeremias; Neumann, Volker; Gauler, ThomasC; Pöttgen, Christoph; Peglow, Anja; Tannapfel, Andrea; Schuler, Martin; Hirsch, FredR; Eberhardt, Wilfried; Theegarten, Dirk
    Impact of dihydrofolate reductase expression for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S1052 - S1053
  • Philipps, E. S.; Mühlenberg, Thomas; Simon, S.; Ecken, S.; Grabellus, Florian; Täger, Georg; Schuler, Martin; Bauer, Sebastian
    Inhibition of the Ras/Raf/MAPK-pathway in GIST : Therapeutic potential?
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 235 - 235
  • Lambertz, N.; Köhler, Johannes; Schulte, D.M.; Kühl, Hilmar; Wohlschläger, Jeremias; Hense, Jörg; Schuler, Martin; Müller, Oliver
    Multivisceral systemic metastases from an intracranial anaplastic meningioma : A case report and review of literature
    In: Clinical Neurology and Neurosurgery Jg. 113 (2011) Nr. 7, S. 592 - 595
  • Köhler, Johannes; Schuler, Martin
    Personalisierte medikamentöse Therapie des fortgeschrittenen nichtkleinzelligen Lungenkarzinoms : Der Pfeil des Wilhelm Tell?
    In: Der Onkologe Jg. 17 (2011) Nr. 8, S. 702 - 708
  • Kasper, Stefan; Breitenbücher, Frank; Even, A.; Pogorzelski, M.; Hoffarth, S.; Stergar, S. L.; Trarbach, Tanja; Schuler, Martin
    Pharmacological Inhibition of NF-k and PLK-1 to the Opening of the RAS-mediated Resistance to anti-EGFR Antibody therapies in Colorectal cancer *
    In: Der Internist Jg. 52 (2011) Nr. 6, S. 726 - 726
  • Christoph, Daniel; Schuler, Martin
    Polo-like kinase 1 inhibitors in mono- and combination therapies : A new strategy for treating malignancies
    In: Expert Review of Anticancer Therapy Jg. 11 (2011) Nr. 7, S. 1117 - 1132
  • Christoph, DanielC; Mascaux, Celine; Wynes, MurryW; Asuncion, Bernadette; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Neumann, Volker; Pöttgen, Christoph; Tran, Cindy; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, FredR
    Predictive value of thymidylate synthase and Folypoly-Glutamate Synthease for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S1092 - S1093
  • Christoph, Daniel; Mascaux, C.; Wynes, M. W.; Reyna Asuncion, B.; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Predictive value of thymidylate synthase and folylpoly-glutamate synthetase for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7024
  • Scheulen, Max Ernst; Nokay, B.; Richly, Heike; Hoffmann, Andreas-Claudius; Kalkmann, J.; Stattaus, Jörg; Bornfeld, Norbert; Schuler, Martin; Hense, Jörg
    Register trial of sorafenib (S) for patients (pts) with metastatic uveal melanoma (metUvMel)
    In: European Journal of Cancer (EJC) Jg. 47 (2011) Nr. Suppl. 4, S. S30
  • Schuler, Martin; Breitenbücher, Frank; Trarbach, Tanja; Brandau, Sven; Schmid, Kurt Werner; Kasper, Stefan
    Simultaneous protection against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR-signaling blockade by oncogenic RAS
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. Suppl. 4, S. 440
  • Schütt, Philipp; Stattaus, Jörg; Schuler, Martin
    Solitärer Lungenrundherd - Weitere Abklärung erforderlich?
    In: TumorDiagnostik & Therapie Jg. 32 (2011) Nr. 1, S. 33 - 37
  • Mühlenberg, Thomas; Simon, S.; Fletcher, J. A.; Grabellus, Florian; Täger, Georg; Treckmann, Jürgen-Walter; Schuler, Martin; Bauer, Sebastian
    The BH3-mimetic ABT-263 enhances the apoptotic response of GIST cells to KIT-inhibitory treatments
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 254
  • Hoiczyk, M.; Grabellus, Florian; Täger, Georg; Schuler, Martin; Bauer, Sebastian
    Trabectedin in heavily pretreated and elderly metastatic soft tissue sarcomas - a single center experience
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 237 - 237
  • Koeppen, Susanne; Hense, Jörg; Nolte, K. W.; Weis, J.; Schuler, Martin
    Treatable Bortezomib-related peripheral neuropathy in multiple myeloma
    In: Journal of the Peripheral Nervous System Jg. 16 (2011) Nr. Suppl. 3, S. 68
  • Christoph, Daniel; Wittkowski, Lukas; Stattaus, Jörg; Pöttgen, Christoph; Keyvani, Kathy; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried
    Very Late and Isolated Leptomeningeal Relapse of a Pulmonary Adenocarcinoma Presenting as Dementia
    In: Onkologie Jg. 34 (2011) Nr. 6, S. 316 - 320
  • Schütt, Philipp; Müller, Stefan; Matuszczyk, Anna; Schmid, Kurt Werner; Bockisch, Andreas; Schuler, Martin; Mann, Klaus
    Zielgerichtete Therapie für Patienten mit Schilddrüsenkarzinom
    In: TumorDiagnostik & Therapie Jg. 32 (2011) Nr. 5, S. 269 - 276
  • Schmidt, Martina; Scheulen, Max Ernst; Dittrich, C.; Obrist, P.; Marschner, N.; Dirix, L.; Schmidt, M.; Rüttinger, D.; Schuler, Martin; Reinhardt, C.; Awada, A.
    An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
    In: Annals of Oncology Jg. 21 (2010) Nr. 2, S. 275 - 282
  • Schuler, Martin; Uttenreuther-Fischer, M. M.; Piccart-Gebhart, M. J.; Harbeck, N.; on behalf of the study group and trial team
    BIBW 2992, a novel irreversible EGFR/HER1 and HER2 tyrosine kinase inhibitor, for the treatment of patients with HER2-negative metastatic breast cancer after failure of no more than two prior chemotherapies
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, S. 1065
  • Petry, I. B.; Fieber, E.; Schmidt, Marcus; Gehrmann, M.; Gebhard, S.; Hermes, M.; Schormann, W.; Selinski, S.; Freis, E.; Schwender, H.; Brulport, M.; Ickstadt, K.; Rahnenführer, J.; Maccoux, L.; West, J.; Kölbl, H.; Schuler, Martin; Hengstler, J. G.
    ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer
    In: Clinical Cancer Research Jg. 16 (2010) Nr. 2, S. 451 - 460
  • Mühlenberg, Thomas; Fletcher, J. A.; Grabellus, Florian; Schuler, Martin; Bauer, Sebastian
    Effective therapeutic sensitization of gastrointestinal stromal tumors by a BH3 mimetic
    In: European Journal of Cancer / EJC Supplements Jg. 8 (2010) Nr. 7, S. 69 - 70
  • Köhler, Jens; Breitenbücher, Frank; Schuler, Martin
    Individualisierte Therapie für Patienten mit fortgeschrittenen Lungenkarzinomen
    In: TumorDiagnostik & Therapie Jg. 31 (2010) Nr. 2, S. 79 - 87
  • Nguyen, B.; Grabellus, Florian; Hoiczyk, M.; Täger, Georg; Schuler, Martin; Bauer, Sebastian
    Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib (IM)
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, S. 10047
  • Hoffmann, Andreas-Claudius; Wild, Peter; Leicht, Christina; Bertz, Simone; Danenberg, Kathleen D.; Danenberg, Peter V.; Stöhr, Robert; Stöckle, Michael; Lehmann, Jan; Schuler, Martin; Hartmann, Arndt
    MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy
    In: Neoplasia: An International Journal for Oncology Research Jg. 12 (2010) Nr. 8, S. 628 - 636
  • Waldner, Maximilian J.; Wirtz, Stefan; Becker, Christoph; Seidel, Daniel; Tubbe, Ingrid; Cappel, Kyra; Hähnel, Patricia S.; Galle, Peter R.; Schuler, Martin; Neurath, Markus F.
    Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancer
    In: Inflammatory Bowel Diseases Jg. 16 (2010) Nr. 4, S. 559 - 567
  • Schütt, Philipp; Schütt, Birgit; Switala, Magdalena; Bauer, Sebastian; Stamatis, Georgios; Opalka, Bertram; Eberhardt, Wilfried; Schuler, Martin; Horn, Peter; Rebmann, Vera
    Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients
    In: Human Immunology Jg. 71 (2010) Nr. 5, S. 489 - 495
  • Advani, Anjali; Coiffier, Bertrand; Czuczman, Myron S.; Dreyling, Martin; Foran, James; Gine, Eva; Gisselbrecht, Christian; Ketterer, Nicolas; Nasta, Sunita; Rohatiner, Ama; Schmidt-Wolf, Ingo G. H.; Schuler, Martin; Sierra, Jorge; Smith, Mitchell R.; Verhoef, Gregor; Winter, Jane N.; Boni, Joseph; Vandendries, Erik; Shapiro, Mark; Fayad, Luis
    Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma : results of a phase I study
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. 12, S. 2085 - 2093
  • Köhler, J.; Schuler, Martin
    Targeted Therapies in der Behandlung solider und hämatologischer Neoplasien
    In: TumorDiagnostik & Therapie Jg. 31 (2010) Nr. 3, S. 133 - 142
  • Sebastian, Martin; Reck, Martin; Waller, Cornelius F.; Kortsik, Cornelius; Frickhofen, Norbert; Schuler, Martin; Fritsch, Holger; Gaschler-Markefski, Birgit; Hanft, Gertraud; Munzert, Gerd; Pawel, Joachim von
    The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy : Results from an open-label, randomized phase ii clinical trial
    In: Journal of Thoracic Oncology Jg. 5 (2010) Nr. 7, S. 1060 - 1067
  • Bauer, Sebastian; Mühlenberg, Thomas; Leahy, Michael; Hoiczyk, Mathias; Gauler, Thomas; Schuler, Martin; Looijenga, Leendert
    Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours
    In: European Urology Jg. 57 (2010) Nr. 4, S. 679 - 687
  • Hoffmann, Andreas-Claudius; Gauler, Thomas; Parr, A.; Eberhardt, Wilfried; Schuler, Martin
    Use of ERCC1 expression levels in circulating tumor cells to predict to response to platinum-based chemotherapy in patients with non-small cell lung cancer
    In: Journal of Clinical Oncology (JCO) Jg. 28 S (2010) Nr. 15, S. Abstract7512
  • Mühlenberg, Thomas; Zhang, Yixiang; Wagner, Andrew J.; Grabellus, Florian; Bradner, James; Täger, Georg; Lang, Hauke; Taguchi, Takahiro; Schuler, Martin; Fletcher, Jonathan A.; Bauer, Sebastian
    Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors
    In: Cancer Research Jg. 69 (2009) Nr. 17, S. 6941 - 6950
  • Thaler, Sonja; Hähnel, Patricia S.; Schad, Arno; Dammann, Reinhard; Schuler, Martin
    RASSF1A mediates p21Cip1/Waf1- dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt
    In: Cancer Research Jg. 69 (2009) S. 1748 - 1757
  • Hähnel, Patricia S.; Thaler, Sonja; Antunes, Edite; Huber, Christoph; Theobald, Matthias; Schuler, Martin
    Targeting AKT signaling sensitizes cancer to cellular immunotherapy
    In: Cancer Research Jg. 68 (2008) S. 3899 - 3906
  • Stolz, Claudia; Hess, Georg; Hähnel, Patricia S.; Grabellus, Florian; Hoffarth, Sandra; Schmid, Kurt Werner; Schuler, Martin
    Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis
    In: Blood Jg. 112 (2008) Nr. 8, S. 3312 - 3321
  • Bargou, R.; Leo, E.; Zugmeier, G.; Klinger, M.; .Goebeler, M.; Knop, S.; Noppeney, Richard; Viardot, A.; Hess, G.; Schuler, Martin; Einsele, H.; Brandl, C.; Wolf, A.; Kirchinger, P.; Klappers, P.; Schmidt, Markus; Riethmüller, G.; Reinhardt, C.; Baeuerle, P.A.; Kufer, P.
    Tumor regression in cancer patients by very low doses of a T cell-engaging antibody.
    In: Science Jg. 5891 (2008) Nr. 321, S. 974 - 977
  • Hoffarth, Sandra; Zitzer, Alexander; Wiewrodt, Rainer; Hähnel, Patricia S.; Beyer, Vera; Kreft, Andreas; Biesterfeld, Stefan; Schuler, Martin
    pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer
    In: Cell Death and Differentiation Jg. 15 (2008) S. 161 - 170
  • Vorworte / Nachworte

  • Reinmuth, Niels; Schuler, Martin
    Shall we use steroids when treating patients with lung cancer with checkpoint inhibitors?
    In: European Journal of Cancer (EJC) Jg. 145 (2021) S. 255 - 257
  • Schuler, Martin
    Inhibiting fibroblast growth factor receptors in cancer – the next generation
    In: Annals of Oncology Jg. 31 (2020) Nr. 10, S. 1285 - 1286
  • Höffken, K.; Heiss, M.M.; Schuler, Martin
    Tumorimmunologie : Beginn einer neuen Ära?
    In: Der Onkologe Jg. 18 (2012) S. 754 - 756
  • Abstracts

  • Lanzafame, Helena; Hamacher, Rainer; Mavroeidi, Ilektra-Antonia; Pabst, Kim; Hirmas, Nader; Kessler, Lukas; Bartel, Timo; Leyser, Stephan; Barbato, Francesco; Schuler, Martin; Bauer, Sebastian; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang;
    68Ga-FAPI PET/CT novel diagnostic tool in sarcoma
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S415
  • Kersting, David; Lazaridis, Lazaros; Barbato, Francesco; Kebir, Sied; Kümmel, Sherko; Welt, Anja; Umutlu, Lale; Milosevic, Aleksandar; Nader, Michael; Costa, Pedro Fragoso; Schmidt, T.; Oster, Christoph; Deuschl, Cornelius; Sure, Ulrich; Stuschke, Martin; Kleinschnitz, Christoph; Scheffler, Björn; Hautzel, Hubertus; Schuler, Martin; Glas, Martin; Fendler, Wolfgang; Herrmann, Ken;
    68Ga-NeoB PET for Glioma and Breast Cancer : First Results from a Prospective Observational Trial
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S265
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Özkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, H.
    68Ga-SSO-120 versus 18F-FDG PET in the Initial Staging of Small-Cell Lung Cancer Patients
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. 488 - S489
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bolukbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus
    68Ga-Satoreotide PET for Staging of Small-Cell Lung Cancer Patients
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P165
  • Schuler, Martin; de Langen, A. J.; Paz-Ares, L.; Skoulidis, F.; et al.;
    Biomarker subgroup analyses of the Phase III study CodeBreaK 200 comparing sotorasib to docetaxel in pretreated patients with KRAS G12C-mutated non-small cell lung cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 148 - 149
  • Mavroeidi, I.; Reissig, T.; Kalbourtzis, S.; Liffers, S-T.; Herold, T.; Kasper-Virchow, S.; Schildhaus, Hans-Ulrich; Schuler, Martin H. H.; Siveke, Jens;
    DNA damage repair pathways in biliary tract cancer : A new target for precision medicine?
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S223
  • Pant, S.; Arnold, D.; Tabernero, J.; Loriot, Y.; Folprecht, G.; Haag, G.M.; Palmer, D.; Prenen, H.; Coward, J.; Lugowska, I.; Goeminne, J-C.; Cervantes, A.; Gutierrez, M.; Sweiti, H.; Hammond, C.; Najmi, S.; Thomas, S.; Triantos, S.; Crow, L.; Schuler, Martin H. H.;
    Efficacy and safety of erdafitinib in adults with pancreatic cancer and prespecified fibroblast growth factor receptor alterations (FGFRalt) in the phase II open-label : Single-arm RAGNAR trial
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S898
  • Pabst, Kim; Hamacher, Rainer; Schaarschmidt, Benedikt; Kessler, Lukas; Cheung, Phyllis; Liffers, Sven-Thorsten; Miera, Monika; Kostbade, Karina; Lanzafame, Helena; Mavroeidi, Ilektra; Hirmas, Nader; Costa, Pedro Fragoso; Nader, Michael; Bartel, Timo; Schuler, Martin; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens; Schildhaus, Hans-Ulrich; Fendler, Wolfgang
    Fibroblast activation protein alpha (FAPα) directed imaging and radioligand therapy in patients with solitary fibrous tumor (SFT)
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P714
  • Loriot, Y.; Pant, S.; Witt, O.; Reardon, D.A.; Doi, T.; Qin, S.; Tabernero, J.; Iyer, G.; Massard, C.; Arnold, D.; Lugowska, I.; Carranza, O.; Gutierrez, M.; Winter, H.; Sweiti, H.; Thomas, S.; Gormley, M.; Zhang, J.; Triantos, S.; Schuler, Martin H. H.;
    Fibroblast growth factor receptor (FGFR) co-alteration (co-alt) landscape and its impact on erdafitinib (erda) response in the phase II open-label, single-arm RAGNAR trial
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S273
  • Stockey, M.; Treckmann, Jürgen-Walter; Rink, A.; Schmidt, H.; Markus, Peter; Albers, David; Zaun, G.; Kostbade, K.; Hilser, T.; Pogorzeslki, M.; Baba, Hideo Andreas; Wiesweg, Marcel; Schuler, Martin; Kasper, Stefan; Virchow, I.;
    HER2-low as potential prognostic biomarker in patients (pts) with metastatic or recurrent Gastric Cancer (GC) or esophageal-gastric junction (AEG) adenocarcinoma
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 117 - 118
  • Schuler, Martin; Cassier, P. A.; Dooms, C.; de Miguel, M. J.; et al.;
    KontRASt-01 update : safety and efficacy of JDQ443 in KRAS G12C-mutated solid tumors including non-small cell lung cancer (NSCLC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 147 - 148
  • Richlitzki, Cedric; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Guberina, Nika; Gauler, Thomas; Hautzel, Hubertus; Eberhardt, Wilfried; Darwiche, Kaid; Theegarten, Dirk; Bölükbas, Servet; Schuler, Martin; Stuschke, Martin; Guberina, Maja
    Kreuzvalidierte Prognoseparameter C-reaktives Protein und Blutbild-Parameter im Verlauf der kurativ intendierten Radiochemotherapie bei Patienten mit nichtkleinzelligem Lungenkarzinom (NSCLC) im Stadium IIIA-C
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S100 - S101
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Cordes, Sebastian; Metzenmacher, Martin; Brintrup, Diana Luetke; Guberina, Maja; Filiz, Özkan; Darwiche, Kaid; Schuler, Martin; Jöckel, Karl-Heinz; Aigner, Clemens; Stamatis, Georgios; Eberhardt, Wilfried
    Langzeitüberleben und konkurrierende Risiken von Patienten einer randomisierten Studie zur defnitiven vs. neoadjuvanten Radiochemotherapie + Resektion mit einem nach der Induktion resektablen NSCLC im Stadium III
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S7 - S8
  • Guberina, Maja; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Richlitzki, Cedric; Plönes, Till; Guberina, Nika; Forsting, Michael; Herrmann, Ken; Gauler, Thomas; Hoffmann, Christian; Theegarten, Dirk; Darwiche, Kaid; Garcia, Alina Santiago; Stuschke, Martin; Schuler, Martin
    Long-term Survival in Patients with oligometastatic Lung Cancer (cT4 or cN2-3, cM1a-c) after thoracic Chemoradiation, Metastasis-directed and Systemic Therapy compared with the Outcome in locally advanced Lung Cancer (cT4 or cN2-3, cM0)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S101 - S102
  • Mavroeidi, I. A.; Reissig, T.; Kalbourtzis, S.; Liffers, S.-T.; Herold, T.; Treckmann, Jürgen-Walter; Schildhaus, Hans-Ulrich; Schuler, Martin; Siveke, Jens T.;
    Molecular characterization of biliary tract cancer at a single comprehensive cancer center focusing on DNA damage repair genes
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 62
  • Wiesweg, Marcel; Küter, C.; Schnorbach, J.; Keyl, J.; Plönes, T.; Metzenmacher, M.; Cvetkovic, J.; Eberhardt, Wilfried E.E.; Oezkan, F.; Theegarten, Dirk; Stenzinger, A.; Darwiche, Kaid; Herth, F.J.F.; Bölükbas, S.; Winter, H.; Weykamp, F.; Stuschke, Martin; Thomas, M.; Schuler, Martin H. H.; Christopoulos, P.;
    Oligometastatic non-small cell lung cancer : Impact of local and systemic treatment approaches on clinical outcome
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S828
  • Fink, M.; Schmidt, K.; Tewes, Mitra; Schuler, Martin; Müller, B. W.; Schadendorf, Dirk; Scherbaum, Norbert; Kowalski, A.; Skoda, E.-M.; Teufel, Martin;
    RCT to Test the Efficacy of an EEG Neurofeedback Intervention in Cancer Patients and Cancer Survivors
    Deutscher Kongress für Psychosomatische Medizin und Psychotherapie, 03.-05.05.2023, Berlin,
    In: Zeitschrift für Psychosomatische Medizin und Psychotherapie Jg. 69 (2023) Nr. 2, S. 148 - 149
  • Lanzafame, H.; Hirmas, N.; Schuler, Martin; Darwiche, Kaid; Eberhardt, Wilfried E. E.; Aigner, Clemens; Stuschke, Martin; Kessler, Lukas; Pabst, K. M.; Barbato, F.; Rischpler, Christoph; Hautzel, H.; Herrmann, Ken; Fendler, Wolfgang;
    68GA-FAPI PET/CT in the evaluation of Non-Small Cell Lung Cancer (NSCLC)
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S107
  • Schuler, Martin H. H.; Cuppens, K.; Ploenes, T.; Vanbockrijck, M.; Wiesweg, Marcel; Darwiche, Kaid; Schramm, Alexander; Maes, B.; Hegedus, B.; Schildhaus, Hans-Ulrich; Hautzel, H.; Theegarten, Dirk; Baas, P.; Hartemink, K.; Du Pont, B.; Aigner, Clemens;
    A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology Jg. 33 (2022) Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1404
  • Petzold, A.; Dujardin, P.; Oeck, S.; Wiesweg, Marcel; Hegedüs, B.; Schuler, Martin; Grüner, Barbara M.; Schramm, Alexander
    Combining Patient-Derived Xenografts and Barcoding Technology to Evaluate Response to Targeted Therapies in ALK+NSCLC
    In: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 611
  • Schuler, Martin; Loriot, Y.; Iyer, G.; Witt, O.; Doi, T.; Qin, S.; Tabernero, J.; Reardon, D. A.; Massard, C.; Palmer, D. H.; Lugowska, I.; Coward, J.; Corassa, M.; Stuyckens, K.; Liao, H.; Najmi, S.; Hammond, C.; Santiago-Walker, A. E.; Sweiti, H.; Pant, S.;
    Entitäten-unabhängige Sicherheit und Wirksamkeit von Erdafitinib bei Patienten mit fortgeschrittenen soliden Tumoren mit präspezifizierten genomischen FGFR- Aberrationen (RAGNAR Interimanalyse)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 27 - 28
  • Hegedüs, Luca; Okumus, Ö.; Mairinger, Fabian; Plönes, Till; Reuter, Sebastian; Schuler, Martin; Theegarten, Dirk; Bankfalvi, Agnes; Aigner, Clemens; Hegedüs, Balazs
    Expression and SN38 Antitumor Activity in Malignant Pleural Mesothelioma Cells
    In: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 118
  • Pogorzelski, M.; Fendler, Wolfgang; Berliner, C.; Hussain, T.; Lang, Stephan; Ting, Saskia; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Gauler, Thomas; Stuschke, Martin; Laue, K.; Herrmann, Ken; Grünwald, V.; Schuler, Martin; Kasper-Virchow, S.;
    Immuntherapie eines Mikrosatelliten-instabilen metastasierten Talgdrüsenkarzinoms der Glandula submandibularis mit Pembrolizumab
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 230 - 231
  • Schuler, Martin; Tan, D. S.; Shimizu, T.; Cassier, P. A.; et al.;
    KontRASt-01 : eine Phase Ib/II Dosiseskalationsstudie von JDQ443 in Patienten mit fortgeschrittenen, KRAS G12C-mutierten soliden Tumoren
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie 07. bis 10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 29
  • Eberhardt, Wilfried; Pöttgen, Christoph; Gauler, Thomas; Schulte, C; Friedel, G.; Kopp, H.-G.; Fischer, B.; Schmidberger, H.; Kimmich, M.; Budach, W.; Cordes, S.; Metzenmacher, M.; de Los Rios, R. Hepp; Spengler, W.; De Ruysscher, D.; Belka, C.; Welter, S.; Brintrup, D. Luetke; Guberina, M.; Oezkan, F.; Darwiche, Kaid; Schuler, Martin; Jöckel, Karl-Heinz; Aigner, Clemens; Stamatis, Georgios; Stuschke, Martin
    Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC
    In: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 65
  • Miura, Satoru; Schuler, Martin; Popat, Sanjay; Park, Keunchil; Passaro, Antonio; De Marinis, Filippo; Solca, Flavio; Märten, Angela; Kim, Edward S.; Chih-Hsin Yang, James;
    MO29-3 A database of 1023 patients with NSCLC and uncommon EGFR mutations treated with afatinib : Focus on Asian patients
    The 19th Annual Meeting of JSMO (Japanese Society of Medical Oncology), 17.–19.02.2022, Kyoto,
    In: Annals of Oncology Jg. 33 (2022) Nr. Suppl. 6: 2022 the Japanese Society of Medical Oncology Annual Meeting 17–19 February 2022, Kyoto, Japan, S. 500
  • Okumus, O.; Mardanzai, K.; Ploenes, T.; Theegarten, Dirk; Darwiche, Kaid; Schuler, Martin; Nensa, Felix; Hautzel, H.; Stuschke, Martin; Hegedues, B.; Aigner, Clemens
    Preoperative PET-SUVmax and Volume Based PET Metrics of the Tumor Fail to Predict Nodal Upstaging in Early-Stage Lung Cancer
    In: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 203
  • Maier, D.; Vehreschild, J. J.; Uhl, B.; Grünwald, V.; Hadaschik, Boris; Palm, S.; Stuschke, Martin; Esins, M.; Ressing, F.; Schuler, Martin; Serve, H.; et al.;
    Profil der multizentrischen Kohorte der Klinischen Kommunicationsplattform des Deutschen Konsortiums für Translationale Krebsforschung (DKTK)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 13
  • Guberina, M.; Pöttgen, Christoph; Guberina, N.; Gauler, Thomas; Metzenmacher, M.; Wiesweg, Marcel; Richlitzki, C.; Plönes, T.; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, H.; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Eberhardt, Wilfried E. E.; Stuschke, Martin;
    Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
    28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S15
  • Hamacher, R.W.; Pabst, K.M.; Kessler, Lukas; Costa, Pedro Fragoso; Ferdinandus, J.; Weber, Manuel; Lippert, M.; Lückerath, Katharina; Hirmas, N.; Kostbade, K.; Mavroeidi, I.A.; Schuler, Martin H. H.; Ahrens, M.; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens T.; Fendler, Wolfgang P.;
    Safety and efficacy of [90Y]Y-FAPI-46 radioligand therapy in patients with advanced sarcomas and other cancer entities
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology Jg. 33 (2022) Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1231 - S1232
  • Martens, U.M.; Schröder, J.; Sellmann, Ludger; Reiser, M.; Frank-Gleich, S.; Decker, T.; Schneeweiss, A.; Schuler, Martin; Grebhardt, S.; Woerner, S.; Zacharias, S.; Marschner, N.W.; Kasenda, B.; Vannier, C.
    Second interim analysis of INFINITY : A registry on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice
    In: Annals of Oncology Jg. 33 (2022) S. 575 - S576
  • Johnson, M.L.; de Langen, A.J.; Waterhouse, D.M.; Mazieres, J.; Dingemans, A-M.C.; Mountzios, G.; Pless, M.; Wolf, J.; Schuler, Martin; Lena, H.; Skoulidis, F.; Okamoto, I.; Kim, S-W.; Linardou, H.; Novello, S.; Chen, Y.; Solomon, B.; Obiozor, C.; Wang, Y.; Paz-Ares, L.;
    Sotorasib versus docetaxel for previously treated non-small cell lung cancer with KRAS G12C mutation : CodeBreaK 200 phase III study
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology Jg. 33 (2022) Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1417 - S1418
  • Tüns, A.I.; Ho, C.S.L.; Schildhaus, Hans-Ulrich; Wiesweg, Marcel; Grüner, Barbara M.; Hegedüs, B.; Schuler, Martin; Schramm, Alexander; Oeck, S.
    Targeting SHP2 Reverts Oncogenic Mediated Resistance to KRAS-G12C Inhibition
    In: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. S586 - S587
  • Loriot, Yohann; Schuler, Martin; Iyer, Gopa; Witt, Olaf; Doi, Toshihiko; Qin, Shukui; Tabernero, Josep; Reardon, David A.; Massard, Christophe; Palmer, Daniel; Lugowska, Iwona; Coward, Jermaine; Corassa, Marcelo; Stuyckens, Kim; Liao, Huimin; Najmi, Saltanat; Hammond, Constance; Santiago-Walker, Ademi E.; Sweiti, Hussein; Pant, Shubham
    Tumor agnostic efficacy and safety of erdafitinib in patients (pts) with advanced solid tumors with prespecified fibroblast growth factor receptor alterations (FGFRalt) in RAGNAR : Interim analysis (IA) results
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 3007
  • Hu, M.I.; Subbiah, V.; Mansfield, A.S.; Taylor, M.; Schuler, Martin H. H.; Zhu, V.; Hadoux, J.; Curigliano, G.; Wirth, L.J.; Garralda, E.; Adkins, D.R.; Godbert, Y.; Ahn, M-J.; Cassier, P.A.; Cho, B.C.; Lin, C-C.; Barata, T.; Zalutskaya, A.; Scalori, A.; Brose, M.S.;
    Updated ARROW data : Pralsetinib in patients (pts) with advanced or metastatic RET-altered thyroid cancer (TC)
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology Jg. 33 (2022) Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1298 - S1299
  • Martens, U.; Schröder, J.; Sellmann, Ludger; Reiser, M.; Frank-Gleich, S.; Decker, T.; Schneeweiss, A.; Schuler, Martin; Grebhardt, S.; Woerner, S.; Zacharias, S.; Marschner, N.; Kasenda, B.; Vannier, C.;
    Zweite Interimsanalyse zu INFINITY : ein Register zur Entscheidungsfindung in der Biomarker-basierten Präzisionsonkologie und deren klinische Bedeutung
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 11 - 12
  • Kessler, Lukas; Ferdinandus, J.; Costa, P. F.; Weber, Manuel; Hirmas, N.; Kostbade, K.; Bauer, Sebastian; Dirksen, U.; Zarrad, F.; Nader, M.; Grafe, Hong; Chodyla, M.; Milosevic, A.; Umutlu, Lale; Schuler, Martin; Ahrens, M.; Podleska, Lars E.; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.; Hamacher, R.;
    A novel theranostic approach for sarcoma : Insights on diagnostic and therapeutic use of FAP-radioligands
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 11 - 12
  • Melero, Ignacio; Calvo, Emiliano; Goebeler, Maria-Elisabeth; Garralda, Elena; Dummer, Reinhard; Rodríguez-Ruiz, María; Miguel, Maria de; Sayehli, Cyrus Michael; Casal, Guzman Alonso; Ramelyte, Egle; Schuler, Martin; Gromke, Tanja; Sanmamed, Miguel; Moreno, Irene; Bargou, Ralf; Lostes, Maria; Maul, Julia-Tatjana; Eggenschwiler, Corinne; Richly, Heike; Fettes, Petra; Klar, Kathrin; Schuberth-Wagner, Christine; Haake, Markus; Wischhusen, Jörg; Leo, Eugen;
    A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced stage solid tumors (Acronym: GDFATHER)
    SITC 36th Anniversary Annual Meeting (SITC 2021), 10-14 November 2021, Washington & virtually,
    In: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. Suppl. 2, S. A536 - A536
  • Melero, Ignacio; Calvo, Emiliano; Dummer, Reinhard; Garralda, Elena; Schuler, Martin; Goebeler, Maria-Elisabeth; Bargou, Ralf C.; Gromke, Tanja; Tabernero, Josep; Ramelyte, Egle; De Miguel, Maria; Sanmamed, Miguel F.; Rodriguez-Ruiz, Maria E.; Fettes, Petra; Klar, Kathrin; Ruediger, Manfred; Schuberth-Wagner, Christine; Haake, Markus; Wischhusen, Joerg; Leo, Eugen;
    A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced-stage solid tumors (ACRONYM: GDFATHER).
    2021 Genitourinary Cancers Symposium, 11 - 13 Feb 2021, online,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_suppl, S. TPS2658
  • Pant, Shubham; Tabernero, Josep; Massard, Christophe; Iyer, Gopa; Witt, Olaf; Doi, Toshihiko; Qin, Shukui; Lu-Emerson, Christine; Hargrave, Darren R.; García-Corbacho, Javier; Little, Shonda Marie; Xia, Qi; Santiago-Walker, Ademi E.; Moy, Christopher; Hammond, Constance; Sweiti, Hussein; Schuler, Martin;
    A phase II open-label study in adult and adolescent patients (pts) with advanced solid tumors harboring fibroblast growth factor receptor (FGFR) gene alterations
    2021 Gastrointestinal Cancers Symposium, 15-17 January 2021, online,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 3, Supplement, S. TPS480
  • Yang, J.Y.C-H.; Schuler, Martin; Popat, Sanjay; Miura, Satoru; Park, Kyungrae; Passaro, Antonio; de Marinis, Filippo; Solca, Flavio F.; Märten, Angela; Kim, Edward S.
    Afatinib for the treatment of NSCLC with uncommon EGFR mutations : An updated database of 1023 cases
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 965
  • Subbiah, Vivek; Cassier, Philippe A.; Siena, Salvatore; Alonso, Guzman; Paz-Ares, Luis G.; Garrido, Pilar; Nadal, Ernest; Curigliano, Giuseppe; Vuky, Jacqueline; Lopes, Gilberto; Kalemkerian, Gregory Peter; Bowles, Daniel W.; Seetharam, Mahesh; Chang, Jianhua; Zhang, Hui; Ye, Chaoyang; Green, Jennifer; Zalutskaya, Alena; Schuler, Martin; Fan, Yun
    Clinical activity and safety of the RET inhibitor pralsetinib in patients with RET fusion-positive solid tumors : Update from the ARROW trial
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 3079 - 3079
  • Subbiah, Vivek; Hu, Mimi I-Nan; Gainor, Justin F.; Mansfield, Aaron Scott; Alonso, Guzman; Taylor, Matthew H.; Zhu, Viola Weijia; Garrido, Pilar; Amatu, Alessio; Doebele, Robert C; Cassier, Philippe; Keam, Bhumsuk; Schuler, Martin; Zhang, Hui; Clifford, Corinne; Palmer, Michael; Green, Jennifer; Turner, Christopher D.; Curigliano, Giuseppe;
    Clinical activity of the RET inhibitor pralsetinib (BLU-667) in patients with RET fusion–positive solid tumors
    2021 Gastrointestinal Cancers Symposium, 15-17 January 2021, online,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 3, Supplement, S. 467 - 467
  • Guberina, M.; Herrmann, Ken; Pöttgen, Christoph; Guberina, N.; Hoffmann, C.; Ploenes, T.; Gauler, Thomas; Wetter, Axel; Umutlu, Lale; Hautzel, H.; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Metzenmacher, M.; Wiesweg, Marcel; Aigner, Clemens; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Stuschke, Martin
    EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLC
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 142
  • Decker, T.; Fasching, P.A.; Nusch, A.; Hartkopf, A.; Heinrich, B.J.; Kurbacher, C.M.; Fuchs, R.; Tesch, H.; Krabisch, P.; Huober, J.; Kümmel, S.; Brucker, S.Y.; Janni, W.; Schneeweiss, A.; Schuler, Martin; Fehm, T.N.; Lüftner, D.; C. Quiering; Kreuzeder, J.; Reinisch, M.
    Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptor–positive advanced breast cancer (ABC) : Secondary and exploratory results of phase 3b RIBECCA study
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 467 - S468
  • Pogorzelski, M.; Lauri, F.; Hilser, T.; Hense, Jörg; Ting, Saskia; Kansy, B.; Gauler, Thomas; Stuschke, Martin; Schmid, Kurt Werner; Lang, Stephan; Zaun, G.; Grünwald, V.; Schuler, Martin; Kasper, Stefan
    Efficacy of immunotherapy (IO) and subsequent systemic treatment after failure of IO in patients with recurrent or metastatic head and neck cancer in a real-world setting
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 812
  • Martens, U.; Schröder, J.; Sellmann, Ludger; Frank-Gleich, S.; Zaiss, M.; Decker, T.; Schneeweiss, A.; Schuler, Martin; Grebhardt, S.; Vannier, C.; Marschner, N.; Kasenda, B.;
    First interim analysis of INFINITY : A registry on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 295
  • Müller, S.; Fink, M.; Schuler, Martin; Hense, Jörg; Przyborek, M.; Teufel, Martin; Tewes, Mitra;
    Influence of external and self-assessment in symptom burden of cancer patients in a palliative care outpatient clinic of a Comprehensive Cancer Center
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 92
  • Ferdinandus, J.; Costa Fragoso, P.; Kessler, Lukas; Weber, Manuel; Hirmas, N.; Kostbade, K.; Bauer, Sebastian; Schuler, Martin; Ahrens, M.; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang; Hamacher, R.
    Initial clinical experience with [Y-90]Y-FAPI-46 radioligand therapy for advanced stage solid tumors
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 290
  • Skoulidis, Ferdinandos; Li, Bob T.; Govindan, Ramaswamy; Dy, Grace K.; Shapiro, Geoffrey; Bauml, Joshua; Schuler, Martin; Addeo, Alfredo; Kato, Terufumi; Besse, Benjamin; Anderson, Abraham; Ang, Agnes; Ngarmchamnanrith, Gataree; Tran, Qui; Velcheti, Vamsidhar
    Overall survival and exploratory subgroup analyses from the phase 2 CodeBreaK 100 trial evaluating sotorasib in pretreated KRAS p.G12C mutated non-small cell lung cancer
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 9003 - 9003
  • Massard, Christophe; Pant, Shubham; Iyer, Gopa; Schuler, Martin; Witt, Olaf; Qin, Shukui; Tabernero, Josep; Doi, Toshihiko; Hargrave, Darren R.; Hammond, Constance; Little, Shonda Marie; Xia, Qi; Cao, Jing; Santiago-Walker, Ademi E.; Sweiti, Hussein
    Preliminary results of molecular screening for FGFR alterations (alts) in the RAGNAR histology-agnostic study with the FGFR-inhibitor (FGFRi) erdafitinib
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 4081 - 4081
  • Kasper, Stefan; Goetze, Thorsten Oliver; Stintzing, Sebastian; Hofheinz, Ralf Dieter; Sinn, Marianne; Dechow, Tobias Nicolaas; Ettrich, Thomas Jens; Keitel, Verena; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Kolov, Alexander; Edelmann, Thomas; Stein, Alexander; Trarbach, Tanja; Junge, Sabine; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    RAMucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic colorectal cancer : Safety results from the phase IIb part of the RAMTAS phase II/III trial of the German AIO (AIO-KRK-0316)
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 3566 - 3566
  • Pöttgen, Christoph; Gauler, Thomas; Guberina, M.; Pierscianek, D.; Wrede, Karsten; Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Stuschke, Martin
    Re-Irradiation of cerebral Metastases after prophylactic Brain Skull irradiation in small-cell neuroendocrine Lung Cancer (SCLC)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 176
  • Schuler, Martin; Wolf, J.
    Registrational phase 2 trial of sotorasib in KRAS p. G12C mutant NSCLC : first disclosure of the CodeBreaK 100 primary analysis
    In: Pneumologie Jg. 75 (2021) Nr. Suppl. 1, 61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. Leipzig digital, 02.–05.06.2021, S. S38
  • Reinisch, Mattea; Nusch, Arndt; Decker, Thomas; Hartkopf, Andreas; Heinrich, Bernhard J.; Kurbacher, Christian M.; Fuchs, Roswitha; Tesch, Hans; Krabisch, Petra; Brucker, Sara Y.; Fehm, Tanja; Janni, Wolfgang; Kuemmel, Sherko; Lüftner, Diana; Schneeweiss, Andreas; Schuler, Martin; Voges, Claudia; Schubert, Jörg; Fasching, Peter A.;
    Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribociclib (lee011) in combination with letrozole : Final results
    San Antonio Breast Cancer Virtual Symposium ; December 8-11, 2020; San Antonio, Texas,
    In: Cancer Research Jg. 81 (2021) Nr. 4, Supplement, S. PS10 - 31
  • Lauri, F.; Hilser, T.; Hense, Jörg; Ting, S. C.; Kansy, B.; Laue, K.; Gauler, Thomas C.; Stuschke, Martin; Schmid, K. W.; Lang, Stephan; Grünwald, Viktor; Schuler, Martin; Kasper, S.;
    Systemic inflammatory response parameters as prognostic markers in patients with recurrent or metastatic head and neck cancer treated with immunotherapy
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 58
  • Lopez, Juanita S.; Camidge, Ross; Iafolla, Marco; Rottey, Sylvie; Schuler, Martin; Hellmann, Matthew; Balmanoukian, Ani; Dirix, Luc; Gordon, Michael; Sullivan, Ryan; Henick, Brian S.; Drake, Charles; Wong, Kit; LoRusso, Patricia; Ott, Patrick; Fong, Lawrence; Schiza, Aglaia; Yachnin, Jeffery; Ottensmeier, Christian; Braiteh, Fadi; Bendell, Johanna; Leidner, Rom; Fisher, George; Jerusalem, Guy; Molenaar-Kuijsten, Laura; Schmidt, Marcus; Laurie, Scott A.; Aljumaily, Raid; Rittmeyer, Achim; Gort, Eelke; Melero, Ignacio; Mueller, Lars; Sabado, Rachel; Twomey, Patrick; Huang, Jack; Yadav, Manesh; Zhang, Jingbin; Mueller, Felicitas; Derhovanessian, Evelyna; Sahin, Ugur; Türeci, Özlem; Powles, Thomas;
    Abstract CT301: A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
    Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,
    In: Cancer Research Jg. 80 (2020) Nr. 16: Supplement, S. CT301
  • Yang, J. C-H.; Schuler, Martin; Popat, S.; Miura, S.; Heeke, S.; Passaro, A.; de Marinis, F.; Park, K.; Kim, E. S.;
    Afatinib in Asian and non-Asian patients (pts) with EGFR mutation positive (EGFRm+) NSCLC harboring major uncommon mutations
    ESMO Asia Virtual Congress 2020 ; 20-22 November 2020,
    In: Annals of Oncology Jg. 31 (2020) Nr. Supplement 6, S. S1396
  • Yang, J.C-H.; Schuler, Martin; Popat, Sanjay; Miura, S.; Heeke, S.; Passaro, A.; de Marinis, Filippo; Park, K.; Kim, E.S.
    Afatinib in Asian and non-Asian patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC harboring uncommon mutations
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S860 - S861
  • Subbiah, Vivek; Hu, Mimi I-Nan; Gainor, Justin F.; Mansfield, Aaron Scott; Alonso, Guzman; Taylor, Matthew H.; Zhu, Viola Weijia; Garrido Lopez, Pilar; Amatu, Alessio; Doebele, Robert C; Cassier, Philippe Alexandre; Keam, Bhumsuk; Schuler, Martin; Zhang, Hui; Clifford, Corinne; Palmer, Michael; Green, Jennifer; Turner, Christopher D.; Curigliano, Giuseppe
    Clinical activity of the RET inhibitor pralsetinib (BLU-667) in patients with RET fusion+ solid tumors.
    In: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. 15_Suppl., S. 109
  • Martens, U.; Reiser, M.; Schirrmacher-Memmel, S.; Sellmann, L.; Decker, T.; Schneeweiss, A.; Schuler, Martin; Bengsch, F.; Vannier, C.; Potthoff, K.; Marschner, N.; Kasenda, B.;
    First results from INFINITY - A registry on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 251 - 252
  • Peuker, C. A.; Yaghobramzi, S.; Grunert, C.; Keilholz, L.; Henning, S.; Schaper, S.; Brucker, S.; Decker, T.; Fasching, P.; Fehm, T.; Janni, W.; Kümmel, Sherko; Schneeweiss, A.; Schuler, Martin; Lüftner, D.; Busse, A.;
    Influence of CDK4/6 inhibitors on the peripheral immune response in hormone receptor-positive breast cancer
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 159
  • Kasper, Stefan; Hofheinz, R.D.; Stintzing, S.; Götze, T.O.; Sinn, M.; Dechow, T.; Ettrich, T.J.; Keitel, V.; Graeven, U.; Fischer von Weikersthal, L.; Kolov, A.; Edelmann, T.; Stein, A.; Trarbach, T.; Junge, S.; Pauligk, C.; Virchow, I.; Siveke, Jens; Al-Batran, S-E.; Schuler, Martin
    Interim safety analysis of the phase IIb study of ramucirumab in combination with TAS102 vs. TAS102 monotherapy in metastatic colorectal cancer : The RAMTAS trial of the German AIO
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S427 - S428
  • Guberina, Marko; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Herrmann, Ken; Theegarten, Dirk; Aigner, Clemens; Plones, Till; Gauler, Thomas; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Darwiche, Kaid; Stuschke, Martin;
    Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer Intention
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 196 (2020) Nr. 1 Supplement: Abstracts DEGRO 2020, S. S143
  • Pöttgen, Christoph; Plajer, D.; Gauler, Thomas; Guberina, Marko; Santiago, Alina; Guberina, Nika; Eberhardt, Wilfried; Schuler, Martin; Darwiche, Kaid; Plönes, Till; Aigner, Clemens; Stuschke, Martin;
    Optimierung prognostischer Modelle für das Überleben von Patienten mit lokal fortgeschrittenen kleinzelligen Lungenkarzinomen nach definitiver Radiochemotherapie mittels künstlicher Intelligenz
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 196 (2020) Nr. 1 Supplement: Abstracts DEGRO 2020, S. S57 - S58
  • Röhrig, T.; Oechsel, K.; Schuler, U.; Rosenbruch, J.; Neukirchen, M.; Hense, Jörg; Weber, M.; Nauck, F.; Junghanß, C.; Kramer, T.; Oorschot, B. van; Ostgathe, C.; Thuss-Patience, P.; Schweda, Adam; Ullrich, A.; Teufel, Martin; Schuler, Martin; Tewes, Mitra;
    Palliative knowledge and self-efficacy expectation of residents before and after palliative care unit rotation - A national study project
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 210
  • Kraskowski, O.; Eberhardt, Wilfried; Metzenmacher, Martin; Zaun, Gregor; McCutcheon, A.; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Kasper, Stefan; Hense, Jörg; Gruenwald, Viktor; Wiesweg, Marcel; Schuler, Martin; Pogorzelski, Michael;
    Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 137
  • Janku, Filip; Elez, Elena; Iyer, Gopa; Yamamoto, Noboru; Tan, Daniel Shao-Weng; Stathis, Anastasios; Stammberger, Uz M.; Evans, Helen; Seroutou, Abdelkader; Mais, Anna; Schuler, Martin
    Phase I dose-finding study of oral ERK1/2 inhibitor LTT462 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations
    In: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. 15_Suppl., S. 3640
  • Schuler, Martin; Tabernero, J.; Massard, C.; Iyer, G. Vasudeva; Witt, Olaf; Doi, T.; Qin, S.; Lu-Emerson, C.; Hargrave, D.; Garcia-Corbacho, J.; Little, S.; Xia, Q.; Santiago-Walker, A.; Moy, C.H.; Hammond, C.; Lau, Y.Y.; Sweiti, H.; Pant, S.
    Phase II, open-label study of erdafitinib in adult and adolescent patients (pts) with advanced solid tumours harboring fibroblast growth factor receptor (FGFR) gene alterations
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. 502 - S503
  • Hartkopf, Andreas; Nusch, Arnd; Decker, Thomas; Reinisch, Mattea; Heinrich, Bernhard J; Kurbacher, Christian; Fuchs, Roswitha; Tesch, Hans; Krabisch, Petra; Brucker, Sara; Fehm, Tanja N; Janni, Wolfgang; Kümmel, Sherko; Lüftner, Diana; Schneeweiss, Andreas; Schuler, Martin; Voges, Claudia; Schubert, Jörg; Fasching, Peter A
    RIBECCA - A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole : Results of the third interim analysis
    In: Cancer Research Jg. 80 (2020) Nr. 4,
  • Thomas, M.; Griesinger, F.; Schuler, Martin; Gainor, J. F.; Curigliano, G.; Kim, D.-W.; Lee, D. H.; Besse, B.; Baik, C. S.; Doebele, R. C.; Cassier, P.; Lopes, G.; Tan, D. S.-W.; Garralda, E.; Paz-Ares, L.; Chul Cho, B.; Gadgeel, S. M.; Liu, S. V.; Turner, C. D.; Subbiah, V.;
    Registrational dataset from the phase 1/2 ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion plus non-small-cell lung cancer (NSCLC)
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 141 - 142
  • Hu, M.; Subbiah, V.; Wirth, L.J.; Schuler, Martin; Mansfield, A.S.; Brose, M.S.; Curigliano, G.; Leboulleux, S.; Zhu, Viola W.; Keam, Bhumsuk; Matos, I.; Lin, C-C.; Adkins, Douglas R.; Baik, C.S.; Lopes, G.; Godbert, Y.; Sarker, Debashis; Zhang, H.; Turner, C.; Taylor, M.
    Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC)
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S1084
  • Keam, B.; Hu, M. I.; Subbiah, V.; Wirth, L.; Schuler, Martin; Mansfield, A. S.; Brose, M. S.; Curigliano, G.; Leboulleux, S.; Zhu, V. W.; Matos, I.; Adkins, D.; Baik, C. S.; Lopes, G.; Godbert, Y.; Sarker, D.; Zhang, H.; Turner, C. D.; Taylor, M. H.; Lin, C.-C.;
    Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC)
    ESMO Asia Virtual Congress 2020 ; 20-22 November 2020,
    In: Annals of Oncology Jg. 31 (2020) Nr. Supplement 6, S. S1413 - S1414
  • Darwiche, Kaid; Theegarten, Dirk; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel; Aigner, Clemens; Karpf-Wissel, Rüdiger
    The impact of needle choice on molecular analysis of ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in NSCLC
    In: European Respiratory Journal (ERJ) Jg. 56 (2020) Nr. Suppl. 64,
  • Stockhammer, P.; Ho, C.S.L.; Bankfalvi, Agnes; Plönes, T.; Hegedus, L.; Schuler, Martin; Aigner, Clemens; Schramm, Alexander; Hegedus, B.
    A Novel Patient Derived Synchronous Cell Pair with Different Mutations in an ALK-Rearranged Lung Adenocarcinoma Underlines Tumor Heterogeneity
    In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S571 - S572
  • Kasper, Stefan; zur Hausen, Gerrit; Stein, Alexander; Stintzing, Sebastian; Berger, Andreas; Loges, Sonja; Hofheinz, Ralf; Trarbach, Tanja; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Goetze, Thorsten Oliver; Hagen, Volker A.; Burock, Susen; Hoffmeister, Albrecht; Dechow, Tobias Nicolaas; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients : The RAMTAS trial of the German AIO (KRK-0316)
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. TPS3617 - TPS3617
  • Zaatar, M.; Stork, T.; Fangmann, L.; Martens, A.; Collaud, S.; Mardanzai, K.; Plönes, T.; Valdivia, D.; Schuler, Martin; Stuschke, Martin; Darwiche, Kaid; Hegedus, B.; Aigner, Clemens
    Advanced Age and High Modified Glasgow Prognostic Score Are Associated with Increased Complications After Pneumonectomy
    In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S677
  • Tewes, Mitra; Goette, M.; Frikkel, J.; Guyot, M.; Kasper, S.; Metzenmacher, M.; Hense, Jörg; Teufel, Martin; Schuler, Martin; Beckmann, M.;
    Barriers and motivation of physical activitiy (PA) in patients with cancer related fatigue (CRF)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 165
  • Michels, Sebastian Yves Friedrich; Nogova, Lucia; Deschler-Baier, Barbara; Felip, Enriqueta; Rodriguez-Abreu, Delvys; Rosell, Rafael; Sebastian, Martin; Schuler, Martin; Wermke, Martin; Fischer, Rieke Nila; Koleczko, Sophia; Abdulla, Diana S.Y.; Riedel, Richard; Scheffler, Matthias; Fassunke, Jana; Hellmich, Martin; Merkelbach-Bruse, Sabine; Buettner, Reinhard; Wolf, Juergen
    EATON: An open-label, multicenter, phase I dose-escalation trial of nazartinib (EGF816) and trametinib in patients with EGFR-mutant non-small cell lung cancer – preliminary data on safety and tolerability
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. e20577 - e20577
  • Joerger, Markus; Cho, Byoung Chul; Mach, Nicolas; Caballero, Cristina; Soo, Ross A.; Wirth, Manfred; Sayehli, Cyrus; Navarro, Alejandro; Keam, Bhumsuk; Piciu, Ana-Maria; Bender, Sebastian; Nogai, Hendrik; Ellinghaus, Peter; Schuler, Martin
    Early clinical experience with the pan-FGFR inhibitor rogaratinib in patients with non-small cell lung cancer selected based on FGFR mRNA expression levels
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. e20661 - e20661
  • Schuler, Martin;
    Integration of immune checkpoint inhibitors in the treatment of early stage lung cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 13
  • Nothdurft, S.; Breitenbücher, Frank; Okimoto, R.; Bivona, T.; Grüner, Barbara M.; Hoelzel, M.; Forster, J.; Kalmbach, S.; Schramm, Alexander; Schuler, Martin
    MA17.07 Identification of AHR as a Novel Regulator of Lung Cancer Metastasis
    In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S319
  • O'Byrne, K.; Yang, J.C.; Wu, Y.; Hirsh, V.; Yamamoto, N.; Popat, S.; Tamiya, A.; Märten, A.; Schuler, Martin
    P2.14-60 Afatinib in EGFR Mutation-Positive NSCLC : Activity in Patients with Brain Metastases, and Impact on CNS Progression/Spread
    In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, S. 855
  • Guberina, M.; Stuschke, Martin; Eberhardt, Wilfried; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Dirk, T.; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph;
    Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
    61st Annual Meeting of the American Society for Radiation Oncology ; September 15-18, 2019, Chicago, IL, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 105 (2019) Nr. 1, Supplement, S. S146 - S147
  • Nusch, Arnd; Decker, Thomas; Reinisch, Mattea; Hartkopf, Andreas D.; Heinrich, Bernhard; Kurbacher, Christian M.; Fuchs, Roswitha Dorothea; Tesch, Hans; Krabisch, Petra; Brucker, Sara; Fehm, Tanja N.; Janni, Wolfgang; Kümmel, Sherko; Luftner, Diana; Schneeweiss, Andreas; Schuler, Martin; Voges, Claudia; Schubert, Joerg; Fasching, Peter A.
    RIBECCA: A phase IIIb, multicenter, open label study for women with estrogen receptor-positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole—Results of the second interim analysis.
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 1061 - 1061
  • Sebastian, M.; Schuler, Martin; Schulz, C.; Deschler-Baier, B.; Kimmich, M.; Hilgert-Daute, K.; Griesinger, F.;
    Adverse events self-reported by patients with advanced non-small cell lung cancer treated with osimertinib or chemotherapy in the AURA3 trial
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 111
  • O'Byrne, K.; Yang, JCH; Wu, Y. L.; Hirsh, V.; Yamamoto, N.; Popat, S.; Tamiya, A.; Maerten, A.; Schuler, Martin;
    Afatinib for patients with EGFR mutation-positive (EGFRm plus ) NSCLC : Activity in patients with baseline brain metastases and impact on the rate of central nervous system (CNS) progression or spread
    COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, 13–15 November 2018, Perth Australia,
    In: Asia-Pacific Journal of Clinical Oncology Jg. 14 (2018) Nr. Suppl. 7, S. 159 - 160
  • O'Byrne, K.; Yang, J. C-H; Wu, Y-L; Hirsh, V.; Yamamoto, N.; Popat, S.; Tamiya, A.; Maerten, A.; Schuler, Martin;
    Central Nervous System or Systemic Progression Analysis for EGFR Mutation-Positive NSCLC Patients Receiving Afatinib in LUX-Lung 3, 6, and 7
    Konferenz Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, New Directions in Personalised Cancer Therapy; 1–3 August 2018; Adelaide, Australia,
    In: Asia-Pacific Journal of Clinical Oncology Jg. 14 (2018) Nr. Supplement 3, S. 69
  • Bogner, Simon; Schmid, Kurt Werner; Metzenmacher, Martin; Hager, Thomas; Herrmann, Ken; Walter, Robert; Hegedues, Balazs; Herold, Thomas; Eberhardt, Wilfried; Reis, Henning; Goetz, Moritz; Mairinger, Fabian Dominik; Wiesweg, Marcel; Darwiche, Kaid; Aigner, Clemens; Schuler, Martin
    Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 15 Suppl., S. e15121
  • Cao, J.; Wiesweg, Marcel; Fuchs, M.; Stein, A.; Karthaus, M.; Lettmaier, S.; Kretzschmar, A.; Draube, A.; Ettrich, T.; Rüssel, J.; Müller, C.; Rafiyan, M.-R.; Borchert, K.; Schuler, Martin; Kasper, Stefan;
    Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 289
  • Slaski, C.; Kasper, Stefan; Paul, Andreas; Gerken, G.; Schmid, Kurt Werner; Meiler, Johannes; Teckelnborg, K.; Dechene, Alexander; Schumacher, B.; Markus, P.; Schuler, Martin; Virchow, I.;
    Evaluation of prognostic markers in patients (pts) with advanced gastric cancer (GC) and adenocarcinoma of the gastroesophageal junction (AEG) treated with systemic chemothearpy (ctx) at the West German Cancer Center
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 67
  • Exner, J.-P.; Nadjm, S.; Gauler, Thomas; Pöttgen, Christoph; Krebs, B.; Cheufou, D.; Darwiche, Kaid; Metzenmacher, M.; Theegarten, Dirk; Umutlu, Lale; Hoffmann, Andreas-Claudius; Oezkan, F.; Aigner, Clemens; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried;
    Long-term Survival (LT-S) and Survivorship Program (SS-P) of Lung Cancer (LC) Patients (Pts) - B : Implications for Follow-up (F-up) and Surveillance (SV)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 109 - 110
  • Nadjm, S.; Exner, J. P.; Gauler, Thomas; Pöttgen, Christoph; Darwiche, Kaid; Cheufou, D.; Krebs, B.; Metzenmacher, M.; Oezkan, F.; Rebmann, Vera; Umutlu, Lale; Deuschl, C.; Li, Y.; Lahner, Harald; Christoph, Daniel; Hoiczyk, M.; Witzke, Oliver; Hoffmann, Andreas-Claudius; Aigner, Clemens; Theegarten, Dirk; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried;
    Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 108
  • Waberer, Lisa; Homann, Nils; Wirtz, Ralph M.; Schmalenberg, Harald; Haag, Georg Martin; Schuler, Martin; Kasper, Stefan; Goetze, Thorsten Oliver; Pauligk, Claudia; Hofheinz, Ralf; Al-Batran, Salah-Eddin
    PD-L1 mRNA expression in patients with resectable gastric cancer and adenocarcinoma of the oesophago-gastric junction undergoing perioperative chemotherapy : Results from the FLOT4 phase III trial of the AIO
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. e24277 - e24277
  • Reis, Henning; Niedworok, Christian; Wiesweg, Marcel; Schuler, Martin; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; Szarvas, Tibor;
    Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
    Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,
    In: Modern Pathology Jg. 31 (2018) Nr. Suppl. 2, S. 378
  • Fasching, Peter A.; Nusch, Arnd; Heinrich, Bernhard; Brucker, Sara; Decker, Thomas; Kurbacher, Christian M.; Tesch, Hans; Krabisch, Petra; Mundhenke, Christoph; Fehm, Tanja N.; Janni, Wolfgang; Lueftner, Diana; Schneeweiss, Andreas; Schuler, Martin; Guderian, Gernot; Voges, Claudia; Schubert, Joerg; Kummel, Sherko
    RIBECCA: A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole : Results of the first interim analysis
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 1051
  • Joerger, Markus; Cassier, Philippe Alexandre; Penel, Nicolas; Cathomas, Richard; Richly, Heike; Schostak, Martin; Janitzky, Andreas; Wermke, Martin; Nogova, Lucia; Tai, David Wai-Meng; Sayehli, Cyrus; Grüllich, Carsten; Grande, Enrique; Navarro, Alejandro; Park, Se Hoon; Nogai, Hendrik; Bender, Sebastian; Ellinghaus, Peter; Schuler, Martin
    Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 4513 - 4513
  • Schuler, Martin; Cassier, P.; Penel, N.; Cathomas, R.; Richly, Heike; Schostak, M.; Janitzky, A.; Wermke, M.; Nogova, L.; Tai, D.; Sayehli, C.; Grüllich, C.; Grande, E.; Navarro, A.; Park, S. H.; Nogai, H.; Bender, S.; Ellinghaus, P.; Joerger, M.;
    Rogaratinib in patients with advanced urothelial carcinomas selected for tumor FGFR mRNA expression and impact of mutations in the FGFR signaling pathway
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; Wien, 28. September - 2. Oktober 2018,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 321
  • Sayehli, Cyrus; Nogova, Lucia; Nogai, Hendrik; Park, Se Hoon; Richly, Heike; Cathomas, Richard; Wermke, Martin; Bender, Sebastian; Navarro, Alejandra; Schostak, Martin; Grande, Enrique; Cassier, Philippe; Janitzky, Andreas; Penel, Nicolas; Ellinghaus, Peter; Tai, David Wai-Meng; Gillessen, Silke; Grüllich, Carsten; Joerger, Markus; Schuler, Martin
    Rogaratinib treatment of patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression.
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 6 Suppl., S. 494
  • Wiesweg, Marcel; Reis, Henning; Köster, T.; Goetz, M.; Worm, K.; Herold, T.; Paul, Andreas; Dechene, Alexander; Schumacher, B.; Markus, P.; Virchow, I.; Kostbade, K.; Wolf, N.; Zaun, G.; Metzenmacher, M.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan;
    Signaling network activation in colorectal cancer : p70S6K phosphorylation as a prognostic marker
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 55
  • Stein, G.; Stelmach, Patrick; Kasper, Stefan; Paul, Andreas; Wedemeyer, Heiner H.; Schmid, Kurt Werner; Schumacher, B.; Markus, P.; Siffert, Winfried; Schuler, Martin; Bachmann, Hagen Sjard; Virchow, I.;
    The prognostic impact of UDP-glucuronyltransferase 1A1*1 (UGT1A1*1) polymorphism in patients with advanced colorectal and non-colorectal cancer treated with irinotecan-based systemic chemotherapies
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 122 - 123
  • Schuler, Martin; Nogova, L.; Heidenreich, A.; Tai, D.; Cassier, P.; Richly, Heike; Cho, B. C.; Sayehli, C. M.; Navarro, A.; Bender, Stefan; Ocker, M.; Nogai, H.; Wagner, A.; Ince, S.; Ellinghaus, P.; Joerger, M.
    Anti-tumor activity of the pan-FGFR inhibitor rogaratinib in patients with advanced urothelial carcinomas selected based on tumor FGFR mRNA expression levels
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
  • Sahin, U.; Schuler, Martin; Bauer, Sebastian; Krilova, A.; Utsch, M.; Huber, C.; Tureci, O.
    First-in-human study of IMAB362, an anti-claudin 18.2 monoclonal antibody, in patients with advanced gastroesophageal cancer
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
  • Schuler, Martin
    Liquid Biopsies for Dynamic Monitoring of EGFR Mutations in Lung Cancer
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 1, Suppl., S. 85
  • Hamacher, R.; Kampfe, D.; Ahrens, M.; Reuter-Jessen, K.; Schuler, Martin; Schildhaus, H. U.; Bauer, Sebastian
    PD-L1 inhibition - a new therapeutic opportunity in cutaneous angiosarcoma?
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
  • Lückerath, M.; Kasper, Stefan; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Meiler, Johannes; Wiesweg, M.; Neuhaus, I.; Dechene, Alexander; Mende, B.; Schumacher, B.; Markus, P.; Schuler, Martin; Virchow, I.;
    Evaluation of prognostic markers in patients (pts) with metastatic colorectal cancer (mCRC) treated with a bevacizumab (bev) based chemotherapy (ctx) at the West German Cancer Center
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 77
  • Pogorzelski, M.; Hilser, T.; Ting, Saskia; Vossebein, I.; Gauler, Thomas; Abendroth, A.; Lang, Stephan; Stuck, Boris; Abu-Jawad, J.; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Evaluation of systemic inflammatory response (SIR) markers in recurrent or metastatic head and neck squamous cell carcinoma (r/m HNSCC)
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 307 - 308
  • Abendroth, A.; Markus, M.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan;
    Evaluation of systemic inflammatory response (SIR) markers in advanced biliary tract cancer (ABTC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 5 - 6
  • Markus, M.; Kasper, Stefan; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Abendroth, A.
    Evaluation of systemic inflammatory response (SIR) markers in pancreatic ductal adenocarcinoma (PDAC)
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. S 5, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz, S. 4 - 5
  • Thomas, M.; Schuler, Martin; Potzner, M.; Szczudlo, T.; Sutradhar, S.; Yovine, A.; Wolf, J.;
    Experience from the ASCEND-1 trial : Ceritinib in patients (Pts) with ALK-rearranged (ALK plus ) Non-Small Cell Lung Cancer (NSCLC) and brain metastases
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 270
  • Pöttgen, Christoph; Stuschke, Martin; Gauler, Thomas; Welter, Stefan; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried;
    Hirnmetastasen bei Patienten mit lokal fortgeschrittenem NSCLC nach multimodaler kurativer Therapie in einem randomisierten Protokoll : prognostische Faktoren
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 191 (2015) Nr. Suppl. 1, S. 36 - 37
  • Falkenhorst, J.; Treckmann, Jürgen-Walter; Nguyen, B. P.; Podleska, Lars; Reis, A. C.; Virchow, I.; Schuler, Martin; Bauer, Sebastian;
    Longitudinal analysis of the impact of the introduction of tyrosine kinase inhibitor therapy on overall survival of patients with gastrointestinal stromal tumors treated at the West German Cancer Center
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 167 - 167
  • Abendroth, A.; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Dechene, Alexander; Schumacher, B.; Kaiser, Gernot Maximil; Schuler, Martin; Kasper, Stefan;
    Prognostische Faktoren bei Patienten mit fortgeschrittenen Pankreaskarzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben
    121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,
    In: Der Internist Jg. 56 (2015) Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 38 - 39
  • Abendroth, A.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Baba, Hideo Andreas; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Bockisch, Andreas; Dechene, Alexander; Forsting, Michael; Schuler, Martin; Kasper, Stefan;
    Prognostische Faktoren bei Patienten mit fortgeschrittenen cholangiozellulären Karzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben
    121. Kongress der Deutschen Gesellschaft für Innere Medizin ; DGIM 2015 ; 18. - 21. April 2015, Mannheim, Germany,
    In: Der Internist Jg. 56 (2015) Nr. Supplement 1: Abstracts zum 121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., S. 37
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;
    Rekursive Partitions-Analyse prognostischer Faktoren für das Langzeit-Überleben nach trimodaler Therapie von Patienten mit lokal fortgeschrittenem NSCLC
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 191 (2015) Nr. Suppl. 1, S. 23
  • Virchow, I.; Podleska, Lars; Pöttgen, Christoph; Reis, A. C.; Steinau, H. U.; Täger, Georg; Farzaliyev, F.; Schuler, Martin; Bauer, Sebastian;
    Solitary fibrous tumors/haemangiopericytoma : Analysis of prognostic factors of 28 patients from a high volume sarcoma center
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 246
  • Mertins, S.; Virchow, I.; Farzaliyev, F.; Geismar, Dirk; Podleska, Lars; Pöttgen, Christoph; Reis, A. C.; Steinau, H. U.; Stuschke, Martin; Täger, Georg; Treckmann, Jürgen-Walter; Schuler, Martin; Bauer, Sebastian;
    TNM-classification for clear cell sarcomas - is it useful?
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 247 - 248
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hohler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Ting, Saskia; Markus, P.; Paul, Andreas; Dechene, Alexander; Kostbade, K.; Schuler, Martin; Trarbach, Tanja;
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) - Primary endpoint analysis of the CEBIFOX trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 99 - 100
  • Köhler, Johannes; Schuler, Martin; Gauler, Thomas; Nopel-Dunnebacke, S.; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, M.; Breitenbücher, Frank; Cheufou, D.; Ozkan, F.; Darwiche, Kaid; Hoiczyk, M.; Welter, Stefan; Eberhardt, Wilfried; Teschler, Helmut; Stamatis, Georgios; Hahn, S. A.; Baraniskin, A.;
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 226 - 227
  • Gauler, Thomas; Nel, I.; Bublitz, K.; Lazaridis, L.; Schuler, Martin; Hoffmann, Andreas-Claudius;
    Circulating tumor cell composition and molecular markers in metastasized renal cell carcinoma (mRCC)
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 131
  • Jehn, U.; Nel, I.; Schuler, Martin; Gauler, Thomas; Hoffmann, Andreas-Claudius;
    Circulating tumor cell subgroups and outcome in patients with non-small-cell-lung-cancer receiving platinum based treatment
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 89
  • Thomas, M.; Wolf, J.; Schuler, Martin; Goldwasser, M.; Boral, A.; Shaw, A. T.;
    Clinical activity of the ALK inhibitor LDK378 in advanced, ALK-positive NSCLC
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 89 - 90
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Veit, S.; Heinrich, V.; Welter, Stefan; Spengler, W.; Schmidberger, H.; Lutke-Brintrup, D.; Lehmann, Nils; Jöckel, Karl-Heinz; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried;
    Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C) : Results From a Multicenter Phase III Study
    56th Annual Meeting of the American Society for Radiation Oncology ; 14-17 September 2014, San Francisco, CA, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 1, Supplement, S. S146 - S147
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Veit, S.; Heinrich, V.; Gkika, E.; Hepp, R.; Welter, Stefan; Spengler, W.; Schmidberger, H.; Lutke-Brintrup, D.; Lehmann, Nils; Jöckel, Karl-Heinz; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried;
    Definitive accelerated-hyperfractionated (AHF) Chemoradiotherapy (CRT) vs. neoadjuvant AHF-CRT and Surgery (S) for Patients with operable NSCLC in Stage IIIA(N2)/IIIB after Induction Chemotherapy (IND-C) : Results of a randomized Multicentre Study
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 190 (2014) Nr. Suppl. 1, S. 5 - 6
  • Kim, D.; Mehra, R.; Tan, DSW; Felip, E.; Chow, LQM; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; Solomon, B. J.; Wolf, J.; Thomas, M.; Schuler, Martin; Liu, G.; Santoro, A.; Geraldes, M.; Boral, A. L.; Yovine, A.; Shaw, A. T.;
    Efficacy and Safety of Ceritinib in Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK plus ) Non-Small Cell Lung Cancer (NSCLC) : An Update of ASCEND-1: Metastatic Non-Small Cell Lung Cancer
    2014 Chicago Multidisciplinary Symposium in Thoracic Oncology ; 30 October-1 November 2014, Chicago, Illinois, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 5, Supplement, S. S33 - S34
  • Wu, Y.; Geater, S. L.; Mok, T.; OByrne, K. J.; Schuler, Martin; Sequist, L. V.; Yang, J. C.; Massey, D.; OBrien, D.; Zazulina, V.;
    Epidermal Growth Factor Receptor (EGFR)-Mediated Adverse Events (AEs) in Patients (pts) With EGFR-Mutation Positive (EGFR M+) Non-Small Cell Lung Cancer (NSCLC) Treated With Afatinib (A) : Metastatic Non-Small Cell Lung Cancer
    2014 Chicago Multidisciplinary Symposium in Thoracic Oncology ; 30 October-1 November 2014, Chicago, Illinois, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 5, Supplement, S. S41
  • Gauler, Thomas; Pogorzelski, M.; Ting, Saskia; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Lang, Stephan; Bergmann, Christoph; Abu Jawad, Jehad; Markowetz, J.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan;
    Impact of human papilloma virus infection on the response of head and neck cancers (HNSCC) to anti-epidermal growth factor receptor (EGFR) antibody therapy
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 76
  • Kasper, Stefan; Ting, Saskia; Meiler, Johannes; Knipp, Heike; Hohler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Worm, K.; Schmid, Kurt Werner; Markus, P.; Paul, Andreas; Dechene, Alexander; Forsting, Michael; Kostbade, K.; Trarbach, Tanja; Schuler, Martin;
    Molecular and clinical predictors of the efficacy of cetuximab in combination with mFOLFOX6 in 1st line treatment of patients (pts) with metastatic colorectal cancer (mCRC) – subgroup analyses of the CEBIFOX trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 100 - 101
  • Kasper, Stefan; Abendroth, A.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Schuler, Martin;
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ)
    Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 51
  • Sequist, L.; Wu, Y.; Schuler, Martin; OByrne, K.; Sebastian, M.; Popat, S.; Boyer, M.; Mok, T.; Yamamoto, N.; Hirsh, V.; Geater, S. L.; Zhou, C.; Massey, D.; Zazulina, V.; Jones, H.; Yang, J.;
    Overall Survival (OS) With Afatinib Versus Chemotherapy in Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring Common (Del19/L858R) Epidermal Growth Factor Receptor Mutations (EGFR Mut) : Results of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6): Metastatic Non-Small Cell Lung Cancer
    2014 Chicago Multidisciplinary Symposium in Thoracic Oncology ; 30 October-1 November 2014, Chicago, Illinois, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 5, Supplement, S. S5 - S6
  • Welt, Anja; Kasper, Stefan; Tewes, Mitra; Aktas, B.; Hoffmann, Oliver; Wiesweg, M.; Ting, Saskia; Reis, Henning; Worm, K.; Richly, Heike; Hense, Jörg; Palmer, M. R.; Lee, B. H.; Wendling, J.; Kossow, J.; Scheulen, Max Ernst; Lehnerdt, C.; Kohl, M.; Derks, C.; Slottky, S.; Haus, U.; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19
  • Abendroth, A.; Abramczyk, M.; Nourredine, R.; Paul, A.; Gerken, Guido; Schmid, Kurt Werner; Baba, Hideo Andreas; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Bockisch, Andreas; Forsting, Michael; Schuler, Martin; Kasper, Stefan;
    Prognostic factors in patients (pts) with advanced cholangiocellular carcinoma (CCC) receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 122 - 123
  • Abendroth, A.; Nourredine, R.; Abramczyk, M.; Paul, A.; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Schuler, Martin; Kasper, Stefan;
    Prognostic factors in patients with pancreatic cancer receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ), one of the 12 Oncology Centers of Excellence in Germany
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 123 - 124
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Kleinhans, J.; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;
    Prognostisches Modell für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 190 (2014) Nr. Suppl 1, S. 17
  • Schuler, Martin; Sequist, L. V.; Yang, J. C.; Yamamoto, N.; OByrne, K. J.; Mok, T.; Geater, S. L.; Massey, D.; Wind, S.; OBrien, D.; Lorence, R.; Wu, Y. L.;
    Safety profile of afatinib in first-line therapy of patients with metastatic EGFR mutation-positive (M plus ) non-small cell lung cancer (NSCLC) : Comparative analysis of Asian and non-Asian patients from two randomized trials
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 90
  • Richly, Heike; Scheulen, Max Ernst; Wiesweg, Marcel; Abendroth, A.; Schuler, Martin; Bauer, Sebastian;
    Systemic treatment of metastatic uveal melanoma - a silver lining on the horizon?
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 118 - 119
  • Nogova, Lucia; Gardizi, Masyar; Bos, Marc Christiaan Allardt; Scheffler, Matthias; Mattonet, Christian; Heukamp, Lukas Carl; Schildhaus, Hans-Ulrich; Fuhr, Uwe; Eberhardt, Wilfried; Reis, Henning; Wiesweg, Marcel; Schmid, Kurt Werner; Schoch, Gernot; Ko, Yon-Dschun; Serke, Monika Heidi; Schuler, Martin H.; Büttner, Reinhard; Wolf, Jürgen
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, Suppl., S. 8109
  • Nogova, L.; Gardizi, M.; Bos, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L.; Schildhaus, H. U.; Fuhr, U.; Sos, M.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R.; Buttner, R.; Wolf, J.;
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 92
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;
    Vergleich von pCR und mediastinalem Downstaging als Surrogat- Marker für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion (Trimodalität)
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 190 (2014) Nr. Suppl. 1, S. 17
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, K.; Kasper, Stefan; Bauer, Sebastian; Gauler, Thomas; Welt, Anja; Richly, Heike; Tewes, Mitra; Meiler, Johannes; Hense, Jörg; Eberhardt, Wilfried; Derks, Christian; Cortes-Incio, D.; Skottky, S.; Wohlschläger, Jeremias; Breitenbucher, F.; Freitag, Lutz; Stamatis, Georgios; Schmid, Kurt Werner; Schuler, Martin;
    WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3
  • Yang, J. C.; Sequist, L. V.; Geater, S. L.; Tsai, C. M.; Mok, TSK; Schuler, Martin; Yamamoto, N.; Massey, D.; Zazulina, V.; Wu, Y. L.;
    Activity of afatinib in uncommon epidermal growth factor receptor (EGFR) mutations : findings from three trials of afatinib in EGFR mutation-positive lung cancer
    15th World Conference on Lung Cancer, October 27 - 30 2013, Sydney, Australia,
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. 141
  • Hoiczyk, M.; Herbrik, M.; Grabellus, Florian; Podleska, Lars; Pöttgen, Christoph; Schuler, Martin; Bauer, Sebastian;
    Brain metastases in soft tissue sarcoma patients - incidence, prognosis and outcome
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 181
  • Sequist, L. V.; Yang, J. C.; Yamamoto, N.; OByrne, K.; Schuler, Martin; Mok, T.; Geater, S. L.; Massey, D.; Wind, S.; OBrien, D.; Lorence, R.; Wu, Y. L.;
    Comparative safety profile of afatinib in asian and non-asian patients with EGFR mutation-positive (EGFR M plus) non-small cell lung cancer (NSCLO)
    15th World Conference on Lung Cancer, October 27 - 30 2013, Sydney, Australia,
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. 1197
  • Schuler, Martin; Yang, J. C.; Sequist, L. V.; Hirsh, V.; OByrne, K.; Yamamoto, N.; Massey, D.; Shahidi, M.; Zazulina, V.; Mok, T.;
    Effiacy of afatinib vs. chemotherapy in treatment-naive patients with non-small cell lung cancer (NSCLC) harbouring activating EGFR mutations with or without metastatic brain disease
    15th World Conference on Lung Cancer, October 27 - 30 2013, Sydney, Australia,
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S299 - S300
  • Kasper, Stefan; Breitenbücher, Frank; Markowetz, J.; Reis, Henning; Ting, Saskia; Worm, K.; Meiler, Johannes; Schmid, Kurt Werner; Trarbach, Tanja; Schuler, Martin;
    Molecular dissection of effector mechanisms of RAS-induced resistance to monoclonal anti-EGFR antibodies
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 116 - 117
  • Abendroth, A.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Tometten, M.; Wiesweg, Marcel; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan;
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ), one of the 11 Oncology Centers of Excellence in Germany
    17 Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 263
  • Tewes, Mitra; Kasper, Stefan; Aktas, B.; Hoffmann, A.; Wiesweg, M.; Ting, Saskia; Reis, Henning; Worm, K.; Richly, Heike; Hense, Jörg; Kern, P.; Scheulen, Max Ernst; Skottky, S.; Peters, M.; Schlegel, R.; Lee, B. H.; Palmer, M. R.; Monahan, J. E.; Haus, U.; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin; Welt, Anja;
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Oncology Research and Treatment Jg. 36 (2013) Nr. Suppl. 7, S. 157
  • Nel, I.; Gauler, Thomas; Nickel, A.; Eberhardt, Wilfried; Thomale, Jürgen; Schuler, Martin; Hoffmann, A.;
    Prä-therapeutische ex-vivo Reparatur Kinetiken von Cisplatin-DNA-Addukten in Zirkulierenden Tumorzellen als Platin-Resistenz Test
    119. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., 06. - 09. April 2013, Wiesbaden,
    In: Der Internist Jg. 54 (2013) Nr. Suppl. 1, S. 95 - 96
  • Nogova, L.; Gardizi, M.; Bos, MCA; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H. U.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R. K.; Buttner, R.; Wolf, J.
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 30
  • Mühlenberg, Thomas; Grunewald, S.; Schuler, Martin; Bauer, Sebastian;
    Targeting glucose metabolism by 2-Deoxyglucose in Gastrointestinal Stromal Tumors
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 246
  • Nogova, L.; Bos, M.; Gardizi, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Buttner, R.; Wolf, J.
    Try : a phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S914 - S915
  • Wolf, Jürgen; LoRusso, Patricia M.; Camidge, Ross D.; Perez, Jose Manuel; Tabernero, Josep; Hidalgo, Manuel; Schuler, Martin; Tian, Gary G.; Soria, Jean Charles; Delord, Jean Pierre; Campone, Mario; Bachelot, Thomas; van der Noll, Ruud; Ringeisen, Francois P.; Nogova, Lucia; Sequist, Lecia V.; Schellens, Jan H. M.
    A phase I dose escalation study of NVP-BGJ398, a selective pan FGFR inhibitor in genetically preselected advanced solid tumors
    In: Cancer Research Jg. 72 (2012) Nr. 8, Suppl., S. LB - 122
  • Christoph, Daniel C.; Asuncion, Bernadette Reyna; Wynes, Murry; Gauler, Thomas C.; Wohlschläger, Jeremias; Theegarten, Dirk; Welter, Stefan; Tran, Cindy; Hassan, Biftu; Loewendick, Heike; Peglow, Anja; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Folylpoly-α-glutamate synthetase and thymidylate synthase are associated with clinical outcome from pemetrexed-based therapy in advanced non-small cell lung cancer (NSCLC)
    In: Cancer Research Jg. 72 (2012) Nr. 8, Suppl., S. 1713
  • Simon, Susanne; Fererra, Loretta; Galietta, Luis; Grabellus, Florian; Breitenbücher, Frank; Schuler, Martin; Fletcher, Jonathan; Bauer, Sebastian
    Functional characterization of DOG1 in Gastrointestinal Stromal Tumors (GIST)
    In: Cancer Research Jg. 72 (2012) Nr. 8, Suppl., S. 1824
  • Falkenhorst, Johanna; Mühlenberg, Thomas; Simon, Susanne; Ecken, Sonja; Henze, Jörn; Grabellus, Florian; Breitenbücher, Frank; Schuler, Martin; Fletcher, Jonathan A.; Bauer, Sebastian
    Inhibitors of apoptosis (IAPs) in gastrointestinal stromal tumors
    In: Cancer Research Jg. 72 (2012) Nr. 8, Suppl., S. 3855 - 3855
  • Schuler, Martin; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O’Byrne, Ken; Hirsh, Vera; Mok, Tony; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Sequist, Lecia
    LUX-lung 3 : A randomized, open-label, phase III study of afatinib vs pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR-activating mutations
    In: Lung Cancer Jg. 77 (2012) Nr. Suppl. 1, S. S25 - S26
  • Markova, B.; Hahnel, P. S.; Herbertz, S.; Schuler, Martin; Breitenbücher, Frank
    Influence of Everolimus and Pemetrexed on Thymidylate Synthase expression as well as on Proliferation and survival of non-small cell ling Cancer Cells
    In: Journal of Thoracic Oncology Jg. 5 (2010) Nr. Suppl. 1, S. S56 - S57
  • Hilger, Ralf A.; Köhler, Johannes; Kalkavan, H.; Richly, Heike; Hoffmann, Andreas-Claudius; Heinrichs, D.; Azaouagh, A.; Schuler, Martin; Trarbach, Tanja;
    Interpatient pharmacokinetic variability of 5-FU within metastatic and adjuvant colon cancer patients : First results from the West German Cancer Center
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 173
  • Nguyen, B. P.; Grabellus, Florian; Hoiczyk, M.; Täger, Georg; Schuler, Martin; Bauer, Sebastian;
    Metastasectomy in patients with GIST in the era of imatinib - improved survival?
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 108
  • Even, A.; Kasper, Stefan; Breitenbucher, F.; Pogorzelski, M.; Hoffarth, S.; Trarbach, Tanja; Schuler, Martin;
    Targeting NF-kappa B and PLK-1 to overcome RAS-mediated resistance to anti-EGFR antibody therapy in colorectal cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 33
  • Beiträge in Sammelwerken und Tagungsbänden

  • Taube, Christian; Schuler, Martin
    Apoptosis in the Physiology and Diseases of the Respiratory Tract
    In: Apoptosis: Physiology and Pathology / Reed, John; Green, Douglas R. 2011, S. 221 - 230
  • Poster / Posterbeiträge

  • Ölschläger, Katrin; Grabellus, Florian; Schnell, Rainer; Geffken, Mareike; Hoiczyk, Mathias; Ahrens, Marit; Podleska, Lars; Täger, Georg; Treckmann, Jürgen-Walter; Pöttgen, Christoph; Schuler, Martin; Bauer, Sebastian;
    Chemotherapie bei resektablen Weichteilsarkomen mit komplexem Karyotyp : eine Single-Center Analyse
    The annual meeting of the German, Austrian and Swiss Society of Haematology and Oncology, 19.-23.10.2013, Stuttgart,
    Stuttgart (2013)